From 97f052aba06f25fbcc8dfe529c7f7b7dcd76dbb1 Mon Sep 17 00:00:00 2001 From: Maria Marin Date: Sat, 30 Mar 2024 17:34:08 +0000 Subject: [PATCH] Upload New File --- analysis/files/drug_categories.csv | 6813 ++++++++++++++++++++++++++++ 1 file changed, 6813 insertions(+) create mode 100644 analysis/files/drug_categories.csv diff --git a/analysis/files/drug_categories.csv b/analysis/files/drug_categories.csv new file mode 100644 index 0000000..68c4198 --- /dev/null +++ b/analysis/files/drug_categories.csv @@ -0,0 +1,6813 @@ +drug_id,class_id,class_name,type +CHEMBL1000,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1000,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL100116,D000701,"Analgesics, Opioid",MESHPA +CHEMBL100116,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL100116,D009292,"Narcotic Antagonists",MESHPA +CHEMBL100116,D009294,Narcotics,MESHPA +CHEMBL1004,D000932,Antiemetics,MESHPA +CHEMBL1004,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1005,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1006,D011837,"Radiation-Protective Agents",MESHPA +CHEMBL1008,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1008,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1008,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1008,D014665,"Vasodilator Agents",MESHPA +CHEMBL1009,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1009,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1009,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1009,D015259,"Dopamine Agents",MESHPA +CHEMBL1009,D018491,"Dopamine Agonists",MESHPA +CHEMBL101,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1013,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1014,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1014,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1017,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1017,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1017,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1018,D004968,"Estrogens, Non-Steroidal",MESHPA +CHEMBL1020,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1020,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL1021,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1023,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1024,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1025,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1025,D011480,"Protease Inhibitors",MESHPA +CHEMBL1027,D000927,Anticonvulsants,MESHPA +CHEMBL1027,D058805,"GABA Uptake Inhibitors",MESHPA +CHEMBL1029,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1029,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1029,D065089,"Glycoside Hydrolase Inhibitors",MESHPA +CHEMBL103,D011372,Progestins,MESHPA +CHEMBL1037,D000959,"Antihypertensive Agents",MESHPA +CHEMBL104,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL104,D000935,"Antifungal Agents",MESHPA +CHEMBL104,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL1040,D014815,Vitamins,MESHPA +CHEMBL1040,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1042,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL1042,D014815,Vitamins,MESHPA +CHEMBL1042,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1043,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1043,D000962,Antimalarials,MESHPA +CHEMBL1043,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL1043,D007917,"Leprostatic Agents",MESHPA +CHEMBL1046,D000933,"Antifibrinolytic Agents",MESHPA +CHEMBL105,D000477,"Alkylating Agents",MESHPA +CHEMBL105,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL105,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL1051,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1054,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1054,D004232,Diuretics,MESHPA +CHEMBL1054,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1055,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1055,D004232,Diuretics,MESHPA +CHEMBL1055,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1059,D000700,Analgesics,MESHPA +CHEMBL1059,D000927,Anticonvulsants,MESHPA +CHEMBL1059,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1059,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL106,D000935,"Antifungal Agents",MESHPA +CHEMBL106,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL106,D065688,"Cytochrome P-450 CYP2C9 Inhibitors",MESHPA +CHEMBL106,D065689,"Cytochrome P-450 CYP2C19 Inhibitors",MESHPA +CHEMBL1064,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1064,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL1064,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1068,D000927,Anticonvulsants,MESHPA +CHEMBL1068,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1068,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL1069,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1069,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1069,D057911,"Angiotensin Receptor Antagonists",MESHPA +CHEMBL107,D006074,"Gout Suppressants",MESHPA +CHEMBL107,D050257,"Tubulin Modulators",MESHPA +CHEMBL1070,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1070,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL1071,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1071,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL1072,D004232,Diuretics,MESHPA +CHEMBL1072,D049994,"Sodium Potassium Chloride Symporter Inhibitors",MESHPA +CHEMBL1073,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1075,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1075,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1076347,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1077,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1077896,D000779,"Anesthetics, Local",MESHPA +CHEMBL1078261,D010276,Parasympatholytics,MESHPA +CHEMBL1078261,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1078261,D064804,"Urological Agents",MESHPA +CHEMBL1079,D000700,Analgesics,MESHPA +CHEMBL1079,D000927,Anticonvulsants,MESHPA +CHEMBL1079,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1079,D010276,Parasympatholytics,MESHPA +CHEMBL1079,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL1079604,D009465,"Neuromuscular Agents",MESHPA +CHEMBL108,D000927,Anticonvulsants,MESHPA +CHEMBL108,D018692,"Antimanic Agents",MESHPA +CHEMBL108,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL108,D026941,"Sodium Channel Blockers",MESHPA +CHEMBL108,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL1082,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1082,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL1083659,D000068776,"Sleep Aids, Pharmaceutical",MESHPA +CHEMBL1083659,D000068796,"Orexin Receptor Antagonists",MESHPA +CHEMBL108545,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1086,D000779,"Anesthetics, Local",MESHPA +CHEMBL1086440,D000980,"Antiplatyhelmintic Agents",MESHPA +CHEMBL1087,D000779,"Anesthetics, Local",MESHPA +CHEMBL1088,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1088,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1089,D000928,"Antidepressive Agents",MESHPA +CHEMBL1089,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL1089318,D065098,"Catechol O-Methyltransferase Inhibitors",MESHPA +CHEMBL109,D000927,Anticonvulsants,MESHPA +CHEMBL109,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL109,D018682,"GABA Agents",MESHPA +CHEMBL109,D018692,"Antimanic Agents",MESHPA +CHEMBL1090,D000963,Antimetabolites,MESHPA +CHEMBL1090,D000998,"Antiviral Agents",MESHPA +CHEMBL1091,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1091,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1093,D000779,"Anesthetics, Local",MESHPA +CHEMBL1094,D000927,Anticonvulsants,MESHPA +CHEMBL1094,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL1094636,D000067856,"Poly(ADP-ribose) Polymerase Inhibitors",MESHPA +CHEMBL1094966,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1094966,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1094966,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1095,D000927,Anticonvulsants,MESHPA +CHEMBL1095,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1095097,D000451,"Mineralocorticoid Receptor Antagonists",MESHPA +CHEMBL1095097,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1095607,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL1095607,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1096,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1096562,D017319,"Photosensitizing Agents",MESHPA +CHEMBL1096882,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1096882,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1096882,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1096885,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1096885,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1096979,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1096979,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1096979,D015259,"Dopamine Agents",MESHPA +CHEMBL1098,D000779,"Anesthetics, Local",MESHPA +CHEMBL1098319,D020011,"Protective Agents",MESHPA +CHEMBL11,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL11,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL110,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL110,D014344,"Trypanocidal Agents",MESHPA +CHEMBL1101,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1101,D010276,Parasympatholytics,MESHPA +CHEMBL1101,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1102,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1104,D000931,Antidotes,MESHPA +CHEMBL1104,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1106,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1107,D000962,Antimalarials,MESHPA +CHEMBL1108,D000700,Analgesics,MESHPA +CHEMBL1108,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1108,D000932,Antiemetics,MESHPA +CHEMBL1108,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1108,D019162,"Anesthetics, Combined",MESHPA +CHEMBL1108,D065127,"Dopamine D2 Receptor Antagonists",MESHPA +CHEMBL1110,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1110,D012702,"Serotonin Antagonists",MESHPA +CHEMBL1111,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1112,D000928,"Antidepressive Agents",MESHPA +CHEMBL1112,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1112,D018491,"Dopamine Agonists",MESHPA +CHEMBL1112,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL1112,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL1112,D065127,"Dopamine D2 Receptor Antagonists",MESHPA +CHEMBL1113,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL1113,D014179,"Neurotransmitter Uptake Inhibitors",MESHPA +CHEMBL1113,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL1113,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1113,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL1115,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1117,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL1117,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1118,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL1118,D000928,"Antidepressive Agents",MESHPA +CHEMBL112,D000700,Analgesics,MESHPA +CHEMBL112,D000701,"Analgesics, Opioid",MESHPA +CHEMBL112,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL112,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL112,D058633,Antipyretics,MESHPA +CHEMBL1120,D000930,Antidiarrheals,MESHPA +CHEMBL1123,D010276,Parasympatholytics,MESHPA +CHEMBL1123,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1129,D000963,Antimetabolites,MESHPA +CHEMBL1129,D000998,"Antiviral Agents",MESHPA +CHEMBL113,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL113,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL113,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL113,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL113,D016587,"Antimutagenic Agents",MESHPA +CHEMBL113,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL113,D058915,"Purinergic P1 Receptor Antagonists",MESHPA +CHEMBL1131,D007641,"Keratolytic Agents",MESHPA +CHEMBL1136,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1138,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1139,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1139,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL114,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL114,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL1140,D014803,"Vitamin B Complex",MESHPA +CHEMBL1144,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1144,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1146,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1148,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1148,D004232,Diuretics,MESHPA +CHEMBL1148,D049994,"Sodium Potassium Chloride Symporter Inhibitors",MESHPA +CHEMBL115,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL1152,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1152,D005938,Glucocorticoids,MESHPA +CHEMBL1152,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1159,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1159,D014665,"Vasodilator Agents",MESHPA +CHEMBL1159,D049990,"Membrane Transport Modulators",MESHPA +CHEMBL1159650,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1159650,D005938,Glucocorticoids,MESHPA +CHEMBL1159717,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL1159717,D001993,"Bronchodilator Agents",MESHPA +CHEMBL116,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL116,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL116,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1161,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1161,D003879,"Dermatologic Agents",MESHPA +CHEMBL1161,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1162,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1162,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL1162,D003277,"Contraceptives, Oral, Combined",MESHPA +CHEMBL1162,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1162,D003279,"Contraceptives, Oral, Sequential",MESHPA +CHEMBL1162,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1163,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL1164729,D006074,"Gout Suppressants",MESHPA +CHEMBL1165,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1165,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1165268,D003287,"Contrast Media",MESHPA +CHEMBL1166,D000991,Antithrombins,MESHPA +CHEMBL1166,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1167,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1168,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1168,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1169,D000995,"Antitubercular Agents",MESHPA +CHEMBL1170,D000728,Androgens,MESHPA +CHEMBL1171837,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1171837,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1172,D018680,"Cholinergic Antagonists",MESHPA +CHEMBL1172,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL117287,D054368,Laxatives,MESHPA +CHEMBL117287,D058828,"Serotonin 5-HT4 Receptor Agonists",MESHPA +CHEMBL1173055,D000067856,"Poly(ADP-ribose) Polymerase Inhibitors",MESHPA +CHEMBL1173655,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1173655,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1174,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1175,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL1175,D000700,Analgesics,MESHPA +CHEMBL1175,D000928,"Antidepressive Agents",MESHPA +CHEMBL1175,D015259,"Dopamine Agents",MESHPA +CHEMBL1177,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL117785,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL1179047,D000779,"Anesthetics, Local",MESHPA +CHEMBL118,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL118,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL1180725,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1180725,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1182833,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1183349,D000935,"Antifungal Agents",MESHPA +CHEMBL1183717,D019141,"Respiratory System Agents",MESHPA +CHEMBL1184,D008082,"Lipotropic Agents",MESHPA +CHEMBL1184,D018697,"Nootropic Agents",MESHPA +CHEMBL1185,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL1186579,D009292,"Narcotic Antagonists",MESHPA +CHEMBL1187417,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1187833,D010276,Parasympatholytics,MESHPA +CHEMBL1187833,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL1187833,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1189432,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1189432,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1189432,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL1189679,D000932,Antiemetics,MESHPA +CHEMBL1189679,D058831,"Serotonin 5-HT3 Receptor Antagonists",MESHPA +CHEMBL119,D000935,"Antifungal Agents",MESHPA +CHEMBL119,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL119,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL1191,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1193,D000982,Antipruritics,MESHPA +CHEMBL1193,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1193,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1194,D000779,"Anesthetics, Local",MESHPA +CHEMBL1194,D019162,"Anesthetics, Combined",MESHPA +CHEMBL119443,D010120,Oxytocics,MESHPA +CHEMBL1194666,D001067,"Appetite Depressants",MESHPA +CHEMBL1196,D000779,"Anesthetics, Local",MESHPA +CHEMBL1197051,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL1197051,D013566,Sympathomimetics,MESHPA +CHEMBL1197051,D014665,"Vasodilator Agents",MESHPA +CHEMBL1197051,D015149,"Tocolytic Agents",MESHPA +CHEMBL1198,D000779,"Anesthetics, Local",MESHPA +CHEMBL1199080,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1199080,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1199080,D018674,"Adrenergic Antagonists",MESHPA +CHEMBL1199324,D000932,Antiemetics,MESHPA +CHEMBL1199324,D064729,"Neurokinin-1 Receptor Antagonists",MESHPA +CHEMBL12,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL12,D000927,Anticonvulsants,MESHPA +CHEMBL12,D000932,Antiemetics,MESHPA +CHEMBL12,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL12,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL12,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL12,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL12,D018757,"GABA Modulators",MESHPA +CHEMBL1200,D000779,"Anesthetics, Local",MESHPA +CHEMBL1200335,D000728,Androgens,MESHPA +CHEMBL1200342,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200342,D005938,Glucocorticoids,MESHPA +CHEMBL1200346,D003287,"Contrast Media",MESHPA +CHEMBL1200354,D012597,"Sclerosing Solutions",MESHPA +CHEMBL1200356,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200370,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1200370,D003879,"Dermatologic Agents",MESHPA +CHEMBL1200374,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1200374,D047072,"Aromatase Inhibitors",MESHPA +CHEMBL1200386,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200386,D005938,Glucocorticoids,MESHPA +CHEMBL1200399,D014131,"Trace Elements",MESHPA +CHEMBL1200406,D000932,Antiemetics,MESHPA +CHEMBL1200406,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1200412,D000728,Androgens,MESHPA +CHEMBL1200412,D045930,"Anabolic Agents",MESHPA +CHEMBL1200412,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1200424,D014131,"Trace Elements",MESHPA +CHEMBL1200430,D004967,Estrogens,MESHPA +CHEMBL1200431,D003287,"Contrast Media",MESHPA +CHEMBL1200434,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1200436,D000728,Androgens,MESHPA +CHEMBL1200436,D045930,"Anabolic Agents",MESHPA +CHEMBL1200438,D000935,"Antifungal Agents",MESHPA +CHEMBL1200438,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL1200453,D000998,"Antiviral Agents",MESHPA +CHEMBL1200455,D003287,"Contrast Media",MESHPA +CHEMBL1200457,D003287,"Contrast Media",MESHPA +CHEMBL1200458,D004232,Diuretics,MESHPA +CHEMBL1200458,D005100,Expectorants,MESHPA +CHEMBL1200459,D002327,"Cariostatic Agents",MESHPA +CHEMBL1200468,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1200472,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1200490,D005300,"Fertility Agents, Female",MESHPA +CHEMBL1200490,D006727,"Hormone Antagonists",MESHPA +CHEMBL1200500,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200500,D005938,Glucocorticoids,MESHPA +CHEMBL1200500,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL1200507,D003287,"Contrast Media",MESHPA +CHEMBL1200522,D013473,"Sunscreening Agents",MESHPA +CHEMBL1200527,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1200527,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1200529,D014131,"Trace Elements",MESHPA +CHEMBL1200539,D000863,Antacids,MESHPA +CHEMBL1200542,D008901,Mineralocorticoids,MESHPA +CHEMBL1200545,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200545,D005938,Glucocorticoids,MESHPA +CHEMBL1200555,D003287,"Contrast Media",MESHPA +CHEMBL1200558,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1200558,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200562,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200571,D003287,"Contrast Media",MESHPA +CHEMBL1200572,D000863,Antacids,MESHPA +CHEMBL1200585,D000728,Androgens,MESHPA +CHEMBL1200585,D045930,"Anabolic Agents",MESHPA +CHEMBL1200588,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200588,D003879,"Dermatologic Agents",MESHPA +CHEMBL1200588,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1200593,D003287,"Contrast Media",MESHPA +CHEMBL1200596,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200596,D000935,"Antifungal Agents",MESHPA +CHEMBL1200600,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200600,D005938,Glucocorticoids,MESHPA +CHEMBL1200600,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1200604,D009184,Mydriatics,MESHPA +CHEMBL1200604,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1200614,D003287,"Contrast Media",MESHPA +CHEMBL1200617,D005938,Glucocorticoids,MESHPA +CHEMBL1200623,D045930,"Anabolic Agents",MESHPA +CHEMBL1200624,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1200624,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1200627,D004202,Disinfectants,MESHPA +CHEMBL1200633,D000977,"Antiparasitic Agents",MESHPA +CHEMBL1200640,D014131,"Trace Elements",MESHPA +CHEMBL1200649,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200649,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1200656,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1200656,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200656,D000935,"Antifungal Agents",MESHPA +CHEMBL1200660,D004234,"Diuretics, Osmotic",MESHPA +CHEMBL1200660,D014665,"Vasodilator Agents",MESHPA +CHEMBL1200660,D020030,"Nitric Oxide Donors",MESHPA +CHEMBL1200666,D003879,"Dermatologic Agents",MESHPA +CHEMBL1200680,D000975,Antioxidants,MESHPA +CHEMBL1200680,D003879,"Dermatologic Agents",MESHPA +CHEMBL1200680,D014131,"Trace Elements",MESHPA +CHEMBL1200682,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1200682,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL1200686,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1200686,D003879,"Dermatologic Agents",MESHPA +CHEMBL1200686,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1200686,D065095,"Calcineurin Inhibitors",MESHPA +CHEMBL1200689,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1200689,D016166,"Free Radical Scavengers",MESHPA +CHEMBL1200689,D018377,"Neurotransmitter Agents",MESHPA +CHEMBL1200689,D045462,"Endothelium-Dependent Relaxing Factors",MESHPA +CHEMBL1200689,D064426,Gasotransmitters,MESHPA +CHEMBL1200690,D006490,Hemostatics,MESHPA +CHEMBL1200690,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1200690,D050034,"Antidiuretic Agents",MESHPA +CHEMBL1200692,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1200692,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1200694,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1200694,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1200695,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL1200695,D001067,"Appetite Depressants",MESHPA +CHEMBL1200695,D013566,Sympathomimetics,MESHPA +CHEMBL1200695,D014663,"Nasal Decongestants",MESHPA +CHEMBL1200706,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1200706,D000863,Antacids,MESHPA +CHEMBL1200706,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1200714,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1200714,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL1200718,D000863,Antacids,MESHPA +CHEMBL1200718,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1200721,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1200721,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1200732,D005938,Glucocorticoids,MESHPA +CHEMBL1200733,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1200761,D004968,"Estrogens, Non-Steroidal",MESHPA +CHEMBL1200761,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1200774,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200774,D005938,Glucocorticoids,MESHPA +CHEMBL1200799,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1200800,D002614,"Chelating Agents",MESHPA +CHEMBL1200807,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1200810,D014815,Vitamins,MESHPA +CHEMBL1200810,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1200821,D003287,"Contrast Media",MESHPA +CHEMBL1200823,D006397,Hematinics,MESHPA +CHEMBL1200826,D000928,"Antidepressive Agents",MESHPA +CHEMBL1200826,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1200826,D018692,"Antimanic Agents",MESHPA +CHEMBL1200845,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200848,D004965,"Estrogen Antagonists",MESHPA +CHEMBL1200848,D011372,Progestins,MESHPA +CHEMBL1200851,D010276,Parasympatholytics,MESHPA +CHEMBL1200853,D011372,Progestins,MESHPA +CHEMBL1200862,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1200865,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1200877,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200877,D005938,Glucocorticoids,MESHPA +CHEMBL1200896,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL1200896,D010120,Oxytocics,MESHPA +CHEMBL1200907,D000021,"Abortifacient Agents, Steroidal",MESHPA +CHEMBL1200907,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1200907,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1200909,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200909,D005938,Glucocorticoids,MESHPA +CHEMBL1200909,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1200910,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1200925,D002327,"Cariostatic Agents",MESHPA +CHEMBL1200927,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1200929,D001252,Astringents,MESHPA +CHEMBL1200932,D003287,"Contrast Media",MESHPA +CHEMBL1200934,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1200934,D003277,"Contraceptives, Oral, Combined",MESHPA +CHEMBL1200934,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1200937,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1200937,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1200946,D000728,Androgens,MESHPA +CHEMBL1200946,D045930,"Anabolic Agents",MESHPA +CHEMBL1200946,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1200953,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200963,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1200969,D058891,"5-alpha Reductase Inhibitors",MESHPA +CHEMBL1200973,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1200973,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL1200973,D004967,Estrogens,MESHPA +CHEMBL1200975,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200975,D005938,Glucocorticoids,MESHPA +CHEMBL1200983,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL1200983,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1200989,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1200989,D005938,Glucocorticoids,MESHPA +CHEMBL1200993,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1200993,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1200994,D019275,Radiopharmaceuticals,MESHPA +CHEMBL1201,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1201,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1201010,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201012,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201012,D005938,Glucocorticoids,MESHPA +CHEMBL1201016,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201046,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201073,D000931,Antidotes,MESHPA +CHEMBL1201073,D002614,"Chelating Agents",MESHPA +CHEMBL1201075,D003287,"Contrast Media",MESHPA +CHEMBL1201087,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1201087,D018491,"Dopamine Agonists",MESHPA +CHEMBL1201101,D000728,Androgens,MESHPA +CHEMBL1201101,D045930,"Anabolic Agents",MESHPA +CHEMBL1201109,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201117,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1201129,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1201129,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1201134,D065101,"Chloride Channel Agonists",MESHPA +CHEMBL1201136,D013473,"Sunscreening Agents",MESHPA +CHEMBL1201136,D017319,"Photosensitizing Agents",MESHPA +CHEMBL1201139,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1201139,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1201139,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201139,D019167,"Appetite Stimulants",MESHPA +CHEMBL1201151,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1201151,D004967,Estrogens,MESHPA +CHEMBL1201154,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1201154,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1201165,D004967,Estrogens,MESHPA +CHEMBL1201168,D000928,"Antidepressive Agents",MESHPA +CHEMBL1201168,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL1201173,D005938,Glucocorticoids,MESHPA +CHEMBL1201185,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201186,D000863,Antacids,MESHPA +CHEMBL1201186,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1201186,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1201187,D023581,"HIV Fusion Inhibitors",MESHPA +CHEMBL1201187,D065100,"CCR5 Receptor Antagonists",MESHPA +CHEMBL1201191,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL1201192,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1201192,D064690,"Wakefulness-Promoting Agents",MESHPA +CHEMBL1201192,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL1201193,D000779,"Anesthetics, Local",MESHPA +CHEMBL1201195,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201196,D000935,"Antifungal Agents",MESHPA +CHEMBL1201197,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1201197,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1201198,D006633,"Histamine Antagonists",MESHPA +CHEMBL1201199,D005300,"Fertility Agents, Female",MESHPA +CHEMBL1201199,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201201,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1201201,D013566,Sympathomimetics,MESHPA +CHEMBL1201201,D015259,"Dopamine Agents",MESHPA +CHEMBL1201201,D018663,"Adrenergic Agents",MESHPA +CHEMBL1201201,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL1201201,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL1201202,D065427,"Factor Xa Inhibitors",MESHPA +CHEMBL1201203,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1201203,D010276,Parasympatholytics,MESHPA +CHEMBL1201203,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201203,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL1201206,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1201206,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1201208,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1201208,D001067,"Appetite Depressants",MESHPA +CHEMBL1201208,D013566,Sympathomimetics,MESHPA +CHEMBL1201212,D013566,Sympathomimetics,MESHPA +CHEMBL1201212,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1201212,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL1201213,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1201213,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1201216,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL1201216,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1201217,D000779,"Anesthetics, Local",MESHPA +CHEMBL1201218,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201219,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1201219,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1201220,D003287,"Contrast Media",MESHPA +CHEMBL1201222,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1201222,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL1201225,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1201225,D014131,"Trace Elements",MESHPA +CHEMBL1201229,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1201231,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201231,D005938,Glucocorticoids,MESHPA +CHEMBL1201231,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201234,D013566,Sympathomimetics,MESHPA +CHEMBL1201234,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1201234,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL1201236,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1201236,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1201236,D015259,"Dopamine Agents",MESHPA +CHEMBL1201236,D018491,"Dopamine Agonists",MESHPA +CHEMBL1201236,D065105,"Aromatic Amino Acid Decarboxylase Inhibitors",MESHPA +CHEMBL1201237,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL1201237,D013565,Sympatholytics,MESHPA +CHEMBL1201239,D003287,"Contrast Media",MESHPA +CHEMBL1201244,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1201247,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201248,D009466,"Neuromuscular Blocking Agents",MESHPA +CHEMBL1201251,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL1201251,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1201256,D000932,Antiemetics,MESHPA +CHEMBL1201260,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1201260,D013565,Sympatholytics,MESHPA +CHEMBL1201260,D018663,"Adrenergic Agents",MESHPA +CHEMBL1201262,D000322,"Adrenergic Agonists",MESHPA +CHEMBL1201264,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201266,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1201266,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1201270,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL1201270,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201271,D006633,"Histamine Antagonists",MESHPA +CHEMBL1201281,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201281,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1201284,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL1201284,D057966,"Calcimimetic Agents",MESHPA +CHEMBL1201286,D009184,Mydriatics,MESHPA +CHEMBL1201286,D010276,Parasympatholytics,MESHPA +CHEMBL1201286,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201287,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1201287,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1201288,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1201291,D003287,"Contrast Media",MESHPA +CHEMBL1201293,D000427,"Alcohol Deterrents",MESHPA +CHEMBL1201294,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1201294,D000930,Antidiarrheals,MESHPA +CHEMBL1201295,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1201295,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1201300,D003287,"Contrast Media",MESHPA +CHEMBL1201301,D003287,"Contrast Media",MESHPA +CHEMBL1201303,D000871,Anthelmintics,MESHPA +CHEMBL1201309,D005300,"Fertility Agents, Female",MESHPA +CHEMBL1201314,D000998,"Antiviral Agents",MESHPA +CHEMBL1201319,D013566,Sympathomimetics,MESHPA +CHEMBL1201319,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1201319,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL1201320,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1201320,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL1201329,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1201329,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1201329,D005730,"Ganglionic Blockers",MESHPA +CHEMBL1201329,D014665,"Vasodilator Agents",MESHPA +CHEMBL1201329,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1201334,D008186,"Luteolytic Agents",MESHPA +CHEMBL1201334,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201335,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1201335,D018680,"Cholinergic Antagonists",MESHPA +CHEMBL1201335,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201336,D000927,Anticonvulsants,MESHPA +CHEMBL1201336,D026941,"Sodium Channel Blockers",MESHPA +CHEMBL1201338,D009184,Mydriatics,MESHPA +CHEMBL1201338,D010276,Parasympatholytics,MESHPA +CHEMBL1201338,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201340,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1201340,D010276,Parasympatholytics,MESHPA +CHEMBL1201341,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1201341,D008916,Miotics,MESHPA +CHEMBL1201341,D010277,Parasympathomimetics,MESHPA +CHEMBL1201346,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1201346,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1201349,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL1201352,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1201353,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1201356,D010120,Oxytocics,MESHPA +CHEMBL1201414,D000925,Anticoagulants,MESHPA +CHEMBL1201414,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201438,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201438,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1201439,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201441,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201444,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1201446,D003879,"Dermatologic Agents",MESHPA +CHEMBL1201447,D011663,"Pulmonary Surfactants",MESHPA +CHEMBL1201448,D000925,Anticoagulants,MESHPA +CHEMBL1201448,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201458,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201458,D003287,"Contrast Media",MESHPA +CHEMBL1201460,D000925,Anticoagulants,MESHPA +CHEMBL1201460,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201464,D012102,"Reproductive Control Agents",MESHPA +CHEMBL1201467,D004967,Estrogens,MESHPA +CHEMBL1201472,D015314,"Dialysis Solutions",MESHPA +CHEMBL1201473,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1201474,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL1201474,D064449,"Sequestering Agents",MESHPA +CHEMBL1201476,D000925,Anticoagulants,MESHPA +CHEMBL1201476,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201477,D004967,Estrogens,MESHPA +CHEMBL1201479,D054368,Laxatives,MESHPA +CHEMBL1201481,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201481,D003879,"Dermatologic Agents",MESHPA +CHEMBL1201481,D017319,"Photosensitizing Agents",MESHPA +CHEMBL1201493,D000863,Antacids,MESHPA +CHEMBL1201493,D000934,"Antifoaming Agents",MESHPA +CHEMBL1201493,D004643,Emollients,MESHPA +CHEMBL1201497,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1201502,D003287,"Contrast Media",MESHPA +CHEMBL1201506,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201507,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1201507,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201507,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201509,D012102,"Reproductive Control Agents",MESHPA +CHEMBL1201513,D000925,Anticoagulants,MESHPA +CHEMBL1201513,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201516,D000925,Anticoagulants,MESHPA +CHEMBL1201529,D019275,Radiopharmaceuticals,MESHPA +CHEMBL1201534,D000925,Anticoagulants,MESHPA +CHEMBL1201534,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201538,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1201539,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1201544,D000925,Anticoagulants,MESHPA +CHEMBL1201544,D006397,Hematinics,MESHPA +CHEMBL1201544,D010952,"Plasma Substitutes",MESHPA +CHEMBL1201550,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201554,D000991,Antithrombins,MESHPA +CHEMBL1201554,D006490,Hemostatics,MESHPA +CHEMBL1201556,D000925,Anticoagulants,MESHPA +CHEMBL1201556,D043925,"Angiogenesis Inducing Agents",MESHPA +CHEMBL1201557,D000998,"Antiviral Agents",MESHPA +CHEMBL1201558,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201558,D000998,"Antiviral Agents",MESHPA +CHEMBL1201560,D000998,"Antiviral Agents",MESHPA +CHEMBL1201561,D000998,"Antiviral Agents",MESHPA +CHEMBL1201562,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1201562,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201562,D000998,"Antiviral Agents",MESHPA +CHEMBL1201563,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1201565,D006397,Hematinics,MESHPA +CHEMBL1201566,D006397,Hematinics,MESHPA +CHEMBL1201567,D006401,"Hematologic Agents",MESHPA +CHEMBL1201569,D018726,"Anti-Dyskinesia Agents",MESHPA +CHEMBL1201569,D065087,"Acetylcholine Release Inhibitors",MESHPA +CHEMBL1201570,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201571,D003879,"Dermatologic Agents",MESHPA +CHEMBL1201571,D007155,"Immunologic Factors",MESHPA +CHEMBL1201572,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1201572,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1201572,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201572,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201573,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201576,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201576,D007155,"Immunologic Factors",MESHPA +CHEMBL1201576,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201577,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201580,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201580,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201581,D003879,"Dermatologic Agents",MESHPA +CHEMBL1201581,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1201581,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201583,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201583,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL1201584,D000925,Anticoagulants,MESHPA +CHEMBL1201584,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1201585,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201585,D050257,"Tubulin Modulators",MESHPA +CHEMBL1201586,D000998,"Antiviral Agents",MESHPA +CHEMBL1201587,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201589,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1201589,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL1201591,D006728,Hormones,MESHPA +CHEMBL1201593,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201594,D006074,"Gout Suppressants",MESHPA +CHEMBL1201607,D007155,"Immunologic Factors",MESHPA +CHEMBL1201608,D007155,"Immunologic Factors",MESHPA +CHEMBL1201608,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201610,D006728,Hormones,MESHPA +CHEMBL1201613,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1201619,D006490,Hemostatics,MESHPA +CHEMBL1201619,D014361,"Trypsin Inhibitors",MESHPA +CHEMBL1201619,D015842,"Serine Proteinase Inhibitors",MESHPA +CHEMBL1201622,D011663,"Pulmonary Surfactants",MESHPA +CHEMBL1201624,D011663,"Pulmonary Surfactants",MESHPA +CHEMBL1201625,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1201649,D004967,Estrogens,MESHPA +CHEMBL1201651,D006494,"Heparin Antagonists",MESHPA +CHEMBL1201662,D000925,Anticoagulants,MESHPA +CHEMBL1201662,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201666,D000991,Antithrombins,MESHPA +CHEMBL1201666,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL1201668,D045283,"Natriuretic Agents",MESHPA +CHEMBL1201670,D007155,"Immunologic Factors",MESHPA +CHEMBL1201688,D000998,"Antiviral Agents",MESHPA +CHEMBL1201692,D006728,Hormones,MESHPA +CHEMBL1201716,D006133,"Growth Substances",MESHPA +CHEMBL1201719,D004643,Emollients,MESHPA +CHEMBL1201724,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1201724,D010952,"Plasma Substitutes",MESHPA +CHEMBL1201747,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1201749,D005938,Glucocorticoids,MESHPA +CHEMBL1201753,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1201754,D000927,Anticonvulsants,MESHPA +CHEMBL1201754,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1201758,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1201760,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1201760,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1201764,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1201764,D064804,"Urological Agents",MESHPA +CHEMBL1201766,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1201772,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1201776,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1201776,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL1201794,D014803,"Vitamin B Complex",MESHPA +CHEMBL1201798,D002614,"Chelating Agents",MESHPA +CHEMBL1201823,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201823,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201825,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL1201827,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1201830,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201831,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1201831,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1201835,D003879,"Dermatologic Agents",MESHPA +CHEMBL1201836,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1201837,D000700,Analgesics,MESHPA +CHEMBL1201837,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1201863,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1201863,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL1201864,D003272,"Contraceptive Agents, Male",MESHPA +CHEMBL1201864,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1201864,D006727,"Hormone Antagonists",MESHPA +CHEMBL1201864,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1201866,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1201866,D054795,Incretins,MESHPA +CHEMBL1201867,D006397,Hematinics,MESHPA +CHEMBL1201867,D057947,"Parenteral Nutrition Solutions",MESHPA +CHEMBL1201891,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1201891,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1206,D006633,"Histamine Antagonists",MESHPA +CHEMBL1206,D018674,"Adrenergic Antagonists",MESHPA +CHEMBL1206,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1206690,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL1208,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1208,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL121,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1213252,D000927,Anticonvulsants,MESHPA +CHEMBL1213252,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL1213252,D018757,"GABA Modulators",MESHPA +CHEMBL1213351,D000700,Analgesics,MESHPA +CHEMBL1213351,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1213351,D009294,Narcotics,MESHPA +CHEMBL1214,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL1214,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1214185,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1215,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1215,D009184,Mydriatics,MESHPA +CHEMBL1215,D013566,Sympathomimetics,MESHPA +CHEMBL1215,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1215,D014663,"Nasal Decongestants",MESHPA +CHEMBL1215,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL121626,D000700,Analgesics,MESHPA +CHEMBL121626,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL121626,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL121626,D011448,"Prostaglandin Antagonists",MESHPA +CHEMBL121626,D012702,"Serotonin Antagonists",MESHPA +CHEMBL1219,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1219,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL122,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL1220,D000477,"Alkylating Agents",MESHPA +CHEMBL1220,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1220,D000994,"Antitrichomonal Agents",MESHPA +CHEMBL1221,D000935,"Antifungal Agents",MESHPA +CHEMBL1224,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL1228,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1229,D000998,"Antiviral Agents",MESHPA +CHEMBL1229,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1229211,D019428,"HIV Integrase Inhibitors",MESHPA +CHEMBL1229517,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1229517,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1229846,D000777,Anesthetics,MESHPA +CHEMBL1229846,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL1231,D010276,Parasympatholytics,MESHPA +CHEMBL1231,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1231,D064804,"Urological Agents",MESHPA +CHEMBL1231723,D012597,"Sclerosing Solutions",MESHPA +CHEMBL1232131,D006490,Hemostatics,MESHPA +CHEMBL1233,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1234579,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1234579,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL1237,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1237,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1237,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1237021,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1237021,D058669,"Adrenergic alpha-2 Receptor Antagonists",MESHPA +CHEMBL1237021,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL1237021,D065127,"Dopamine D2 Receptor Antagonists",MESHPA +CHEMBL1237023,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1237026,D006133,"Growth Substances",MESHPA +CHEMBL1237044,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1237044,D009294,Narcotics,MESHPA +CHEMBL1237054,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL1237054,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL1237054,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1237054,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL1237080,D000932,Antiemetics,MESHPA +CHEMBL1237080,D012702,"Serotonin Antagonists",MESHPA +CHEMBL1237105,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL1237105,D010120,Oxytocics,MESHPA +CHEMBL1237119,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1237123,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1237132,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1238,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1238,D003879,"Dermatologic Agents",MESHPA +CHEMBL1241,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1241,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL125,D000935,"Antifungal Agents",MESHPA +CHEMBL125,D000970,"Antineoplastic Agents",MESHPA +CHEMBL125,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL1251,D006727,"Hormone Antagonists",MESHPA +CHEMBL1252,D006727,"Hormone Antagonists",MESHPA +CHEMBL1254682,D009292,"Narcotic Antagonists",MESHPA +CHEMBL1255,D004202,Disinfectants,MESHPA +CHEMBL1255800,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1256,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1256391,D000700,Analgesics,MESHPA +CHEMBL1256391,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1256391,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1256786,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1256786,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1256841,D000928,"Antidepressive Agents",MESHPA +CHEMBL1256841,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL1257,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1257051,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1259,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL1259059,D000998,"Antiviral Agents",MESHPA +CHEMBL126,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL126,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1261,D000925,Anticoagulants,MESHPA +CHEMBL1261,D065096,"Calcium Chelating Agents",MESHPA +CHEMBL12610,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1262,D000935,"Antifungal Agents",MESHPA +CHEMBL1263,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1263,D005938,Glucocorticoids,MESHPA +CHEMBL1263,D013566,Sympathomimetics,MESHPA +CHEMBL1263,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1265,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1265,D003879,"Dermatologic Agents",MESHPA +CHEMBL1266,D009883,"Ophthalmic Solutions",MESHPA +CHEMBL1266,D013566,Sympathomimetics,MESHPA +CHEMBL1266,D014663,"Nasal Decongestants",MESHPA +CHEMBL1269025,D065427,"Factor Xa Inhibitors",MESHPA +CHEMBL127,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL12713,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1272,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1274,D000726,"Androgen Antagonists",MESHPA +CHEMBL1274,D000970,"Antineoplastic Agents",MESHPA +CHEMBL127516,D000779,"Anesthetics, Local",MESHPA +CHEMBL1276308,D000021,"Abortifacient Agents, Steroidal",MESHPA +CHEMBL1276308,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1276308,D003283,"Contraceptives, Postcoital, Synthetic",MESHPA +CHEMBL1276308,D006727,"Hormone Antagonists",MESHPA +CHEMBL1276308,D008186,"Luteolytic Agents",MESHPA +CHEMBL1276308,D008600,"Menstruation-Inducing Agents",MESHPA +CHEMBL1278,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1278,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL1279,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL128,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL128,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL1282,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1282,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1282,D007369,"Interferon Inducers",MESHPA +CHEMBL12856,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL12856,D002316,"Cardiotonic Agents",MESHPA +CHEMBL12856,D014665,"Vasodilator Agents",MESHPA +CHEMBL12856,D058987,"Phosphodiesterase 3 Inhibitors",MESHPA +CHEMBL1286,D000927,Anticonvulsants,MESHPA +CHEMBL1286,D018697,"Nootropic Agents",MESHPA +CHEMBL1289,D000935,"Antifungal Agents",MESHPA +CHEMBL1289601,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1289601,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1289926,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1289926,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL129,D000963,Antimetabolites,MESHPA +CHEMBL129,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL129,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1290,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL1290,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1291,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL1291,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1291,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1291,D013565,Sympatholytics,MESHPA +CHEMBL1292,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1292,D007917,"Leprostatic Agents",MESHPA +CHEMBL1293,D000072664,Provitamins,MESHPA +CHEMBL1294,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL1294,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1294,D000962,Antimalarials,MESHPA +CHEMBL1294,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1294,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1294,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1294,D065690,"Cytochrome P-450 CYP2D6 Inhibitors",MESHPA +CHEMBL1295,D000935,"Antifungal Agents",MESHPA +CHEMBL1296,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1297,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1297,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL13,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL13,D000959,"Antihypertensive Agents",MESHPA +CHEMBL13,D013565,Sympatholytics,MESHPA +CHEMBL13,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL130,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL130,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1303,D018491,"Dopamine Agonists",MESHPA +CHEMBL1305,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1305,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1306,D000935,"Antifungal Agents",MESHPA +CHEMBL1308,D000931,Antidotes,MESHPA +CHEMBL1308,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL131,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL131,D005938,Glucocorticoids,MESHPA +CHEMBL131,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1311,D004234,"Diuretics, Osmotic",MESHPA +CHEMBL1311,D014665,"Vasodilator Agents",MESHPA +CHEMBL1311,D020030,"Nitric Oxide Donors",MESHPA +CHEMBL1316,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1316,D017319,"Photosensitizing Agents",MESHPA +CHEMBL13209,D000927,Anticonvulsants,MESHPA +CHEMBL13209,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL13209,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL13209,D018757,"GABA Modulators",MESHPA +CHEMBL1321,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1323,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL1323699,D013473,"Sunscreening Agents",MESHPA +CHEMBL1324,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1324,D065098,"Catechol O-Methyltransferase Inhibitors",MESHPA +CHEMBL132530,D000970,"Antineoplastic Agents",MESHPA +CHEMBL132530,D047072,"Aromatase Inhibitors",MESHPA +CHEMBL13280,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL13280,D018757,"GABA Modulators",MESHPA +CHEMBL1329455,D014665,"Vasodilator Agents",MESHPA +CHEMBL1329455,D020030,"Nitric Oxide Donors",MESHPA +CHEMBL1331216,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1331216,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1331216,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1331216,D009184,Mydriatics,MESHPA +CHEMBL1331216,D010276,Parasympatholytics,MESHPA +CHEMBL1331216,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1334078,D004202,Disinfectants,MESHPA +CHEMBL1334860,D000563,Amebicides,MESHPA +CHEMBL1336,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1336,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1337,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL134,D000700,Analgesics,MESHPA +CHEMBL134,D000959,"Antihypertensive Agents",MESHPA +CHEMBL134,D013565,Sympatholytics,MESHPA +CHEMBL134,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL1341,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL1342,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL1342,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL134342,D000975,Antioxidants,MESHPA +CHEMBL134342,D014803,"Vitamin B Complex",MESHPA +CHEMBL1346,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1346,D064804,"Urological Agents",MESHPA +CHEMBL1349,D000998,"Antiviral Agents",MESHPA +CHEMBL135,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL135,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL135,D004967,Estrogens,MESHPA +CHEMBL1350,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1351,D000970,"Antineoplastic Agents",MESHPA +CHEMBL135400,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1354199,D010276,Parasympatholytics,MESHPA +CHEMBL1355,D000925,Anticoagulants,MESHPA +CHEMBL1355,D065096,"Calcium Chelating Agents",MESHPA +CHEMBL1358,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1358,D065171,"Estrogen Receptor Antagonists",MESHPA +CHEMBL1359,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1363,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1363,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1364,D014803,"Vitamin B Complex",MESHPA +CHEMBL1366,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1367605,D013566,Sympathomimetics,MESHPA +CHEMBL1367605,D015149,"Tocolytic Agents",MESHPA +CHEMBL1367605,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL137,D000890,"Anti-Infective Agents",MESHPA +CHEMBL137,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL137,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL1370,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1370,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1370,D005938,Glucocorticoids,MESHPA +CHEMBL1370561,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1370561,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1370561,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL1370561,D058915,"Purinergic P1 Receptor Antagonists",MESHPA +CHEMBL1371,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL1371770,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1371770,D018491,"Dopamine Agonists",MESHPA +CHEMBL1372950,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL1372950,D014665,"Vasodilator Agents",MESHPA +CHEMBL1372950,D018697,"Nootropic Agents",MESHPA +CHEMBL1373,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1373,D064690,"Wakefulness-Promoting Agents",MESHPA +CHEMBL1373,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL1373254,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1373254,D004232,Diuretics,MESHPA +CHEMBL1373254,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1374379,D000996,"Antitussive Agents",MESHPA +CHEMBL1377,D000962,Antimalarials,MESHPA +CHEMBL1377,D000963,Antimetabolites,MESHPA +CHEMBL1378,D000932,Antiemetics,MESHPA +CHEMBL1378,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1378024,D000995,"Antitubercular Agents",MESHPA +CHEMBL1380,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL1380,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1382,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1382,D064804,"Urological Agents",MESHPA +CHEMBL1382627,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL13828,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL13828,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL13828,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL1384,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1384,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1387,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1387,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1389,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1389,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL1389,D003277,"Contraceptives, Oral, Combined",MESHPA +CHEMBL1389,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL139,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL139,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL1393,D000451,"Mineralocorticoid Receptor Antagonists",MESHPA +CHEMBL1393,D004232,Diuretics,MESHPA +CHEMBL139367,D000998,"Antiviral Agents",MESHPA +CHEMBL139367,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1395,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1395,D045930,"Anabolic Agents",MESHPA +CHEMBL1396,D000077444,"Smoking Cessation Agents",MESHPA +CHEMBL1396,D018722,"Nicotinic Agonists",MESHPA +CHEMBL1397,D000935,"Antifungal Agents",MESHPA +CHEMBL1397,D014344,"Trypanocidal Agents",MESHPA +CHEMBL1397,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL139835,D000726,"Androgen Antagonists",MESHPA +CHEMBL139835,D000970,"Antineoplastic Agents",MESHPA +CHEMBL139835,D003272,"Contraceptive Agents, Male",MESHPA +CHEMBL1399,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1399,D047072,"Aromatase Inhibitors",MESHPA +CHEMBL1401,D000977,"Antiparasitic Agents",MESHPA +CHEMBL1404,D002317,"Cardiovascular Agents",MESHPA +CHEMBL1404,D026941,"Sodium Channel Blockers",MESHPA +CHEMBL1405,D004967,Estrogens,MESHPA +CHEMBL14060,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL14060,D004202,Disinfectants,MESHPA +CHEMBL14060,D012597,"Sclerosing Solutions",MESHPA +CHEMBL141,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL141,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1410,D013089,"Spermatocidal Agents",MESHPA +CHEMBL1410743,D000927,Anticonvulsants,MESHPA +CHEMBL1410743,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1411979,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1411979,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1411979,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1412,D000871,Anthelmintics,MESHPA +CHEMBL1412,D000969,"Antinematodal Agents",MESHPA +CHEMBL1413,D000935,"Antifungal Agents",MESHPA +CHEMBL1419,D000928,"Antidepressive Agents",MESHPA +CHEMBL1419,D001067,"Appetite Depressants",MESHPA +CHEMBL1420,D000931,Antidotes,MESHPA +CHEMBL1420,D002801,"Cholinesterase Reactivators",MESHPA +CHEMBL1421,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1421,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL1422,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1422,D054795,Incretins,MESHPA +CHEMBL1422,D054873,"Dipeptidyl-Peptidase IV Inhibitors",MESHPA +CHEMBL1423,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1423,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1423,D018726,"Anti-Dyskinesia Agents",MESHPA +CHEMBL1425,D000963,Antimetabolites,MESHPA +CHEMBL1425,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1425,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1425,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL142703,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL142703,D054873,"Dipeptidyl-Peptidase IV Inhibitors",MESHPA +CHEMBL1428,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1428,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1428,D014665,"Vasodilator Agents",MESHPA +CHEMBL1429,D006490,Hemostatics,MESHPA +CHEMBL1429,D050034,"Antidiuretic Agents",MESHPA +CHEMBL1430,D000931,Antidotes,MESHPA +CHEMBL1430,D002614,"Chelating Agents",MESHPA +CHEMBL1430,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1431,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1433,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1433,D000962,Antimalarials,MESHPA +CHEMBL1434,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1435,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1436,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1437,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL1437,D013566,Sympathomimetics,MESHPA +CHEMBL1437,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL14370,D000928,"Antidepressive Agents",MESHPA +CHEMBL14370,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL14376,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1440,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1440,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1441,D000995,"Antitubercular Agents",MESHPA +CHEMBL1441,D054872,"Fatty Acid Synthesis Inhibitors",MESHPA +CHEMBL1442422,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL1443,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1444,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1444,D047072,"Aromatase Inhibitors",MESHPA +CHEMBL1445,D045930,"Anabolic Agents",MESHPA +CHEMBL144673,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL144673,D000935,"Antifungal Agents",MESHPA +CHEMBL1447,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1447,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1448,D000923,"Anticestodal Agents",MESHPA +CHEMBL1448,D000969,"Antinematodal Agents",MESHPA +CHEMBL1449,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1449676,D000563,Amebicides,MESHPA +CHEMBL1449676,D000994,"Antitrichomonal Agents",MESHPA +CHEMBL1449676,D011838,"Radiation-Sensitizing Agents",MESHPA +CHEMBL1450,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1450,D000962,Antimalarials,MESHPA +CHEMBL1450,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1451,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1451,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1451,D005938,Glucocorticoids,MESHPA +CHEMBL1451,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1453317,D007302,"Insect Repellents",MESHPA +CHEMBL1454,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL1454,D000969,"Antinematodal Agents",MESHPA +CHEMBL1454,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1455,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1456,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL1456,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL1456,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1457,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1457,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1457,D000996,"Antitussive Agents",MESHPA +CHEMBL1457,D009294,Narcotics,MESHPA +CHEMBL1460,D000963,Antimetabolites,MESHPA +CHEMBL1460,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL1460,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1463,D000935,"Antifungal Agents",MESHPA +CHEMBL1463,D000963,Antimetabolites,MESHPA +CHEMBL1463345,D000451,"Mineralocorticoid Receptor Antagonists",MESHPA +CHEMBL1464,D000925,Anticoagulants,MESHPA +CHEMBL1465,D000925,Anticoagulants,MESHPA +CHEMBL1466,D000925,Anticoagulants,MESHPA +CHEMBL1466,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1466,D014475,"Uncoupling Agents",MESHPA +CHEMBL1467,D000963,Antimetabolites,MESHPA +CHEMBL1467,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1467,D006074,"Gout Suppressants",MESHPA +CHEMBL1467,D016166,"Free Radical Scavengers",MESHPA +CHEMBL1469,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1471,D000932,Antiemetics,MESHPA +CHEMBL1471,D064729,"Neurokinin-1 Receptor Antagonists",MESHPA +CHEMBL1472,D006728,Hormones,MESHPA +CHEMBL1473,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1473,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1473,D003879,"Dermatologic Agents",MESHPA +CHEMBL1473,D005938,Glucocorticoids,MESHPA +CHEMBL1473,D013566,Sympathomimetics,MESHPA +CHEMBL1473,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1474889,D000996,"Antitussive Agents",MESHPA +CHEMBL1475,D017319,"Photosensitizing Agents",MESHPA +CHEMBL1477,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1479,D004965,"Estrogen Antagonists",MESHPA +CHEMBL148,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL148,D011480,"Protease Inhibitors",MESHPA +CHEMBL1480,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1480,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1480,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1480,D014665,"Vasodilator Agents",MESHPA +CHEMBL1480987,D014665,"Vasodilator Agents",MESHPA +CHEMBL1481,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1481,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1481,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1482,D010277,Parasympathomimetics,MESHPA +CHEMBL1482,D018721,"Muscarinic Agonists",MESHPA +CHEMBL1483,D000871,Anthelmintics,MESHPA +CHEMBL1483,D000923,"Anticestodal Agents",MESHPA +CHEMBL1483,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL1483,D050257,"Tubulin Modulators",MESHPA +CHEMBL1484,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1484,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1484,D014665,"Vasodilator Agents",MESHPA +CHEMBL1487,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1487,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1487,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1487,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1488,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1489,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1489,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1490,D000978,"Antiparkinson Agents",MESHPA +CHEMBL1490,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1491,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1491,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1491,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1491,D014665,"Vasodilator Agents",MESHPA +CHEMBL1491,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1491,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1492500,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL1492500,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL1493,D010276,Parasympatholytics,MESHPA +CHEMBL1493,D064804,"Urological Agents",MESHPA +CHEMBL1496,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL1496,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL1501,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1501,D005938,Glucocorticoids,MESHPA +CHEMBL1501,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1502,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1502,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL1503,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1503,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL1505,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL1506,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1506,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1508,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL1508,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL1509,D000451,"Mineralocorticoid Receptor Antagonists",MESHPA +CHEMBL1509,D012102,"Reproductive Control Agents",MESHPA +CHEMBL1510,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL1511,D004967,Estrogens,MESHPA +CHEMBL1512,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1512,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL1513,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1513,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL1514,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1515,D013956,"Antithyroid Agents",MESHPA +CHEMBL1517,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1518,D000963,Antimetabolites,MESHPA +CHEMBL1518,D013956,"Antithyroid Agents",MESHPA +CHEMBL1519,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1519,D000959,"Antihypertensive Agents",MESHPA +CHEMBL152,D000998,"Antiviral Agents",MESHPA +CHEMBL152,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1520,D014665,"Vasodilator Agents",MESHPA +CHEMBL1520,D058986,"Phosphodiesterase 5 Inhibitors",MESHPA +CHEMBL1520,D064804,"Urological Agents",MESHPA +CHEMBL1521,D000927,Anticonvulsants,MESHPA +CHEMBL1521,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL1521,D018757,"GABA Modulators",MESHPA +CHEMBL1522,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL15245,D009184,Mydriatics,MESHPA +CHEMBL15245,D058669,"Adrenergic alpha-2 Receptor Antagonists",MESHPA +CHEMBL15245,D064804,"Urological Agents",MESHPA +CHEMBL1525,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1525826,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1525826,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL1525826,D000962,Antimalarials,MESHPA +CHEMBL1528,D002327,"Cariostatic Agents",MESHPA +CHEMBL1530428,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1530428,D000932,Antiemetics,MESHPA +CHEMBL1530428,D005938,Glucocorticoids,MESHPA +CHEMBL1530428,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1531,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL1531,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL1532,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1533,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1533,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL1533,D011372,Progestins,MESHPA +CHEMBL1534,D014803,"Vitamin B Complex",MESHPA +CHEMBL1534,D017319,"Photosensitizing Agents",MESHPA +CHEMBL1535,D000962,Antimalarials,MESHPA +CHEMBL1535,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1535,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1536,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL1536,D014815,Vitamins,MESHPA +CHEMBL1536,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1537,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1538,D000998,"Antiviral Agents",MESHPA +CHEMBL1538,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL1538,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1539,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1539,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL1539,D000962,Antimalarials,MESHPA +CHEMBL154,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL154,D006074,"Gout Suppressants",MESHPA +CHEMBL154,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL1540,D000998,"Antiviral Agents",MESHPA +CHEMBL1541,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL154111,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1542,D000963,Antimetabolites,MESHPA +CHEMBL1542,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1542,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1542,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1546,D009184,Mydriatics,MESHPA +CHEMBL1546,D013566,Sympathomimetics,MESHPA +CHEMBL1547,D014803,"Vitamin B Complex",MESHPA +CHEMBL1549,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1550,D000933,"Antifibrinolytic Agents",MESHPA +CHEMBL1550,D014815,Vitamins,MESHPA +CHEMBL1551,D002756,"Cholagogues and Choleretics",MESHPA +CHEMBL1554,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1554,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL1554,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1554,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL1560,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1560,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1560,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1561,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1561,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL1561,D065089,"Glycoside Hydrolase Inhibitors",MESHPA +CHEMBL1566,D065089,"Glycoside Hydrolase Inhibitors",MESHPA +CHEMBL1569487,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1571,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL157101,D000935,"Antifungal Agents",MESHPA +CHEMBL157101,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL157101,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL157138,D000978,"Antiparkinson Agents",MESHPA +CHEMBL157138,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL157138,D018491,"Dopamine Agonists",MESHPA +CHEMBL1571863,D000935,"Antifungal Agents",MESHPA +CHEMBL1572,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1572,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1574,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1574,D001067,"Appetite Depressants",MESHPA +CHEMBL1574,D013566,Sympathomimetics,MESHPA +CHEMBL1574,D018663,"Adrenergic Agents",MESHPA +CHEMBL1577,D004232,Diuretics,MESHPA +CHEMBL1577,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL15770,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL15770,D000970,"Antineoplastic Agents",MESHPA +CHEMBL15770,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL1578,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL158,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1580,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1580,D058892,"Adenosine Deaminase Inhibitors",MESHPA +CHEMBL1581,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1581,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1583,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1585,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1587,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1587,D004232,Diuretics,MESHPA +CHEMBL1587,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1589,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL159,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL159,D050257,"Tubulin Modulators",MESHPA +CHEMBL1590,D000996,"Antitussive Agents",MESHPA +CHEMBL1590,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1590,D005100,Expectorants,MESHPA +CHEMBL1590,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1590,D014663,"Nasal Decongestants",MESHPA +CHEMBL1590,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL1591,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1592,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL1592,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1592,D002317,"Cardiovascular Agents",MESHPA +CHEMBL1592101,D000890,"Anti-Infective Agents",MESHPA +CHEMBL1592101,D006490,Hemostatics,MESHPA +CHEMBL159226,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL159226,D008916,Miotics,MESHPA +CHEMBL159226,D013565,Sympatholytics,MESHPA +CHEMBL159226,D014665,"Vasodilator Agents",MESHPA +CHEMBL1594,D014803,"Vitamin B Complex",MESHPA +CHEMBL1595,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1597,D002614,"Chelating Agents",MESHPA +CHEMBL1599,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL16,D000927,Anticonvulsants,MESHPA +CHEMBL16,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL16,D065694,"Cytochrome P-450 CYP1A2 Inducers",MESHPA +CHEMBL160,D000935,"Antifungal Agents",MESHPA +CHEMBL160,D003879,"Dermatologic Agents",MESHPA +CHEMBL160,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL160,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL160,D018501,"Antirheumatic Agents",MESHPA +CHEMBL160,D065095,"Calcineurin Inhibitors",MESHPA +CHEMBL1601,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1601669,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1604,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1605,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL16073,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL161,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1614,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1614,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1614,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1614637,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1615438,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL1615439,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1616951,D000451,"Mineralocorticoid Receptor Antagonists",MESHPA +CHEMBL1617,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1617,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1618018,D010276,Parasympatholytics,MESHPA +CHEMBL1618102,D010276,Parasympatholytics,MESHPA +CHEMBL1618102,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1619,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1619,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL162036,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1621,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1621,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL1621,D065127,"Dopamine D2 Receptor Antagonists",MESHPA +CHEMBL1621597,D000701,"Analgesics, Opioid",MESHPA +CHEMBL1621597,D000930,Antidiarrheals,MESHPA +CHEMBL1621597,D000996,"Antitussive Agents",MESHPA +CHEMBL1621597,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1621597,D009294,Narcotics,MESHPA +CHEMBL1621597,D018680,"Cholinergic Antagonists",MESHPA +CHEMBL1622,D006397,Hematinics,MESHPA +CHEMBL1622,D014803,"Vitamin B Complex",MESHPA +CHEMBL1623,D000932,Antiemetics,MESHPA +CHEMBL1623,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1623,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1624126,D014665,"Vasodilator Agents",MESHPA +CHEMBL1625,D013473,"Sunscreening Agents",MESHPA +CHEMBL1626,D000982,Antipruritics,MESHPA +CHEMBL1626,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL1626,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1626223,D000871,Anthelmintics,MESHPA +CHEMBL1626223,D000969,"Antinematodal Agents",MESHPA +CHEMBL1626223,D009467,"Neuromuscular Depolarizing Agents",MESHPA +CHEMBL1628227,D000068776,"Sleep Aids, Pharmaceutical",MESHPA +CHEMBL1628227,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL1628227,D006633,"Histamine Antagonists",MESHPA +CHEMBL1628233,D003287,"Contrast Media",MESHPA +CHEMBL1628385,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1628502,D000700,Analgesics,MESHPA +CHEMBL1628502,D000927,Anticonvulsants,MESHPA +CHEMBL1628502,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL1628502,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL1628502,D018692,"Antimanic Agents",MESHPA +CHEMBL163,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL163,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL1643,D000963,Antimetabolites,MESHPA +CHEMBL1643,D000998,"Antiviral Agents",MESHPA +CHEMBL1644,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1648,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1648,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1648,D014665,"Vasodilator Agents",MESHPA +CHEMBL1650,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1650619,D000935,"Antifungal Agents",MESHPA +CHEMBL1651906,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL1652,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL1652,D010277,Parasympathomimetics,MESHPA +CHEMBL1655,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1655,D020845,"Selective Estrogen Receptor Modulators",MESHPA +CHEMBL1655,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL1657,D003879,"Dermatologic Agents",MESHPA +CHEMBL1657,D007641,"Keratolytic Agents",MESHPA +CHEMBL1658,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1660,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL1660,D007917,"Leprostatic Agents",MESHPA +CHEMBL1661,D002400,Cathartics,MESHPA +CHEMBL1663,D003287,"Contrast Media",MESHPA +CHEMBL1664,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL1664,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1670,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1676,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1676,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1676,D003879,"Dermatologic Agents",MESHPA +CHEMBL1676,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL1679,D000931,Antidotes,MESHPA +CHEMBL1679,D014803,"Vitamin B Complex",MESHPA +CHEMBL1680,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1680,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL1682,D002400,Cathartics,MESHPA +CHEMBL1683,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1683,D003879,"Dermatologic Agents",MESHPA +CHEMBL1684,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1684,D004232,Diuretics,MESHPA +CHEMBL1684,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1685,D000701,"Analgesics, Opioid",MESHPA +CHEMBL168815,D010277,Parasympathomimetics,MESHPA +CHEMBL168815,D018721,"Muscarinic Agonists",MESHPA +CHEMBL1688530,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1689063,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1689063,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL1697733,D014803,"Vitamin B Complex",MESHPA +CHEMBL1697733,D018697,"Nootropic Agents",MESHPA +CHEMBL1697744,D005100,Expectorants,MESHPA +CHEMBL1697782,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1697782,D000932,Antiemetics,MESHPA +CHEMBL1697782,D005938,Glucocorticoids,MESHPA +CHEMBL1697782,D018696,"Neuroprotective Agents",MESHPA +CHEMBL169901,D000959,"Antihypertensive Agents",MESHPA +CHEMBL169901,D013565,Sympatholytics,MESHPA +CHEMBL169901,D018663,"Adrenergic Agents",MESHPA +CHEMBL17,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL170,D000962,Antimalarials,MESHPA +CHEMBL170,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL170,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL1705709,D007502,"Iron Chelating Agents",MESHPA +CHEMBL170988,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL17157,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL1725,D003287,"Contrast Media",MESHPA +CHEMBL1726,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1726,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1726,D014665,"Vasodilator Agents",MESHPA +CHEMBL1727,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1729,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1729,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1729,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL1730,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1731,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1732,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL1732,D018491,"Dopamine Agonists",MESHPA +CHEMBL1732,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL1734,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1734,D064804,"Urological Agents",MESHPA +CHEMBL1738,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1738,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1738,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1738990,D000996,"Antitussive Agents",MESHPA +CHEMBL1739,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL174,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1740659,D014803,"Vitamin B Complex",MESHPA +CHEMBL1741,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1741,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL1741,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL1742990,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1742990,D018501,"Antirheumatic Agents",MESHPA +CHEMBL1742991,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL1742992,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1742994,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1742996,D003879,"Dermatologic Agents",MESHPA +CHEMBL1743007,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743010,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743029,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1743034,D003879,"Dermatologic Agents",MESHPA +CHEMBL1743041,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743043,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743047,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1743048,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1743049,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743062,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743070,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1743082,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1743082,D050257,"Tubulin Modulators",MESHPA +CHEMBL1743087,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL1747,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1749,D000925,Anticoagulants,MESHPA +CHEMBL1749,D065096,"Calcium Chelating Agents",MESHPA +CHEMBL1750,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL1751,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1751,D002316,"Cardiotonic Agents",MESHPA +CHEMBL1751,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL1752,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1752,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL1752,D014665,"Vasodilator Agents",MESHPA +CHEMBL175247,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL175247,D019440,"Anti-Obesity Agents",MESHPA +CHEMBL175247,D057847,"Lipid Regulating Agents",MESHPA +CHEMBL1754,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL1754,D019141,"Respiratory System Agents",MESHPA +CHEMBL1755,D065092,"Antidiuretic Hormone Receptor Antagonists",MESHPA +CHEMBL1756,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL1756,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL175691,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL175691,D019380,"Anti-HIV Agents",MESHPA +CHEMBL1757,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1760,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1760,D013566,Sympathomimetics,MESHPA +CHEMBL1760,D015149,"Tocolytic Agents",MESHPA +CHEMBL1760,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL1762,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL1762,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL1763,D000959,"Antihypertensive Agents",MESHPA +CHEMBL1763,D004232,Diuretics,MESHPA +CHEMBL1763,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL1764,D014150,"Antipsychotic Agents",MESHPA +CHEMBL1764,D018492,"Dopamine Antagonists",MESHPA +CHEMBL1764,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL1766,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL1766,D005938,Glucocorticoids,MESHPA +CHEMBL177,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1770248,D000077203,"Sodium-Glucose Transporter 2 Inhibitors",MESHPA +CHEMBL1771,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL1771,D058921,"Purinergic P2Y Receptor Antagonists",MESHPA +CHEMBL1773,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL177367,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL178,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL178,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL17860,D000959,"Antihypertensive Agents",MESHPA +CHEMBL17860,D009292,"Narcotic Antagonists",MESHPA +CHEMBL17860,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL1789843,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1789844,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL1790041,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL1790041,D006635,"Histamine H2 Antagonists",MESHPA +CHEMBL181,D000959,"Antihypertensive Agents",MESHPA +CHEMBL181,D014665,"Vasodilator Agents",MESHPA +CHEMBL182,D000998,"Antiviral Agents",MESHPA +CHEMBL184,D000998,"Antiviral Agents",MESHPA +CHEMBL184412,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL18442,D019380,"Anti-HIV Agents",MESHPA +CHEMBL185,D000963,Antimetabolites,MESHPA +CHEMBL185,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL185,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL185073,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL185073,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL186,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1863514,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1868702,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL1868702,D011372,Progestins,MESHPA +CHEMBL1888176,D010276,Parasympatholytics,MESHPA +CHEMBL1888176,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL1888176,D064804,"Urological Agents",MESHPA +CHEMBL189,D002316,"Cardiotonic Agents",MESHPA +CHEMBL189,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL189,D014665,"Vasodilator Agents",MESHPA +CHEMBL189,D058987,"Phosphodiesterase 3 Inhibitors",MESHPA +CHEMBL189171,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL189963,D000970,"Antineoplastic Agents",MESHPA +CHEMBL189963,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL19,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL19,D004232,Diuretics,MESHPA +CHEMBL190,D001993,"Bronchodilator Agents",MESHPA +CHEMBL190,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL190,D014665,"Vasodilator Agents",MESHPA +CHEMBL190,D058915,"Purinergic P1 Receptor Antagonists",MESHPA +CHEMBL1900528,D001993,"Bronchodilator Agents",MESHPA +CHEMBL1900528,D010276,Parasympatholytics,MESHPA +CHEMBL1900528,D018680,"Cholinergic Antagonists",MESHPA +CHEMBL19019,D000427,"Alcohol Deterrents",MESHPA +CHEMBL19019,D009292,"Narcotic Antagonists",MESHPA +CHEMBL1908307,D014665,"Vasodilator Agents",MESHPA +CHEMBL1908315,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL1908359,D002327,"Cariostatic Agents",MESHPA +CHEMBL1908360,D000970,"Antineoplastic Agents",MESHPA +CHEMBL1908360,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL1908362,D003287,"Contrast Media",MESHPA +CHEMBL1908370,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL1908370,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL1908370,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL1908841,D000931,Antidotes,MESHPA +CHEMBL1909079,D002327,"Cariostatic Agents",MESHPA +CHEMBL1909324,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL1909324,D010276,Parasympatholytics,MESHPA +CHEMBL191,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL191,D000959,"Antihypertensive Agents",MESHPA +CHEMBL191,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL191083,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL192,D014665,"Vasodilator Agents",MESHPA +CHEMBL192,D058986,"Phosphodiesterase 5 Inhibitors",MESHPA +CHEMBL192,D064804,"Urological Agents",MESHPA +CHEMBL19215,D012702,"Serotonin Antagonists",MESHPA +CHEMBL19215,D018491,"Dopamine Agonists",MESHPA +CHEMBL19224,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL19224,D014665,"Vasodilator Agents",MESHPA +CHEMBL19224,D064804,"Urological Agents",MESHPA +CHEMBL19236,D000959,"Antihypertensive Agents",MESHPA +CHEMBL193,D000959,"Antihypertensive Agents",MESHPA +CHEMBL193,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL193,D014665,"Vasodilator Agents",MESHPA +CHEMBL193,D015149,"Tocolytic Agents",MESHPA +CHEMBL19490,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL1950576,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL196,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL196,D000975,Antioxidants,MESHPA +CHEMBL196,D014815,Vitamins,MESHPA +CHEMBL1983350,D000927,Anticonvulsants,MESHPA +CHEMBL198362,D065427,"Factor Xa Inhibitors",MESHPA +CHEMBL2,D000959,"Antihypertensive Agents",MESHPA +CHEMBL2,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL20,D000927,Anticonvulsants,MESHPA +CHEMBL20,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL20,D004232,Diuretics,MESHPA +CHEMBL2007641,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL2007641,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2009089,D014131,"Trace Elements",MESHPA +CHEMBL2010507,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL2010601,D065101,"Chloride Channel Agonists",MESHPA +CHEMBL2021423,D000700,Analgesics,MESHPA +CHEMBL2021423,D000777,Anesthetics,MESHPA +CHEMBL2021423,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL2021423,D000927,Anticonvulsants,MESHPA +CHEMBL2021423,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL2021423,D015149,"Tocolytic Agents",MESHPA +CHEMBL2028019,D014150,"Antipsychotic Agents",MESHPA +CHEMBL2028661,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL2028663,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2028663,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL2028850,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL2028850,D065094,"Bradykinin B2 Receptor Antagonists",MESHPA +CHEMBL203266,D014665,"Vasodilator Agents",MESHPA +CHEMBL2040682,D005938,Glucocorticoids,MESHPA +CHEMBL2040682,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL2042122,D003287,"Contrast Media",MESHPA +CHEMBL2042122,D019275,Radiopharmaceuticals,MESHPA +CHEMBL2048028,D009883,"Ophthalmic Solutions",MESHPA +CHEMBL2048484,D000077203,"Sodium-Glucose Transporter 2 Inhibitors",MESHPA +CHEMBL2063090,D000998,"Antiviral Agents",MESHPA +CHEMBL2068237,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2068237,D011838,"Radiation-Sensitizing Agents",MESHPA +CHEMBL207538,D000081227,Neurosteroids,MESHPA +CHEMBL207538,D018757,"GABA Modulators",MESHPA +CHEMBL2079587,D000728,Androgens,MESHPA +CHEMBL2079587,D045930,"Anabolic Agents",MESHPA +CHEMBL2079699,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL2079699,D012556,Schistosomicides,MESHPA +CHEMBL20883,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL2095208,D019380,"Anti-HIV Agents",MESHPA +CHEMBL2095208,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL2095209,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL2095212,D058667,"Adrenergic beta-3 Receptor Agonists",MESHPA +CHEMBL2095212,D064804,"Urological Agents",MESHPA +CHEMBL2096629,D000931,Antidotes,MESHPA +CHEMBL2096633,D000863,Antacids,MESHPA +CHEMBL2097081,D000959,"Antihypertensive Agents",MESHPA +CHEMBL2097081,D014665,"Vasodilator Agents",MESHPA +CHEMBL2097081,D020030,"Nitric Oxide Donors",MESHPA +CHEMBL21,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2103737,D006397,Hematinics,MESHPA +CHEMBL2103737,D014803,"Vitamin B Complex",MESHPA +CHEMBL2103742,D014131,"Trace Elements",MESHPA +CHEMBL2103749,D000991,Antithrombins,MESHPA +CHEMBL2103752,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL2103752,D018696,"Neuroprotective Agents",MESHPA +CHEMBL2103752,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL2103758,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL2103772,D000930,Antidiarrheals,MESHPA +CHEMBL2103772,D011480,"Protease Inhibitors",MESHPA +CHEMBL2103774,D000726,"Androgen Antagonists",MESHPA +CHEMBL2103774,D000959,"Antihypertensive Agents",MESHPA +CHEMBL2103774,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL2103774,D020847,"Estrogen Receptor Modulators",MESHPA +CHEMBL2103774,D045930,"Anabolic Agents",MESHPA +CHEMBL2103784,D006728,Hormones,MESHPA +CHEMBL2103827,D000978,"Antiparkinson Agents",MESHPA +CHEMBL2103846,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL2103846,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL2103867,D000074268,"Guanylyl Cyclase C Agonists",MESHPA +CHEMBL2103867,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL2103872,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL2103872,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2103872,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL2103873,D065130,"Endothelin A Receptor Antagonists",MESHPA +CHEMBL2103873,D065131,"Endothelin B Receptor Antagonists",MESHPA +CHEMBL2103875,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2103875,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL2103877,D000935,"Antifungal Agents",MESHPA +CHEMBL2103929,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2104095,D008082,"Lipotropic Agents",MESHPA +CHEMBL2104095,D018697,"Nootropic Agents",MESHPA +CHEMBL2104356,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL2104391,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL2104415,D000871,Anthelmintics,MESHPA +CHEMBL2104415,D000969,"Antinematodal Agents",MESHPA +CHEMBL2104445,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL2104987,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL2104987,D011837,"Radiation-Protective Agents",MESHPA +CHEMBL2104993,D000928,"Antidepressive Agents",MESHPA +CHEMBL2104993,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL2104993,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL2104993,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL2104993,D058831,"Serotonin 5-HT3 Receptor Antagonists",MESHPA +CHEMBL2105002,D000996,"Antitussive Agents",MESHPA +CHEMBL2105224,D000700,Analgesics,MESHPA +CHEMBL2105224,D000996,"Antitussive Agents",MESHPA +CHEMBL2105233,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL2105611,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL2105611,D003879,"Dermatologic Agents",MESHPA +CHEMBL2105614,D005100,Expectorants,MESHPA +CHEMBL2105637,D000890,"Anti-Infective Agents",MESHPA +CHEMBL2105669,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2105689,D000935,"Antifungal Agents",MESHPA +CHEMBL2105720,D006074,"Gout Suppressants",MESHPA +CHEMBL2105720,D014528,"Uricosuric Agents",MESHPA +CHEMBL2105760,D018490,"Serotonin Agents",MESHPA +CHEMBL2105760,D018491,"Dopamine Agonists",MESHPA +CHEMBL2105842,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL2105897,D003287,"Contrast Media",MESHPA +CHEMBL2106441,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL2106794,D006490,Hemostatics,MESHPA +CHEMBL2106825,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL2106939,D004202,Disinfectants,MESHPA +CHEMBL2107067,D000728,Androgens,MESHPA +CHEMBL2107333,D003879,"Dermatologic Agents",MESHPA +CHEMBL2107333,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL2107333,D011838,"Radiation-Sensitizing Agents",MESHPA +CHEMBL2107797,D003277,"Contraceptives, Oral, Combined",MESHPA +CHEMBL2107797,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL2107797,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL2107797,D003282,"Contraceptives, Postcoital, Hormonal",MESHPA +CHEMBL2107797,D003283,"Contraceptives, Postcoital, Synthetic",MESHPA +CHEMBL2107816,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2107830,D000077203,"Sodium-Glucose Transporter 2 Inhibitors",MESHPA +CHEMBL2107834,D020536,"Enzyme Activators",MESHPA +CHEMBL2107841,D054795,Incretins,MESHPA +CHEMBL2107884,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL2107885,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2107886,D000925,Anticoagulants,MESHPA +CHEMBL2107886,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2108027,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL2108041,D007155,"Immunologic Factors",MESHPA +CHEMBL2108074,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL2108078,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL2108122,D010952,"Plasma Substitutes",MESHPA +CHEMBL2108147,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2108232,D007641,"Keratolytic Agents",MESHPA +CHEMBL2108250,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2108336,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL2108350,D051056,"Complement Inactivating Agents",MESHPA +CHEMBL2108396,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2108396,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL2108448,D010952,"Plasma Substitutes",MESHPA +CHEMBL2108546,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2108574,D000991,Antithrombins,MESHPA +CHEMBL2108611,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL2108611,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL2108727,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL2108738,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL2108758,D000932,Antiemetics,MESHPA +CHEMBL2108758,D010276,Parasympatholytics,MESHPA +CHEMBL2108791,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL2108806,D000925,Anticoagulants,MESHPA +CHEMBL2108832,D000931,Antidotes,MESHPA +CHEMBL2108989,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2109001,D054368,Laxatives,MESHPA +CHEMBL2109005,D002400,Cathartics,MESHPA +CHEMBL2109035,D003879,"Dermatologic Agents",MESHPA +CHEMBL2109065,D000890,"Anti-Infective Agents",MESHPA +CHEMBL2109128,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL2109128,D006401,"Hematologic Agents",MESHPA +CHEMBL2109152,D004643,Emollients,MESHPA +CHEMBL2109188,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2110563,D014803,"Vitamin B Complex",MESHPA +CHEMBL2110576,D019275,Radiopharmaceuticals,MESHPA +CHEMBL2110588,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL2110774,D006633,"Histamine Antagonists",MESHPA +CHEMBL2110774,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL2110816,D000928,"Antidepressive Agents",MESHPA +CHEMBL2110816,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL2110824,D005300,"Fertility Agents, Female",MESHPA +CHEMBL2111018,D019275,Radiopharmaceuticals,MESHPA +CHEMBL2111101,D000978,"Antiparkinson Agents",MESHPA +CHEMBL2111101,D014150,"Antipsychotic Agents",MESHPA +CHEMBL2111101,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL211456,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL211456,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL211456,D013566,Sympathomimetics,MESHPA +CHEMBL211456,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL211456,D018663,"Adrenergic Agents",MESHPA +CHEMBL2135460,D000959,"Antihypertensive Agents",MESHPA +CHEMBL2135460,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL2141296,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2141296,D011480,"Protease Inhibitors",MESHPA +CHEMBL2159122,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL21731,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL21731,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL218490,D000959,"Antihypertensive Agents",MESHPA +CHEMBL218490,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL219916,D000932,Antiemetics,MESHPA +CHEMBL219916,D018492,"Dopamine Antagonists",MESHPA +CHEMBL22,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL22,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL22,D000962,Antimalarials,MESHPA +CHEMBL22,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL22,D018726,"Anti-Dyskinesia Agents",MESHPA +CHEMBL22,D065687,"Cytochrome P-450 CYP2C8 Inhibitors",MESHPA +CHEMBL220491,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL220492,D000927,Anticonvulsants,MESHPA +CHEMBL220492,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL22097,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL22108,D000982,Antipruritics,MESHPA +CHEMBL22108,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL22108,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL2216870,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2216870,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL2218860,D003287,"Contrast Media",MESHPA +CHEMBL2218885,D017319,"Photosensitizing Agents",MESHPA +CHEMBL2218896,D000932,Antiemetics,MESHPA +CHEMBL2218896,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL2218908,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2218913,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2218913,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL2218913,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL2219418,D009292,"Narcotic Antagonists",MESHPA +CHEMBL2219425,D014150,"Antipsychotic Agents",MESHPA +CHEMBL221959,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL2221312,D003287,"Contrast Media",MESHPA +CHEMBL22242,D014150,"Antipsychotic Agents",MESHPA +CHEMBL22242,D018492,"Dopamine Antagonists",MESHPA +CHEMBL222559,D019380,"Anti-HIV Agents",MESHPA +CHEMBL222645,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL222813,D000998,"Antiviral Agents",MESHPA +CHEMBL222813,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL222863,D002316,"Cardiotonic Agents",MESHPA +CHEMBL222863,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL223228,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL223228,D019380,"Anti-HIV Agents",MESHPA +CHEMBL223228,D065688,"Cytochrome P-450 CYP2C9 Inhibitors",MESHPA +CHEMBL223228,D065689,"Cytochrome P-450 CYP2C19 Inhibitors",MESHPA +CHEMBL223228,D065695,"Cytochrome P-450 CYP2B6 Inducers",MESHPA +CHEMBL223228,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL224325,D000890,"Anti-Infective Agents",MESHPA +CHEMBL225071,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL225071,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL225072,D000970,"Antineoplastic Agents",MESHPA +CHEMBL225072,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL225072,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL225072,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL229128,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL23,D000959,"Antihypertensive Agents",MESHPA +CHEMBL23,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL23,D002317,"Cardiovascular Agents",MESHPA +CHEMBL23,D014665,"Vasodilator Agents",MESHPA +CHEMBL2308885,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL2308885,D005938,Glucocorticoids,MESHPA +CHEMBL2311030,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL2311030,D014665,"Vasodilator Agents",MESHPA +CHEMBL2311030,D018697,"Nootropic Agents",MESHPA +CHEMBL231779,D065427,"Factor Xa Inhibitors",MESHPA +CHEMBL233406,D002400,Cathartics,MESHPA +CHEMBL2336071,D000081243,"Sphingosine 1 Phosphate Receptor Modulators",MESHPA +CHEMBL2354773,D018501,"Antirheumatic Agents",MESHPA +CHEMBL2355051,D004965,"Estrogen Antagonists",MESHPA +CHEMBL2355051,D005300,"Fertility Agents, Female",MESHPA +CHEMBL2355051,D020845,"Selective Estrogen Receptor Modulators",MESHPA +CHEMBL2356023,D014815,Vitamins,MESHPA +CHEMBL2356023,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL23588,D000700,Analgesics,MESHPA +CHEMBL23588,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL2362016,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2364632,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL2364632,D003879,"Dermatologic Agents",MESHPA +CHEMBL2364655,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL2367706,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL2368861,D000701,"Analgesics, Opioid",MESHPA +CHEMBL2368861,D009292,"Narcotic Antagonists",MESHPA +CHEMBL2368861,D009294,Narcotics,MESHPA +CHEMBL2368925,D000932,Antiemetics,MESHPA +CHEMBL2368925,D012702,"Serotonin Antagonists",MESHPA +CHEMBL2374220,D000998,"Antiviral Agents",MESHPA +CHEMBL237500,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL237500,D054795,Incretins,MESHPA +CHEMBL237500,D054873,"Dipeptidyl-Peptidase IV Inhibitors",MESHPA +CHEMBL238071,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL238071,D050257,"Tubulin Modulators",MESHPA +CHEMBL238804,D000959,"Antihypertensive Agents",MESHPA +CHEMBL24,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL24,D000959,"Antihypertensive Agents",MESHPA +CHEMBL24,D013565,Sympatholytics,MESHPA +CHEMBL24,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL2403108,D000970,"Antineoplastic Agents",MESHPA +CHEMBL2403108,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL240597,D002400,Cathartics,MESHPA +CHEMBL240597,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL24072,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL24072,D014665,"Vasodilator Agents",MESHPA +CHEMBL24072,D018663,"Adrenergic Agents",MESHPA +CHEMBL24171,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL24171,D003879,"Dermatologic Agents",MESHPA +CHEMBL24171,D017319,"Photosensitizing Agents",MESHPA +CHEMBL243712,D014150,"Antipsychotic Agents",MESHPA +CHEMBL243712,D018492,"Dopamine Antagonists",MESHPA +CHEMBL243712,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL24441,D014665,"Vasodilator Agents",MESHPA +CHEMBL24441,D017442,"Histamine Agonists",MESHPA +CHEMBL24778,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL24778,D064804,"Urological Agents",MESHPA +CHEMBL248702,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL24924,D000925,Anticoagulants,MESHPA +CHEMBL249837,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL249856,D002316,"Cardiotonic Agents",MESHPA +CHEMBL249856,D014665,"Vasodilator Agents",MESHPA +CHEMBL249856,D058987,"Phosphodiesterase 3 Inhibitors",MESHPA +CHEMBL25,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL25,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL25,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL25,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL25,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL25,D058633,Antipyretics,MESHPA +CHEMBL250270,D000959,"Antihypertensive Agents",MESHPA +CHEMBL250270,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL251634,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL251634,D005938,Glucocorticoids,MESHPA +CHEMBL252556,D000975,Antioxidants,MESHPA +CHEMBL253371,D010276,Parasympatholytics,MESHPA +CHEMBL253376,D005100,Expectorants,MESHPA +CHEMBL254219,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL254219,D002316,"Cardiotonic Agents",MESHPA +CHEMBL254219,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL254316,D019380,"Anti-HIV Agents",MESHPA +CHEMBL254316,D019428,"HIV Integrase Inhibitors",MESHPA +CHEMBL254328,D000970,"Antineoplastic Agents",MESHPA +CHEMBL254328,D065088,"Steroid Synthesis Inhibitors",MESHPA +CHEMBL254328,D065607,"Cytochrome P-450 Enzyme Inhibitors",MESHPA +CHEMBL259209,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL259209,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL26,D014150,"Antipsychotic Agents",MESHPA +CHEMBL26,D018492,"Dopamine Antagonists",MESHPA +CHEMBL26,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL262777,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL264241,D000935,"Antifungal Agents",MESHPA +CHEMBL264374,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL266481,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL266481,D006728,Hormones,MESHPA +CHEMBL267345,D000563,Amebicides,MESHPA +CHEMBL267345,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL267345,D000935,"Antifungal Agents",MESHPA +CHEMBL267345,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL267648,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL267648,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL267648,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL267894,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL267894,D018757,"GABA Modulators",MESHPA +CHEMBL267936,D000959,"Antihypertensive Agents",MESHPA +CHEMBL267936,D005730,"Ganglionic Blockers",MESHPA +CHEMBL267936,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL269732,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL269732,D065095,"Calcineurin Inhibitors",MESHPA +CHEMBL27,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL27,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL27,D000959,"Antihypertensive Agents",MESHPA +CHEMBL27,D014665,"Vasodilator Agents",MESHPA +CHEMBL270190,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL273575,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL276832,D000959,"Antihypertensive Agents",MESHPA +CHEMBL276832,D014665,"Vasodilator Agents",MESHPA +CHEMBL277062,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL277062,D018757,"GABA Modulators",MESHPA +CHEMBL277100,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL277100,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL277474,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL277522,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL277522,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL277535,D000935,"Antifungal Agents",MESHPA +CHEMBL278020,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL278020,D010277,Parasympathomimetics,MESHPA +CHEMBL27810,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL27810,D000959,"Antihypertensive Agents",MESHPA +CHEMBL27810,D013566,Sympathomimetics,MESHPA +CHEMBL27810,D014665,"Vasodilator Agents",MESHPA +CHEMBL27810,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL278172,D000779,"Anesthetics, Local",MESHPA +CHEMBL278398,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL278819,D000928,"Antidepressive Agents",MESHPA +CHEMBL279516,D000959,"Antihypertensive Agents",MESHPA +CHEMBL279516,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL282052,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL282121,D000927,Anticonvulsants,MESHPA +CHEMBL282121,D010276,Parasympatholytics,MESHPA +CHEMBL28218,D014150,"Antipsychotic Agents",MESHPA +CHEMBL282575,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL282575,D004967,Estrogens,MESHPA +CHEMBL284348,D026902,"Potassium Channel Blockers",MESHPA +CHEMBL284906,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL284906,D000959,"Antihypertensive Agents",MESHPA +CHEMBL284906,D014665,"Vasodilator Agents",MESHPA +CHEMBL284906,D014803,"Vitamin B Complex",MESHPA +CHEMBL285674,D000927,Anticonvulsants,MESHPA +CHEMBL285674,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL285674,D018757,"GABA Modulators",MESHPA +CHEMBL285802,D014150,"Antipsychotic Agents",MESHPA +CHEMBL29,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL290916,D016166,"Free Radical Scavengers",MESHPA +CHEMBL290916,D018696,"Neuroprotective Agents",MESHPA +CHEMBL290960,D014344,"Trypanocidal Agents",MESHPA +CHEMBL291157,D000890,"Anti-Infective Agents",MESHPA +CHEMBL29411,D000890,"Anti-Infective Agents",MESHPA +CHEMBL29411,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL29411,D000935,"Antifungal Agents",MESHPA +CHEMBL294199,D000982,Antipruritics,MESHPA +CHEMBL294199,D018689,"Sensory System Agents",MESHPA +CHEMBL296306,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL296419,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL296419,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL297302,D014150,"Antipsychotic Agents",MESHPA +CHEMBL297302,D018492,"Dopamine Antagonists",MESHPA +CHEMBL298470,D000962,Antimalarials,MESHPA +CHEMBL3,D000077444,"Smoking Cessation Agents",MESHPA +CHEMBL3,D005731,"Ganglionic Stimulants",MESHPA +CHEMBL3,D018722,"Nicotinic Agonists",MESHPA +CHEMBL30,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL30,D006635,"Histamine H2 Antagonists",MESHPA +CHEMBL30,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL30008,D000927,Anticonvulsants,MESHPA +CHEMBL30008,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL30008,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL30008,D014665,"Vasodilator Agents",MESHPA +CHEMBL301265,D000975,Antioxidants,MESHPA +CHEMBL301265,D000978,"Antiparkinson Agents",MESHPA +CHEMBL301265,D018491,"Dopamine Agonists",MESHPA +CHEMBL302795,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL302795,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL3039583,D006728,Hormones,MESHPA +CHEMBL3039594,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3039594,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL3039598,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL3039598,D000959,"Antihypertensive Agents",MESHPA +CHEMBL304902,D014150,"Antipsychotic Agents",MESHPA +CHEMBL305187,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL305187,D014665,"Vasodilator Agents",MESHPA +CHEMBL305187,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL305906,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL306700,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL306700,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL308954,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL31,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL31,D009883,"Ophthalmic Solutions",MESHPA +CHEMBL31,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL3112741,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL312448,D014663,"Nasal Decongestants",MESHPA +CHEMBL3137301,D057911,"Angiotensin Receptor Antagonists",MESHPA +CHEMBL3137309,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3137320,D000067856,"Poly(ADP-ribose) Polymerase Inhibitors",MESHPA +CHEMBL3137342,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3137343,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL313972,D000975,Antioxidants,MESHPA +CHEMBL313972,D016859,"Lipoxygenase Inhibitors",MESHPA +CHEMBL313972,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL314854,D000081243,"Sphingosine 1 Phosphate Receptor Modulators",MESHPA +CHEMBL314854,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL315795,D000927,Anticonvulsants,MESHPA +CHEMBL315795,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL315795,D018696,"Neuroprotective Agents",MESHPA +CHEMBL315795,D018757,"GABA Modulators",MESHPA +CHEMBL315838,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL315838,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL315985,D000927,Anticonvulsants,MESHPA +CHEMBL315985,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL317052,D058908,"Adenosine A2 Receptor Agonists",MESHPA +CHEMBL317094,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL317094,D000959,"Antihypertensive Agents",MESHPA +CHEMBL3182343,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3183075,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL3183075,D006635,"Histamine H2 Antagonists",MESHPA +CHEMBL3183184,D013473,"Sunscreening Agents",MESHPA +CHEMBL32,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL32,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL325041,D000970,"Antineoplastic Agents",MESHPA +CHEMBL32800,D001993,"Bronchodilator Agents",MESHPA +CHEMBL32800,D013566,Sympathomimetics,MESHPA +CHEMBL32800,D015149,"Tocolytic Agents",MESHPA +CHEMBL32800,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL33,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL33,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL33,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL33,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL3301581,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL3301587,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL3301669,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3301675,D000074268,"Guanylyl Cyclase C Agonists",MESHPA +CHEMBL3301800,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3317857,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3317857,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL333826,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL334966,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL334966,D058921,"Purinergic P2Y Receptor Antagonists",MESHPA +CHEMBL3353410,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3353410,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL339427,D003473,"Neuromuscular Nondepolarizing Agents",MESHPA +CHEMBL339427,D018733,"Nicotinic Antagonists",MESHPA +CHEMBL33986,D000701,"Analgesics, Opioid",MESHPA +CHEMBL33986,D000996,"Antitussive Agents",MESHPA +CHEMBL33986,D009292,"Narcotic Antagonists",MESHPA +CHEMBL33986,D009294,Narcotics,MESHPA +CHEMBL34259,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL34259,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL34259,D003879,"Dermatologic Agents",MESHPA +CHEMBL34259,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL34259,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL34259,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL34259,D018501,"Antirheumatic Agents",MESHPA +CHEMBL34259,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL343448,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL344159,D065092,"Antidiuretic Hormone Receptor Antagonists",MESHPA +CHEMBL345714,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL346977,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL349803,D004232,Diuretics,MESHPA +CHEMBL349803,D049994,"Sodium Potassium Chloride Symporter Inhibitors",MESHPA +CHEMBL35,D004232,Diuretics,MESHPA +CHEMBL35,D049994,"Sodium Potassium Chloride Symporter Inhibitors",MESHPA +CHEMBL350221,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL354077,D009465,"Neuromuscular Agents",MESHPA +CHEMBL354077,D026902,"Potassium Channel Blockers",MESHPA +CHEMBL3544974,D014150,"Antipsychotic Agents",MESHPA +CHEMBL3545057,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL3545057,D002316,"Cardiotonic Agents",MESHPA +CHEMBL3545057,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL3545062,D000998,"Antiviral Agents",MESHPA +CHEMBL3545985,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL3545985,D013566,Sympathomimetics,MESHPA +CHEMBL3545985,D015259,"Dopamine Agents",MESHPA +CHEMBL3545985,D018663,"Adrenergic Agents",MESHPA +CHEMBL3545985,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL3545985,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL36,D000962,Antimalarials,MESHPA +CHEMBL36,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL36,D005493,"Folic Acid Antagonists",MESHPA +CHEMBL361497,D000962,Antimalarials,MESHPA +CHEMBL361497,D000970,"Antineoplastic Agents",MESHPA +CHEMBL361497,D000998,"Antiviral Agents",MESHPA +CHEMBL361497,D012556,Schistosomicides,MESHPA +CHEMBL364713,D000996,"Antitussive Agents",MESHPA +CHEMBL36506,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL36506,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL36506,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL365795,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL36715,D018696,"Neuroprotective Agents",MESHPA +CHEMBL36715,D018697,"Nootropic Agents",MESHPA +CHEMBL370143,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL370143,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL3707227,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3707232,D006397,Hematinics,MESHPA +CHEMBL3707328,D000077221,"Calcitonin Gene-Related Peptide Receptor Antagonists",MESHPA +CHEMBL3707331,D064729,"Neurokinin-1 Receptor Antagonists",MESHPA +CHEMBL370805,D000779,"Anesthetics, Local",MESHPA +CHEMBL370805,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL370805,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL372795,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL372795,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL373742,D006490,Hemostatics,MESHPA +CHEMBL373742,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL373742,D050034,"Antidiuretic Agents",MESHPA +CHEMBL374478,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL374478,D000995,"Antitubercular Agents",MESHPA +CHEMBL374478,D007917,"Leprostatic Agents",MESHPA +CHEMBL374478,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL374478,D065695,"Cytochrome P-450 CYP2B6 Inducers",MESHPA +CHEMBL374478,D065696,"Cytochrome P-450 CYP2C8 Inducers",MESHPA +CHEMBL374478,D065697,"Cytochrome P-450 CYP2C19 Inducers",MESHPA +CHEMBL374478,D065698,"Cytochrome P-450 CYP2C9 Inducers",MESHPA +CHEMBL374478,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL374731,D000998,"Antiviral Agents",MESHPA +CHEMBL374731,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL374975,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL374975,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL376140,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL376140,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL376359,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL376359,D054795,Incretins,MESHPA +CHEMBL376359,D054873,"Dipeptidyl-Peptidase IV Inhibitors",MESHPA +CHEMBL376488,D000995,"Antitubercular Agents",MESHPA +CHEMBL376897,D010276,Parasympatholytics,MESHPA +CHEMBL38,D000970,"Antineoplastic Agents",MESHPA +CHEMBL38,D003879,"Dermatologic Agents",MESHPA +CHEMBL38,D007641,"Keratolytic Agents",MESHPA +CHEMBL382301,D006727,"Hormone Antagonists",MESHPA +CHEMBL382301,D015149,"Tocolytic Agents",MESHPA +CHEMBL3833303,D006397,Hematinics,MESHPA +CHEMBL3833327,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL3833327,D000998,"Antiviral Agents",MESHPA +CHEMBL3833329,D000077221,"Calcitonin Gene-Related Peptide Receptor Antagonists",MESHPA +CHEMBL3833339,D014665,"Vasodilator Agents",MESHPA +CHEMBL3833350,D000863,Antacids,MESHPA +CHEMBL3833351,D000863,Antacids,MESHPA +CHEMBL3833402,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL383634,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL383675,D000970,"Antineoplastic Agents",MESHPA +CHEMBL383675,D011838,"Radiation-Sensitizing Agents",MESHPA +CHEMBL383675,D017319,"Photosensitizing Agents",MESHPA +CHEMBL384467,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL384467,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL384467,D000932,Antiemetics,MESHPA +CHEMBL384467,D005938,Glucocorticoids,MESHPA +CHEMBL384467,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL384467,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL385517,D054795,Incretins,MESHPA +CHEMBL385517,D054873,"Dipeptidyl-Peptidase IV Inhibitors",MESHPA +CHEMBL386630,D000728,Androgens,MESHPA +CHEMBL386630,D045930,"Anabolic Agents",MESHPA +CHEMBL387675,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL38827,D000962,Antimalarials,MESHPA +CHEMBL388590,D014528,"Uricosuric Agents",MESHPA +CHEMBL389621,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL389621,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL389621,D003879,"Dermatologic Agents",MESHPA +CHEMBL395091,D000928,"Antidepressive Agents",MESHPA +CHEMBL395429,D010120,Oxytocics,MESHPA +CHEMBL396416,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL396416,D005100,Expectorants,MESHPA +CHEMBL397420,D000925,Anticoagulants,MESHPA +CHEMBL398435,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL398435,D058921,"Purinergic P2Y Receptor Antagonists",MESHPA +CHEMBL398440,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL398440,D004202,Disinfectants,MESHPA +CHEMBL398440,D012556,Schistosomicides,MESHPA +CHEMBL398707,D000701,"Analgesics, Opioid",MESHPA +CHEMBL398707,D009294,Narcotics,MESHPA +CHEMBL3988900,D003879,"Dermatologic Agents",MESHPA +CHEMBL3988900,D013473,"Sunscreening Agents",MESHPA +CHEMBL3989480,D002400,Cathartics,MESHPA +CHEMBL3989517,D064907,"Diagnostic Uses of Chemicals",MESHPA +CHEMBL3989523,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3989523,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL3989523,D019275,Radiopharmaceuticals,MESHPA +CHEMBL3989529,D012597,"Sclerosing Solutions",MESHPA +CHEMBL3989698,D000928,"Antidepressive Agents",MESHPA +CHEMBL3989698,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL3989698,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL3989714,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL3989714,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3989727,D000975,Antioxidants,MESHPA +CHEMBL3989727,D014815,Vitamins,MESHPA +CHEMBL3989751,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL3989751,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL3989751,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL3989850,D013473,"Sunscreening Agents",MESHPA +CHEMBL3989859,D000975,Antioxidants,MESHPA +CHEMBL3989859,D014815,Vitamins,MESHPA +CHEMBL3989958,D000970,"Antineoplastic Agents",MESHPA +CHEMBL3989958,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL3989986,D051056,"Complement Inactivating Agents",MESHPA +CHEMBL4,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL4,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL4,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL4,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL40,D000927,Anticonvulsants,MESHPA +CHEMBL40,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL40,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL40,D018757,"GABA Modulators",MESHPA +CHEMBL40,D065695,"Cytochrome P-450 CYP2B6 Inducers",MESHPA +CHEMBL40,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL400599,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL400599,D001067,"Appetite Depressants",MESHPA +CHEMBL403,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL403,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL403664,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL404,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL404,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL404,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL404422,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL404520,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL404520,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL404520,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL405,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL405,D013566,Sympathomimetics,MESHPA +CHEMBL405,D015259,"Dopamine Agents",MESHPA +CHEMBL405,D018663,"Adrenergic Agents",MESHPA +CHEMBL405,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL405,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL406,D000959,"Antihypertensive Agents",MESHPA +CHEMBL406,D004232,Diuretics,MESHPA +CHEMBL406,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL406393,D002756,"Cholagogues and Choleretics",MESHPA +CHEMBL407,D000931,Antidotes,MESHPA +CHEMBL407,D018757,"GABA Modulators",MESHPA +CHEMBL408,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL408403,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL408513,D000970,"Antineoplastic Agents",MESHPA +CHEMBL408513,D056572,"Histone Deacetylase Inhibitors",MESHPA +CHEMBL409,D000726,"Androgen Antagonists",MESHPA +CHEMBL409,D000970,"Antineoplastic Agents",MESHPA +CHEMBL409153,D000935,"Antifungal Agents",MESHPA +CHEMBL41,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL41,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL41,D065690,"Cytochrome P-450 CYP2D6 Inhibitors",MESHPA +CHEMBL411,D004968,"Estrogens, Non-Steroidal",MESHPA +CHEMBL41286,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL413,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL413,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL413,D000935,"Antifungal Agents",MESHPA +CHEMBL413,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL41355,D000927,Anticonvulsants,MESHPA +CHEMBL41355,D049990,"Membrane Transport Modulators",MESHPA +CHEMBL414357,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL414357,D019440,"Anti-Obesity Agents",MESHPA +CHEMBL414357,D054795,Incretins,MESHPA +CHEMBL414804,D000970,"Antineoplastic Agents",MESHPA +CHEMBL415,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL415,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL416,D017319,"Photosensitizing Agents",MESHPA +CHEMBL416146,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL416146,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL416956,D000962,Antimalarials,MESHPA +CHEMBL417,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL417,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL418995,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL418995,D011619,"Psychotropic Drugs",MESHPA +CHEMBL419,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL419,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL419,D002257,"Carbonic Anhydrase Inhibitors",MESHPA +CHEMBL42,D012702,"Serotonin Antagonists",MESHPA +CHEMBL42,D014150,"Antipsychotic Agents",MESHPA +CHEMBL42,D018756,"GABA Antagonists",MESHPA +CHEMBL420,D000959,"Antihypertensive Agents",MESHPA +CHEMBL420,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL421,D000890,"Anti-Infective Agents",MESHPA +CHEMBL421,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL421,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL421,D018501,"Antirheumatic Agents",MESHPA +CHEMBL422,D000932,Antiemetics,MESHPA +CHEMBL422,D014150,"Antipsychotic Agents",MESHPA +CHEMBL422,D018492,"Dopamine Antagonists",MESHPA +CHEMBL423,D000959,"Antihypertensive Agents",MESHPA +CHEMBL423,D013565,Sympatholytics,MESHPA +CHEMBL423,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL424,D000890,"Anti-Infective Agents",MESHPA +CHEMBL424,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL424,D000935,"Antifungal Agents",MESHPA +CHEMBL424,D007641,"Keratolytic Agents",MESHPA +CHEMBL424,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL425,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL425,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL427,D000477,"Alkylating Agents",MESHPA +CHEMBL427,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL427216,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL428,D000890,"Anti-Infective Agents",MESHPA +CHEMBL428,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL428647,D000970,"Antineoplastic Agents",MESHPA +CHEMBL428647,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL428647,D050257,"Tubulin Modulators",MESHPA +CHEMBL428880,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL429,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL429,D000959,"Antihypertensive Agents",MESHPA +CHEMBL429,D013566,Sympathomimetics,MESHPA +CHEMBL429,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL4297166,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL4297503,D000998,"Antiviral Agents",MESHPA +CHEMBL4297503,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL4297549,D051056,"Complement Inactivating Agents",MESHPA +CHEMBL4297723,D000074322,"Antineoplastic Agents, Immunological",MESHPA +CHEMBL4297727,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL4297756,D000077221,"Calcitonin Gene-Related Peptide Receptor Antagonists",MESHPA +CHEMBL4297862,D009465,"Neuromuscular Agents",MESHPA +CHEMBL4297862,D065087,"Acetylcholine Release Inhibitors",MESHPA +CHEMBL429910,D000077203,"Sodium-Glucose Transporter 2 Inhibitors",MESHPA +CHEMBL43,D000970,"Antineoplastic Agents",MESHPA +CHEMBL430,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL430,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL43064,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL43064,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL431,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL431,D000959,"Antihypertensive Agents",MESHPA +CHEMBL434,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL434,D001993,"Bronchodilator Agents",MESHPA +CHEMBL434,D002316,"Cardiotonic Agents",MESHPA +CHEMBL434,D013566,Sympathomimetics,MESHPA +CHEMBL434394,D000959,"Antihypertensive Agents",MESHPA +CHEMBL434394,D014665,"Vasodilator Agents",MESHPA +CHEMBL434394,D058665,"Adrenergic beta-1 Receptor Agonists",MESHPA +CHEMBL43452,D007155,"Immunologic Factors",MESHPA +CHEMBL43452,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL435,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL435,D000959,"Antihypertensive Agents",MESHPA +CHEMBL435,D004232,Diuretics,MESHPA +CHEMBL435,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL435,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL435966,D000994,"Antitrichomonal Agents",MESHPA +CHEMBL436,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL437,D000890,"Anti-Infective Agents",MESHPA +CHEMBL437765,D018501,"Antirheumatic Agents",MESHPA +CHEMBL438,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL439,D000890,"Anti-Infective Agents",MESHPA +CHEMBL439,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL439,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL439,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL439,D003049,Coccidiostats,MESHPA +CHEMBL439849,D000928,"Antidepressive Agents",MESHPA +CHEMBL439849,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL439849,D058825,"Serotonin 5-HT1 Receptor Agonists",MESHPA +CHEMBL440,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL440,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL440,D018757,"GABA Modulators",MESHPA +CHEMBL441,D000927,Anticonvulsants,MESHPA +CHEMBL441,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL441,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL441,D018757,"GABA Modulators",MESHPA +CHEMBL441738,D003879,"Dermatologic Agents",MESHPA +CHEMBL442,D010120,Oxytocics,MESHPA +CHEMBL442,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL442,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL442,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL442,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL443,D000890,"Anti-Infective Agents",MESHPA +CHEMBL443,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL443,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL443,D000962,Antimalarials,MESHPA +CHEMBL443052,D000935,"Antifungal Agents",MESHPA +CHEMBL44354,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL44354,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL443605,D000871,Anthelmintics,MESHPA +CHEMBL444,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL444,D018757,"GABA Modulators",MESHPA +CHEMBL444633,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL444633,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL445,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL445,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL446,D000890,"Anti-Infective Agents",MESHPA +CHEMBL44657,D000970,"Antineoplastic Agents",MESHPA +CHEMBL44657,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL44657,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL447,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL447,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL447,D018757,"GABA Modulators",MESHPA +CHEMBL448,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL448,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL448,D018757,"GABA Modulators",MESHPA +CHEMBL44884,D000995,"Antitubercular Agents",MESHPA +CHEMBL449,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL45,D000975,Antioxidants,MESHPA +CHEMBL45,D002492,"Central Nervous System Depressants",MESHPA +CHEMBL45029,D000927,Anticonvulsants,MESHPA +CHEMBL45029,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL45029,D018757,"GABA Modulators",MESHPA +CHEMBL450449,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL450895,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL450895,D000935,"Antifungal Agents",MESHPA +CHEMBL450895,D007476,Ionophores,MESHPA +CHEMBL451,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL451,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL451,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL451,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL451,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL451,D018757,"GABA Modulators",MESHPA +CHEMBL452,D000927,Anticonvulsants,MESHPA +CHEMBL452,D018757,"GABA Modulators",MESHPA +CHEMBL452231,D000970,"Antineoplastic Agents",MESHPA +CHEMBL452231,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL453,D000890,"Anti-Infective Agents",MESHPA +CHEMBL453514,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL453514,D003049,Coccidiostats,MESHPA +CHEMBL454,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL454,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL454446,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL455,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL455,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL455,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL455186,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL455917,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL456,D004232,Diuretics,MESHPA +CHEMBL456,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL457,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL457,D065687,"Cytochrome P-450 CYP2C8 Inhibitors",MESHPA +CHEMBL457547,D000935,"Antifungal Agents",MESHPA +CHEMBL45816,D000959,"Antihypertensive Agents",MESHPA +CHEMBL45816,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL45816,D014665,"Vasodilator Agents",MESHPA +CHEMBL45816,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL459,D000959,"Antihypertensive Agents",MESHPA +CHEMBL459,D013565,Sympatholytics,MESHPA +CHEMBL459,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL459265,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL459324,D000701,"Analgesics, Opioid",MESHPA +CHEMBL459324,D009294,Narcotics,MESHPA +CHEMBL46,D000932,Antiemetics,MESHPA +CHEMBL46,D000982,Antipruritics,MESHPA +CHEMBL46,D012702,"Serotonin Antagonists",MESHPA +CHEMBL46,D014150,"Antipsychotic Agents",MESHPA +CHEMBL46,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL460,D014150,"Antipsychotic Agents",MESHPA +CHEMBL460291,D000959,"Antihypertensive Agents",MESHPA +CHEMBL460291,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL46058,D000779,"Anesthetics, Local",MESHPA +CHEMBL461522,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL461522,D058633,Antipyretics,MESHPA +CHEMBL462547,D000970,"Antineoplastic Agents",MESHPA +CHEMBL462547,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL46286,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL46286,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL46469,D003879,"Dermatologic Agents",MESHPA +CHEMBL465,D006213,Hallucinogens,MESHPA +CHEMBL465,D011619,"Psychotropic Drugs",MESHPA +CHEMBL465,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL465,D063386,"Cannabinoid Receptor Agonists",MESHPA +CHEMBL465026,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL46516,D014150,"Antipsychotic Agents",MESHPA +CHEMBL46516,D018492,"Dopamine Antagonists",MESHPA +CHEMBL466659,D014665,"Vasodilator Agents",MESHPA +CHEMBL467,D000970,"Antineoplastic Agents",MESHPA +CHEMBL467,D000986,"Antisickling Agents",MESHPA +CHEMBL467,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL467,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL46740,D020845,"Selective Estrogen Receptor Modulators",MESHPA +CHEMBL46740,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL468,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL468,D007917,"Leprostatic Agents",MESHPA +CHEMBL468,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL469,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL469,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL471,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL471,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL471,D013565,Sympatholytics,MESHPA +CHEMBL471737,D002317,"Cardiovascular Agents",MESHPA +CHEMBL472,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL473,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL473,D026902,"Potassium Channel Blockers",MESHPA +CHEMBL474579,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL475534,D000959,"Antihypertensive Agents",MESHPA +CHEMBL475534,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL475534,D014665,"Vasodilator Agents",MESHPA +CHEMBL476,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL477,D000700,Analgesics,MESHPA +CHEMBL477,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL477,D014665,"Vasodilator Agents",MESHPA +CHEMBL477,D058906,"Purinergic P1 Receptor Agonists",MESHPA +CHEMBL479,D014150,"Antipsychotic Agents",MESHPA +CHEMBL479,D018492,"Dopamine Antagonists",MESHPA +CHEMBL480,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL480,D054328,"Proton Pump Inhibitors",MESHPA +CHEMBL481,D059004,"Topoisomerase I Inhibitors",MESHPA +CHEMBL483254,D000970,"Antineoplastic Agents",MESHPA +CHEMBL483254,D056572,"Histone Deacetylase Inhibitors",MESHPA +CHEMBL48449,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL485,D000701,"Analgesics, Opioid",MESHPA +CHEMBL485,D000996,"Antitussive Agents",MESHPA +CHEMBL485,D009294,Narcotics,MESHPA +CHEMBL485253,D012702,"Serotonin Antagonists",MESHPA +CHEMBL485253,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL487253,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL488,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL488,D047072,"Aromatase Inhibitors",MESHPA +CHEMBL489411,D000935,"Antifungal Agents",MESHPA +CHEMBL49,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL49,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL490,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL490,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL490,D065690,"Cytochrome P-450 CYP2D6 Inhibitors",MESHPA +CHEMBL49080,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL49080,D001993,"Bronchodilator Agents",MESHPA +CHEMBL49080,D013566,Sympathomimetics,MESHPA +CHEMBL491571,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL492,D000779,"Anesthetics, Local",MESHPA +CHEMBL493,D000978,"Antiparkinson Agents",MESHPA +CHEMBL493,D006727,"Hormone Antagonists",MESHPA +CHEMBL493,D018491,"Dopamine Agonists",MESHPA +CHEMBL493982,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL494,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL494,D014665,"Vasodilator Agents",MESHPA +CHEMBL495,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL495,D014665,"Vasodilator Agents",MESHPA +CHEMBL495,D064804,"Urological Agents",MESHPA +CHEMBL496,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL498,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL498847,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL499,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL499,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL499,D000959,"Antihypertensive Agents",MESHPA +CHEMBL499808,D000935,"Antifungal Agents",MESHPA +CHEMBL499808,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL5,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL5,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL500,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL500,D000959,"Antihypertensive Agents",MESHPA +CHEMBL500,D012702,"Serotonin Antagonists",MESHPA +CHEMBL500,D014665,"Vasodilator Agents",MESHPA +CHEMBL501122,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL501849,D000998,"Antiviral Agents",MESHPA +CHEMBL501849,D011480,"Protease Inhibitors",MESHPA +CHEMBL501867,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL501867,D050257,"Tubulin Modulators",MESHPA +CHEMBL502,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL502,D018697,"Nootropic Agents",MESHPA +CHEMBL502097,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL502835,D000970,"Antineoplastic Agents",MESHPA +CHEMBL502835,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL503,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL503,D019161,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MESHPA +CHEMBL504,D003451,"Cryoprotective Agents",MESHPA +CHEMBL504,D016166,"Free Radical Scavengers",MESHPA +CHEMBL504760,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL505,D000982,Antipruritics,MESHPA +CHEMBL505,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL505,D013566,Sympathomimetics,MESHPA +CHEMBL505,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL506,D000962,Antimalarials,MESHPA +CHEMBL506110,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL506110,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL507674,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL507870,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL508102,D013956,"Antithyroid Agents",MESHPA +CHEMBL509,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL509,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL509924,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL509924,D005938,Glucocorticoids,MESHPA +CHEMBL51,D000959,"Antihypertensive Agents",MESHPA +CHEMBL51,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL51,D012702,"Serotonin Antagonists",MESHPA +CHEMBL511,D000068776,"Sleep Aids, Pharmaceutical",MESHPA +CHEMBL511,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL511,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL512351,D065427,"Factor Xa Inhibitors",MESHPA +CHEMBL513,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL514,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL514446,D002756,"Cholagogues and Choleretics",MESHPA +CHEMBL514800,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL515,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL515606,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL515606,D000959,"Antihypertensive Agents",MESHPA +CHEMBL516,D000982,Antipruritics,MESHPA +CHEMBL516,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL516,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL516,D012702,"Serotonin Antagonists",MESHPA +CHEMBL516,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL517,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL517,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL517712,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL517712,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL517712,D001993,"Bronchodilator Agents",MESHPA +CHEMBL517712,D009184,Mydriatics,MESHPA +CHEMBL517712,D010276,Parasympatholytics,MESHPA +CHEMBL517712,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL521,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL521,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL521,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL521686,D000067856,"Poly(ADP-ribose) Polymerase Inhibitors",MESHPA +CHEMBL521686,D000970,"Antineoplastic Agents",MESHPA +CHEMBL524,D013566,Sympathomimetics,MESHPA +CHEMBL524,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL524,D058646,"Adrenergic alpha-1 Receptor Agonists",MESHPA +CHEMBL52440,D000996,"Antitussive Agents",MESHPA +CHEMBL52440,D001993,"Bronchodilator Agents",MESHPA +CHEMBL52440,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL52440,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL525076,D023581,"HIV Fusion Inhibitors",MESHPA +CHEMBL525610,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL525610,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL526,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL526,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL527,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL527,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL528,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL529,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL529888,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL53,D004639,Emetics,MESHPA +CHEMBL53,D018491,"Dopamine Agonists",MESHPA +CHEMBL531,D018491,"Dopamine Agonists",MESHPA +CHEMBL532,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL532,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL532,D005765,"Gastrointestinal Agents",MESHPA +CHEMBL532,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL533,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL534,D000982,Antipruritics,MESHPA +CHEMBL534,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL534,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL53418,D002400,Cathartics,MESHPA +CHEMBL53463,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL53463,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL535,D000970,"Antineoplastic Agents",MESHPA +CHEMBL535,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL535,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL537,D000975,Antioxidants,MESHPA +CHEMBL537,D011837,"Radiation-Protective Agents",MESHPA +CHEMBL539,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL539697,D000991,Antithrombins,MESHPA +CHEMBL54,D000932,Antiemetics,MESHPA +CHEMBL54,D014150,"Antipsychotic Agents",MESHPA +CHEMBL54,D018492,"Dopamine Antagonists",MESHPA +CHEMBL54,D018726,"Anti-Dyskinesia Agents",MESHPA +CHEMBL541,D000935,"Antifungal Agents",MESHPA +CHEMBL544,D000970,"Antineoplastic Agents",MESHPA +CHEMBL544,D000975,Antioxidants,MESHPA +CHEMBL545,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL545,D002492,"Central Nervous System Depressants",MESHPA +CHEMBL546,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL546,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL546,D000959,"Antihypertensive Agents",MESHPA +CHEMBL546,D013565,Sympatholytics,MESHPA +CHEMBL546,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL546,D014665,"Vasodilator Agents",MESHPA +CHEMBL547,D003879,"Dermatologic Agents",MESHPA +CHEMBL548,D010120,Oxytocics,MESHPA +CHEMBL549,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL549,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL54976,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL55,D000935,"Antifungal Agents",MESHPA +CHEMBL55,D000981,"Antiprotozoal Agents",MESHPA +CHEMBL55,D014344,"Trypanocidal Agents",MESHPA +CHEMBL550,D008916,Miotics,MESHPA +CHEMBL550,D018721,"Muscarinic Agonists",MESHPA +CHEMBL550348,D007502,"Iron Chelating Agents",MESHPA +CHEMBL553,D000970,"Antineoplastic Agents",MESHPA +CHEMBL553,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL553025,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL553025,D050257,"Tubulin Modulators",MESHPA +CHEMBL554,D000970,"Antineoplastic Agents",MESHPA +CHEMBL554,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL55400,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL556,D017262,Siderophores,MESHPA +CHEMBL55643,D014131,"Trace Elements",MESHPA +CHEMBL557555,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL558,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL558,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL561,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL561,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL562,D000935,"Antifungal Agents",MESHPA +CHEMBL563,D000700,Analgesics,MESHPA +CHEMBL563,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL563,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL56367,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL56367,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL564,D000932,Antiemetics,MESHPA +CHEMBL564,D014150,"Antipsychotic Agents",MESHPA +CHEMBL564,D018492,"Dopamine Antagonists",MESHPA +CHEMBL564085,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL565,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL565,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL56564,D000932,Antiemetics,MESHPA +CHEMBL56564,D058831,"Serotonin 5-HT3 Receptor Antagonists",MESHPA +CHEMBL566534,D000962,Antimalarials,MESHPA +CHEMBL567,D014150,"Antipsychotic Agents",MESHPA +CHEMBL567,D018492,"Dopamine Antagonists",MESHPA +CHEMBL568,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL568,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL568,D018757,"GABA Modulators",MESHPA +CHEMBL569,D000779,"Anesthetics, Local",MESHPA +CHEMBL569713,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL569713,D000932,Antiemetics,MESHPA +CHEMBL569713,D009184,Mydriatics,MESHPA +CHEMBL569713,D018680,"Cholinergic Antagonists",MESHPA +CHEMBL569713,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL57,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL57,D019380,"Anti-HIV Agents",MESHPA +CHEMBL57,D065701,"Cytochrome P-450 CYP3A Inducers",MESHPA +CHEMBL570,D000932,Antiemetics,MESHPA +CHEMBL570,D014150,"Antipsychotic Agents",MESHPA +CHEMBL570,D018492,"Dopamine Antagonists",MESHPA +CHEMBL571,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL571,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL572,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL572,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL573,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL573,D014665,"Vasodilator Agents",MESHPA +CHEMBL573,D014803,"Vitamin B Complex",MESHPA +CHEMBL575,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL577,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL577,D000959,"Antihypertensive Agents",MESHPA +CHEMBL577736,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL577736,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL578,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL578,D000959,"Antihypertensive Agents",MESHPA +CHEMBL579205,D003287,"Contrast Media",MESHPA +CHEMBL579205,D019275,Radiopharmaceuticals,MESHPA +CHEMBL58,D000700,Analgesics,MESHPA +CHEMBL58,D000970,"Antineoplastic Agents",MESHPA +CHEMBL58,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL580,D000927,Anticonvulsants,MESHPA +CHEMBL580,D000932,Antiemetics,MESHPA +CHEMBL580,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL580,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL580,D018757,"GABA Modulators",MESHPA +CHEMBL583,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL583,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL58323,D000927,Anticonvulsants,MESHPA +CHEMBL58323,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL584,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL585,D000959,"Antihypertensive Agents",MESHPA +CHEMBL585,D004232,Diuretics,MESHPA +CHEMBL585,D062686,"Epithelial Sodium Channel Blockers",MESHPA +CHEMBL588,D000959,"Antihypertensive Agents",MESHPA +CHEMBL588,D014665,"Vasodilator Agents",MESHPA +CHEMBL588,D018491,"Dopamine Agonists",MESHPA +CHEMBL589,D000978,"Antiparkinson Agents",MESHPA +CHEMBL589,D018491,"Dopamine Agonists",MESHPA +CHEMBL59,D002316,"Cardiotonic Agents",MESHPA +CHEMBL59,D013566,Sympathomimetics,MESHPA +CHEMBL59,D015259,"Dopamine Agents",MESHPA +CHEMBL590,D000933,"Antifibrinolytic Agents",MESHPA +CHEMBL590,D014815,Vitamins,MESHPA +CHEMBL591,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL591665,D000975,Antioxidants,MESHPA +CHEMBL591665,D014815,Vitamins,MESHPA +CHEMBL592,D000701,"Analgesics, Opioid",MESHPA +CHEMBL592,D009294,Narcotics,MESHPA +CHEMBL593,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL593,D019380,"Anti-HIV Agents",MESHPA +CHEMBL594,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL594,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL595,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL596,D000700,Analgesics,MESHPA +CHEMBL596,D000701,"Analgesics, Opioid",MESHPA +CHEMBL596,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL596,D009294,Narcotics,MESHPA +CHEMBL596,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL596,D019162,"Anesthetics, Combined",MESHPA +CHEMBL597,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL597,D000959,"Antihypertensive Agents",MESHPA +CHEMBL599,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL599,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL6,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL6,D002317,"Cardiovascular Agents",MESHPA +CHEMBL6,D006074,"Gout Suppressants",MESHPA +CHEMBL6,D015149,"Tocolytic Agents",MESHPA +CHEMBL6,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL600,D000998,"Antiviral Agents",MESHPA +CHEMBL600,D005100,Expectorants,MESHPA +CHEMBL600,D016166,"Free Radical Scavengers",MESHPA +CHEMBL601,D017319,"Photosensitizing Agents",MESHPA +CHEMBL601719,D000970,"Antineoplastic Agents",MESHPA +CHEMBL601719,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL602,D065104,"Cystine Depleting Agents",MESHPA +CHEMBL603,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL603,D020024,"Leukotriene Antagonists",MESHPA +CHEMBL604,D000931,Antidotes,MESHPA +CHEMBL604,D004639,Emetics,MESHPA +CHEMBL605846,D001993,"Bronchodilator Agents",MESHPA +CHEMBL606,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL606,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL606,D010120,Oxytocics,MESHPA +CHEMBL607,D000701,"Analgesics, Opioid",MESHPA +CHEMBL607,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL607,D009294,Narcotics,MESHPA +CHEMBL607400,D000927,Anticonvulsants,MESHPA +CHEMBL607710,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL608,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL608,D000975,Antioxidants,MESHPA +CHEMBL608533,D000970,"Antineoplastic Agents",MESHPA +CHEMBL608533,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL609,D002614,"Chelating Agents",MESHPA +CHEMBL61,D000972,"Antineoplastic Agents, Phytogenic",MESHPA +CHEMBL61,D007641,"Keratolytic Agents",MESHPA +CHEMBL61,D050257,"Tubulin Modulators",MESHPA +CHEMBL611,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL611,D064804,"Urological Agents",MESHPA +CHEMBL612,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL612,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL614,D000995,"Antitubercular Agents",MESHPA +CHEMBL615,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL61593,D000959,"Antihypertensive Agents",MESHPA +CHEMBL61593,D004232,Diuretics,MESHPA +CHEMBL617,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL621,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL621,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL621,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL62193,D000890,"Anti-Infective Agents",MESHPA +CHEMBL62193,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL62193,D003049,Coccidiostats,MESHPA +CHEMBL622,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL622,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL623,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL623,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL623,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL625,D000871,Anthelmintics,MESHPA +CHEMBL626,D000935,"Antifungal Agents",MESHPA +CHEMBL628,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL628,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL628,D011837,"Radiation-Protective Agents",MESHPA +CHEMBL628,D014665,"Vasodilator Agents",MESHPA +CHEMBL628,D016166,"Free Radical Scavengers",MESHPA +CHEMBL629,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL629,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL629,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL629,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL631,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL631,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL632,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL632,D005938,Glucocorticoids,MESHPA +CHEMBL632,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL633,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL633,D014665,"Vasodilator Agents",MESHPA +CHEMBL633,D026902,"Potassium Channel Blockers",MESHPA +CHEMBL633,D026941,"Sodium Channel Blockers",MESHPA +CHEMBL633,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL633,D065688,"Cytochrome P-450 CYP2C9 Inhibitors",MESHPA +CHEMBL633,D065690,"Cytochrome P-450 CYP2D6 Inhibitors",MESHPA +CHEMBL633,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL634,D000701,"Analgesics, Opioid",MESHPA +CHEMBL634,D009294,Narcotics,MESHPA +CHEMBL634,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL635,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL635,D005938,Glucocorticoids,MESHPA +CHEMBL635,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL636,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL636,D018696,"Neuroprotective Agents",MESHPA +CHEMBL637,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL637,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL638,D000935,"Antifungal Agents",MESHPA +CHEMBL638,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL638,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL639,D001993,"Bronchodilator Agents",MESHPA +CHEMBL639,D016859,"Lipoxygenase Inhibitors",MESHPA +CHEMBL639,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL639,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL64,D000995,"Antitubercular Agents",MESHPA +CHEMBL64,D054872,"Fatty Acid Synthesis Inhibitors",MESHPA +CHEMBL640,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL640,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL641,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL642,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL642,D000959,"Antihypertensive Agents",MESHPA +CHEMBL642,D013566,Sympathomimetics,MESHPA +CHEMBL642,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL643,D000982,Antipruritics,MESHPA +CHEMBL643,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL643,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL6437,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL6437,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL6437,D012702,"Serotonin Antagonists",MESHPA +CHEMBL6437,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL64391,D000935,"Antifungal Agents",MESHPA +CHEMBL64391,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL64391,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL644,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL644,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL645,D000959,"Antihypertensive Agents",MESHPA +CHEMBL645,D013565,Sympatholytics,MESHPA +CHEMBL645,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL646,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL646,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL646,D018757,"GABA Modulators",MESHPA +CHEMBL647,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL648,D000932,Antiemetics,MESHPA +CHEMBL648,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL649,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL649,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL649,D000959,"Antihypertensive Agents",MESHPA +CHEMBL649,D013565,Sympatholytics,MESHPA +CHEMBL650,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL650,D000932,Antiemetics,MESHPA +CHEMBL650,D005938,Glucocorticoids,MESHPA +CHEMBL650,D018696,"Neuroprotective Agents",MESHPA +CHEMBL650,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL651,D000701,"Analgesics, Opioid",MESHPA +CHEMBL651,D000996,"Antitussive Agents",MESHPA +CHEMBL651,D009294,Narcotics,MESHPA +CHEMBL652,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL652,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL654,D000928,"Antidepressive Agents",MESHPA +CHEMBL654,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL654,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL654,D058669,"Adrenergic alpha-2 Receptor Antagonists",MESHPA +CHEMBL654,D058830,"Serotonin 5-HT2 Receptor Antagonists",MESHPA +CHEMBL654,D058831,"Serotonin 5-HT3 Receptor Antagonists",MESHPA +CHEMBL655,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL655,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL655,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL655,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL655,D018757,"GABA Modulators",MESHPA +CHEMBL656,D000701,"Analgesics, Opioid",MESHPA +CHEMBL656,D009294,Narcotics,MESHPA +CHEMBL657,D000068776,"Sleep Aids, Pharmaceutical",MESHPA +CHEMBL657,D000779,"Anesthetics, Local",MESHPA +CHEMBL657,D000932,Antiemetics,MESHPA +CHEMBL657,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL657,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL657,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL65794,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL658,D000701,"Analgesics, Opioid",MESHPA +CHEMBL658,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL658,D009294,Narcotics,MESHPA +CHEMBL658,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL659,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL659,D010277,Parasympathomimetics,MESHPA +CHEMBL659,D018697,"Nootropic Agents",MESHPA +CHEMBL660,D000978,"Antiparkinson Agents",MESHPA +CHEMBL660,D000998,"Antiviral Agents",MESHPA +CHEMBL660,D015259,"Dopamine Agents",MESHPA +CHEMBL660,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL661,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL661,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL661,D018757,"GABA Modulators",MESHPA +CHEMBL6622,D014665,"Vasodilator Agents",MESHPA +CHEMBL6622,D020030,"Nitric Oxide Donors",MESHPA +CHEMBL666,D000998,"Antiviral Agents",MESHPA +CHEMBL666,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL667,D014665,"Vasodilator Agents",MESHPA +CHEMBL667,D018679,"Cholinergic Agonists",MESHPA +CHEMBL668,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL668,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL669,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL669,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL669,D014149,"Tranquilizing Agents",MESHPA +CHEMBL671,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL671,D019653,"Myeloablative Agonists",MESHPA +CHEMBL672,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL672,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL673,D000959,"Antihypertensive Agents",MESHPA +CHEMBL673,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL677,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL679,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL679,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL679,D001993,"Bronchodilator Agents",MESHPA +CHEMBL679,D009184,Mydriatics,MESHPA +CHEMBL679,D013566,Sympathomimetics,MESHPA +CHEMBL679,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL680,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL681,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL681,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL682,D000962,Antimalarials,MESHPA +CHEMBL684,D005369,Filaricides,MESHPA +CHEMBL684,D016859,"Lipoxygenase Inhibitors",MESHPA +CHEMBL685,D000969,"Antinematodal Agents",MESHPA +CHEMBL685,D050257,"Tubulin Modulators",MESHPA +CHEMBL686,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL686,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL689,D004234,"Diuretics, Osmotic",MESHPA +CHEMBL691,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL691,D003277,"Contraceptives, Oral, Combined",MESHPA +CHEMBL691,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL691,D003279,"Contraceptives, Oral, Sequential",MESHPA +CHEMBL691,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL691,D003282,"Contraceptives, Postcoital, Hormonal",MESHPA +CHEMBL691,D003283,"Contraceptives, Postcoital, Synthetic",MESHPA +CHEMBL691,D004967,Estrogens,MESHPA +CHEMBL691,D012102,"Reproductive Control Agents",MESHPA +CHEMBL692,D003451,"Cryoprotective Agents",MESHPA +CHEMBL695,D000927,Anticonvulsants,MESHPA +CHEMBL696,D000927,Anticonvulsants,MESHPA +CHEMBL6966,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL6966,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL6966,D014665,"Vasodilator Agents",MESHPA +CHEMBL697,D000927,Anticonvulsants,MESHPA +CHEMBL698,D000779,"Anesthetics, Local",MESHPA +CHEMBL6995,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL6995,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL70,D000701,"Analgesics, Opioid",MESHPA +CHEMBL70,D000930,Antidiarrheals,MESHPA +CHEMBL70,D009294,Narcotics,MESHPA +CHEMBL700,D000890,"Anti-Infective Agents",MESHPA +CHEMBL700,D003879,"Dermatologic Agents",MESHPA +CHEMBL701,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL701,D058786,"GABA-B Receptor Agonists",MESHPA +CHEMBL702,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL702,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL703,D009467,"Neuromuscular Depolarizing Agents",MESHPA +CHEMBL704,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL70418,D000927,Anticonvulsants,MESHPA +CHEMBL70418,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL70418,D058785,"GABA-A Receptor Agonists",MESHPA +CHEMBL705,D000970,"Antineoplastic Agents",MESHPA +CHEMBL705,D003879,"Dermatologic Agents",MESHPA +CHEMBL707,D000959,"Antihypertensive Agents",MESHPA +CHEMBL707,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL708,D012702,"Serotonin Antagonists",MESHPA +CHEMBL708,D014150,"Antipsychotic Agents",MESHPA +CHEMBL708,D018492,"Dopamine Antagonists",MESHPA +CHEMBL709,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL709,D064804,"Urological Agents",MESHPA +CHEMBL70927,D007502,"Iron Chelating Agents",MESHPA +CHEMBL71,D000932,Antiemetics,MESHPA +CHEMBL71,D014150,"Antipsychotic Agents",MESHPA +CHEMBL71,D018492,"Dopamine Antagonists",MESHPA +CHEMBL710,D058891,"5-alpha Reductase Inhibitors",MESHPA +CHEMBL710,D064804,"Urological Agents",MESHPA +CHEMBL711,D000925,Anticoagulants,MESHPA +CHEMBL713,D000998,"Antiviral Agents",MESHPA +CHEMBL714,D001993,"Bronchodilator Agents",MESHPA +CHEMBL714,D015149,"Tocolytic Agents",MESHPA +CHEMBL714,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL715,D000932,Antiemetics,MESHPA +CHEMBL715,D014150,"Antipsychotic Agents",MESHPA +CHEMBL715,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL71595,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL716,D000928,"Antidepressive Agents",MESHPA +CHEMBL716,D014150,"Antipsychotic Agents",MESHPA +CHEMBL717,D000080066,"Contraceptive Agents, Hormonal",MESHPA +CHEMBL717,D003271,"Contraceptive Agents, Female",MESHPA +CHEMBL717,D003272,"Contraceptive Agents, Male",MESHPA +CHEMBL717,D003278,"Contraceptives, Oral, Hormonal",MESHPA +CHEMBL717,D003280,"Contraceptives, Oral, Synthetic",MESHPA +CHEMBL717,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL71752,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL71752,D014665,"Vasodilator Agents",MESHPA +CHEMBL71752,D018696,"Neuroprotective Agents",MESHPA +CHEMBL71752,D018697,"Nootropic Agents",MESHPA +CHEMBL719,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL719,D011500,"Protein Synthesis Inhibitors",MESHPA +CHEMBL72,D000929,"Antidepressive Agents, Tricyclic",MESHPA +CHEMBL72,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL72,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL720,D000779,"Anesthetics, Local",MESHPA +CHEMBL723,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL723,D000959,"Antihypertensive Agents",MESHPA +CHEMBL723,D000975,Antioxidants,MESHPA +CHEMBL723,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL723,D014665,"Vasodilator Agents",MESHPA +CHEMBL723,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL726,D014150,"Antipsychotic Agents",MESHPA +CHEMBL726,D018492,"Dopamine Antagonists",MESHPA +CHEMBL727,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL728,D000932,Antiemetics,MESHPA +CHEMBL728,D014150,"Antipsychotic Agents",MESHPA +CHEMBL728,D018492,"Dopamine Antagonists",MESHPA +CHEMBL729,D017320,"HIV Protease Inhibitors",MESHPA +CHEMBL729,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL730,D014665,"Vasodilator Agents",MESHPA +CHEMBL73234,D000996,"Antitussive Agents",MESHPA +CHEMBL734,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL741,D000927,Anticonvulsants,MESHPA +CHEMBL741,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL741,D014150,"Antipsychotic Agents",MESHPA +CHEMBL741,D026941,"Sodium Channel Blockers",MESHPA +CHEMBL7413,D018686,"Anesthetics, Intravenous",MESHPA +CHEMBL742,D000700,Analgesics,MESHPA +CHEMBL742,D000778,"Anesthetics, Dissociative",MESHPA +CHEMBL742,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL744,D000927,Anticonvulsants,MESHPA +CHEMBL744,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL744,D018696,"Neuroprotective Agents",MESHPA +CHEMBL746,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL746,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL746,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL74632,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL750,D000927,Anticonvulsants,MESHPA +CHEMBL750,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL752,D000700,Analgesics,MESHPA +CHEMBL752,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL752,D014665,"Vasodilator Agents",MESHPA +CHEMBL752,D058906,"Purinergic P1 Receptor Agonists",MESHPA +CHEMBL753,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL753,D000959,"Antihypertensive Agents",MESHPA +CHEMBL753,D014665,"Vasodilator Agents",MESHPA +CHEMBL75435,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL75753,D058665,"Adrenergic beta-1 Receptor Agonists",MESHPA +CHEMBL75880,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL75880,D002317,"Cardiovascular Agents",MESHPA +CHEMBL75880,D014665,"Vasodilator Agents",MESHPA +CHEMBL76,D000563,Amebicides,MESHPA +CHEMBL76,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL76,D000962,Antimalarials,MESHPA +CHEMBL76,D005369,Filaricides,MESHPA +CHEMBL76,D018501,"Antirheumatic Agents",MESHPA +CHEMBL760,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL760,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL761,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL761,D014663,"Nasal Decongestants",MESHPA +CHEMBL762,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL762,D013566,Sympathomimetics,MESHPA +CHEMBL762,D014663,"Nasal Decongestants",MESHPA +CHEMBL76370,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL765,D000959,"Antihypertensive Agents",MESHPA +CHEMBL765,D013565,Sympatholytics,MESHPA +CHEMBL765,D018663,"Adrenergic Agents",MESHPA +CHEMBL766,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL766,D011480,"Protease Inhibitors",MESHPA +CHEMBL768,D058671,"Adrenergic beta-1 Receptor Antagonists",MESHPA +CHEMBL770,D000317,"Adrenergic alpha-Antagonists",MESHPA +CHEMBL770,D000959,"Antihypertensive Agents",MESHPA +CHEMBL770,D014665,"Vasodilator Agents",MESHPA +CHEMBL771,D000892,"Anti-Infective Agents, Urinary",MESHPA +CHEMBL771,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL771,D000963,Antimetabolites,MESHPA +CHEMBL772,D000959,"Antihypertensive Agents",MESHPA +CHEMBL772,D014150,"Antipsychotic Agents",MESHPA +CHEMBL772,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL773,D018684,"Glycine Agents",MESHPA +CHEMBL776,D001993,"Bronchodilator Agents",MESHPA +CHEMBL776,D013566,Sympathomimetics,MESHPA +CHEMBL776,D015149,"Tocolytic Agents",MESHPA +CHEMBL776,D058666,"Adrenergic beta-2 Receptor Agonists",MESHPA +CHEMBL77622,D000318,"Adrenergic beta-Agonists",MESHPA +CHEMBL77622,D014665,"Vasodilator Agents",MESHPA +CHEMBL77622,D018491,"Dopamine Agonists",MESHPA +CHEMBL777,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL777,D065093,"beta-Lactamase Inhibitors",MESHPA +CHEMBL778,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL778,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL778,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL779,D014665,"Vasodilator Agents",MESHPA +CHEMBL779,D058986,"Phosphodiesterase 5 Inhibitors",MESHPA +CHEMBL779,D064804,"Urological Agents",MESHPA +CHEMBL780,D000931,Antidotes,MESHPA +CHEMBL780,D002614,"Chelating Agents",MESHPA +CHEMBL780,D007502,"Iron Chelating Agents",MESHPA +CHEMBL781,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL781,D018759,"Adrenergic Uptake Inhibitors",MESHPA +CHEMBL781,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL782,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL783,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL787,D018927,"Anti-Asthmatic Agents",MESHPA +CHEMBL787,D020024,"Leukotriene Antagonists",MESHPA +CHEMBL787,D065694,"Cytochrome P-450 CYP1A2 Inducers",MESHPA +CHEMBL788,D000998,"Antiviral Agents",MESHPA +CHEMBL788,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL79,D000779,"Anesthetics, Local",MESHPA +CHEMBL79,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL79,D019162,"Anesthetics, Combined",MESHPA +CHEMBL79,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL790,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL790,D003879,"Dermatologic Agents",MESHPA +CHEMBL790,D004202,Disinfectants,MESHPA +CHEMBL796,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL796,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL799,D001993,"Bronchodilator Agents",MESHPA +CHEMBL799,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL799,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL799,D014665,"Vasodilator Agents",MESHPA +CHEMBL799,D018696,"Neuroprotective Agents",MESHPA +CHEMBL799,D058987,"Phosphodiesterase 3 Inhibitors",MESHPA +CHEMBL8,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL8,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL8,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL80,D000701,"Analgesics, Opioid",MESHPA +CHEMBL80,D009292,"Narcotic Antagonists",MESHPA +CHEMBL802,D000959,"Antihypertensive Agents",MESHPA +CHEMBL802,D014665,"Vasodilator Agents",MESHPA +CHEMBL803,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL803,D000998,"Antiviral Agents",MESHPA +CHEMBL803,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL806,D000726,"Androgen Antagonists",MESHPA +CHEMBL806,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL807,D000978,"Antiparkinson Agents",MESHPA +CHEMBL807,D015259,"Dopamine Agents",MESHPA +CHEMBL807,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL808,D000935,"Antifungal Agents",MESHPA +CHEMBL808,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL809,D000928,"Antidepressive Agents",MESHPA +CHEMBL809,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL81,D004965,"Estrogen Antagonists",MESHPA +CHEMBL81,D020845,"Selective Estrogen Receptor Modulators",MESHPA +CHEMBL81,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL810,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL811,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL811,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL813,D000959,"Antihypertensive Agents",MESHPA +CHEMBL813,D057912,"Angiotensin II Type 2 Receptor Blockers",MESHPA +CHEMBL814,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL814,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL814,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL814,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL814,D065689,"Cytochrome P-450 CYP2C19 Inhibitors",MESHPA +CHEMBL815,D000020,"Abortifacient Agents, Nonsteroidal",MESHPA +CHEMBL815,D010120,Oxytocics,MESHPA +CHEMBL817,D007004,"Hypoglycemic Agents",MESHPA +CHEMBL818,D000970,"Antineoplastic Agents",MESHPA +CHEMBL818,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL818,D019275,Radiopharmaceuticals,MESHPA +CHEMBL819,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL820,D000477,"Alkylating Agents",MESHPA +CHEMBL820,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL820,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL820,D019653,"Myeloablative Agonists",MESHPA +CHEMBL822,D000935,"Antifungal Agents",MESHPA +CHEMBL822,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL826,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL826,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL826,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL827,D000697,"Central Nervous System Stimulants",MESHPA +CHEMBL827,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL829,D000982,Antipruritics,MESHPA +CHEMBL829,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL83,D004965,"Estrogen Antagonists",MESHPA +CHEMBL83,D018931,"Antineoplastic Agents, Hormonal",MESHPA +CHEMBL83,D020845,"Selective Estrogen Receptor Modulators",MESHPA +CHEMBL83,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL830,D000970,"Antineoplastic Agents",MESHPA +CHEMBL830,D014344,"Trypanocidal Agents",MESHPA +CHEMBL830,D065108,"Ornithine Decarboxylase Inhibitors",MESHPA +CHEMBL831,D014150,"Antipsychotic Agents",MESHPA +CHEMBL831,D018492,"Dopamine Antagonists",MESHPA +CHEMBL832,D014528,"Uricosuric Agents",MESHPA +CHEMBL833,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL833,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL833,D058921,"Purinergic P2Y Receptor Antagonists",MESHPA +CHEMBL833,D065689,"Cytochrome P-450 CYP2C19 Inhibitors",MESHPA +CHEMBL834,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL836,D058668,"Adrenergic alpha-1 Receptor Antagonists",MESHPA +CHEMBL836,D064804,"Urological Agents",MESHPA +CHEMBL83668,D000935,"Antifungal Agents",MESHPA +CHEMBL838,D000806,"Angiotensin-Converting Enzyme Inhibitors",MESHPA +CHEMBL838,D000959,"Antihypertensive Agents",MESHPA +CHEMBL839,D000319,"Adrenergic beta-Antagonists",MESHPA +CHEMBL839,D000889,"Anti-Arrhythmia Agents",MESHPA +CHEMBL839,D000959,"Antihypertensive Agents",MESHPA +CHEMBL839,D013565,Sympatholytics,MESHPA +CHEMBL84,D059004,"Topoisomerase I Inhibitors",MESHPA +CHEMBL841,D000930,Antidiarrheals,MESHPA +CHEMBL842,D000959,"Antihypertensive Agents",MESHPA +CHEMBL842,D004232,Diuretics,MESHPA +CHEMBL842,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL844,D000959,"Antihypertensive Agents",MESHPA +CHEMBL844,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL846,D000077264,"Calcium-Regulating Hormones and Agents",MESHPA +CHEMBL846,D002120,"Calcium Channel Agonists",MESHPA +CHEMBL846,D014815,Vitamins,MESHPA +CHEMBL846,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL847,D012556,Schistosomicides,MESHPA +CHEMBL848,D007155,"Immunologic Factors",MESHPA +CHEMBL848,D020533,"Angiogenesis Inhibitors",MESHPA +CHEMBL849,D000891,"Anti-Infective Agents, Local",MESHPA +CHEMBL849,D054872,"Fatty Acid Synthesis Inhibitors",MESHPA +CHEMBL85,D012702,"Serotonin Antagonists",MESHPA +CHEMBL85,D014150,"Antipsychotic Agents",MESHPA +CHEMBL85,D018492,"Dopamine Antagonists",MESHPA +CHEMBL850,D000995,"Antitubercular Agents",MESHPA +CHEMBL850,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL852,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL852,D019653,"Myeloablative Agonists",MESHPA +CHEMBL853,D000963,Antimetabolites,MESHPA +CHEMBL853,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL853,D019380,"Anti-HIV Agents",MESHPA +CHEMBL855,D005100,Expectorants,MESHPA +CHEMBL855,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL855,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL856,D000927,Anticonvulsants,MESHPA +CHEMBL856,D018757,"GABA Modulators",MESHPA +CHEMBL857,D014803,"Vitamin B Complex",MESHPA +CHEMBL86,D000932,Antiemetics,MESHPA +CHEMBL86,D065127,"Dopamine D2 Receptor Antagonists",MESHPA +CHEMBL861,D000927,Anticonvulsants,MESHPA +CHEMBL862,D000959,"Antihypertensive Agents",MESHPA +CHEMBL862,D058647,"Adrenergic alpha-2 Receptor Agonists",MESHPA +CHEMBL86304,D000928,"Antidepressive Agents",MESHPA +CHEMBL86304,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL864,D000996,"Antitussive Agents",MESHPA +CHEMBL864,D001993,"Bronchodilator Agents",MESHPA +CHEMBL864,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL864,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL865,D052246,"Cyclooxygenase 2 Inhibitors",MESHPA +CHEMBL866,D000903,"Antibiotics, Antineoplastic",MESHPA +CHEMBL866,D000904,"Antibiotics, Antitubercular",MESHPA +CHEMBL866,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL867,D003287,"Contrast Media",MESHPA +CHEMBL86715,D000978,"Antiparkinson Agents",MESHPA +CHEMBL86715,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL86882,D000316,"Adrenergic alpha-Agonists",MESHPA +CHEMBL86882,D002316,"Cardiotonic Agents",MESHPA +CHEMBL86882,D013566,Sympathomimetics,MESHPA +CHEMBL86882,D014662,"Vasoconstrictor Agents",MESHPA +CHEMBL86882,D058665,"Adrenergic beta-1 Receptor Agonists",MESHPA +CHEMBL869,D000890,"Anti-Infective Agents",MESHPA +CHEMBL870,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL871,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL87493,D017367,"Serotonin Uptake Inhibitors",MESHPA +CHEMBL87493,D018490,"Serotonin Agents",MESHPA +CHEMBL877,D000933,"Antifibrinolytic Agents",MESHPA +CHEMBL878,D000959,"Antihypertensive Agents",MESHPA +CHEMBL878,D004232,Diuretics,MESHPA +CHEMBL878,D049993,"Sodium Chloride Symporter Inhibitors",MESHPA +CHEMBL87992,D000927,Anticonvulsants,MESHPA +CHEMBL87992,D061567,"Voltage-Gated Sodium Channel Blockers",MESHPA +CHEMBL88,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL88,D018501,"Antirheumatic Agents",MESHPA +CHEMBL88,D018906,"Antineoplastic Agents, Alkylating",MESHPA +CHEMBL88,D019653,"Myeloablative Agonists",MESHPA +CHEMBL880,D000998,"Antiviral Agents",MESHPA +CHEMBL880,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL885,D000998,"Antiviral Agents",MESHPA +CHEMBL885,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL885,D019380,"Anti-HIV Agents",MESHPA +CHEMBL887,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL887,D018696,"Neuroprotective Agents",MESHPA +CHEMBL888,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL888,D000998,"Antiviral Agents",MESHPA +CHEMBL888,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL888,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL888,D011838,"Radiation-Sensitizing Agents",MESHPA +CHEMBL891,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL893,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL894,D000077444,"Smoking Cessation Agents",MESHPA +CHEMBL894,D018687,"Antidepressive Agents, Second-Generation",MESHPA +CHEMBL894,D018765,"Dopamine Uptake Inhibitors",MESHPA +CHEMBL894,D065690,"Cytochrome P-450 CYP2D6 Inhibitors",MESHPA +CHEMBL895,D000701,"Analgesics, Opioid",MESHPA +CHEMBL89598,D000927,Anticonvulsants,MESHPA +CHEMBL89598,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL89598,D018682,"GABA Agents",MESHPA +CHEMBL896,D000982,Antipruritics,MESHPA +CHEMBL896,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL897,D014528,"Uricosuric Agents",MESHPA +CHEMBL898,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL898,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL9,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL9,D059005,"Topoisomerase II Inhibitors",MESHPA +CHEMBL9,D065609,"Cytochrome P-450 CYP1A2 Inhibitors",MESHPA +CHEMBL90,D017442,"Histamine Agonists",MESHPA +CHEMBL90,D018494,"Histamine Agents",MESHPA +CHEMBL900,D000978,"Antiparkinson Agents",MESHPA +CHEMBL900,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL900,D010276,Parasympatholytics,MESHPA +CHEMBL900,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL900,D065686,"Cytochrome P-450 CYP2B6 Inhibitors",MESHPA +CHEMBL902,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL902,D006635,"Histamine H2 Antagonists",MESHPA +CHEMBL905,D017366,"Serotonin Receptor Agonists",MESHPA +CHEMBL90593,D000276,"Adjuvants, Immunologic",MESHPA +CHEMBL908,D014150,"Antipsychotic Agents",MESHPA +CHEMBL908,D018492,"Dopamine Antagonists",MESHPA +CHEMBL91,D000935,"Antifungal Agents",MESHPA +CHEMBL91,D058888,"14-alpha Demethylase Inhibitors",MESHPA +CHEMBL91,D065688,"Cytochrome P-450 CYP2C9 Inhibitors",MESHPA +CHEMBL91,D065692,"Cytochrome P-450 CYP3A Inhibitors",MESHPA +CHEMBL911,D000068776,"Sleep Aids, Pharmaceutical",MESHPA +CHEMBL911,D058785,"GABA-A Receptor Agonists",MESHPA +CHEMBL914,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL914,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL916,D005343,"Fibrinolytic Agents",MESHPA +CHEMBL916,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL917,D000964,"Antimetabolites, Antineoplastic",MESHPA +CHEMBL92,D000970,"Antineoplastic Agents",MESHPA +CHEMBL92,D050257,"Tubulin Modulators",MESHPA +CHEMBL922,D000998,"Antiviral Agents",MESHPA +CHEMBL922,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL923,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL923,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL924,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL92401,D000928,"Antidepressive Agents",MESHPA +CHEMBL92401,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL926,D002316,"Cardiotonic Agents",MESHPA +CHEMBL926,D013566,Sympathomimetics,MESHPA +CHEMBL926,D058665,"Adrenergic beta-1 Receptor Agonists",MESHPA +CHEMBL927,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL92870,D002121,"Calcium Channel Blockers",MESHPA +CHEMBL92870,D014665,"Vasodilator Agents",MESHPA +CHEMBL93,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL93,D016859,"Lipoxygenase Inhibitors",MESHPA +CHEMBL93,D020024,"Leukotriene Antagonists",MESHPA +CHEMBL931,D018685,"Anesthetics, Inhalation",MESHPA +CHEMBL932,D010726,"Phosphodiesterase Inhibitors",MESHPA +CHEMBL932,D010975,"Platelet Aggregation Inhibitors",MESHPA +CHEMBL932,D014665,"Vasodilator Agents",MESHPA +CHEMBL934,D000963,Antimetabolites,MESHPA +CHEMBL934,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL936,D000932,Antiemetics,MESHPA +CHEMBL93645,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL938,D047228,"Angiotensin II Type 1 Receptor Blockers",MESHPA +CHEMBL939,D000970,"Antineoplastic Agents",MESHPA +CHEMBL939,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL94,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL94,D008916,Miotics,MESHPA +CHEMBL940,D000700,Analgesics,MESHPA +CHEMBL940,D000927,Anticonvulsants,MESHPA +CHEMBL940,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL940,D018691,"Excitatory Amino Acid Antagonists",MESHPA +CHEMBL940,D018692,"Antimanic Agents",MESHPA +CHEMBL941,D000970,"Antineoplastic Agents",MESHPA +CHEMBL941,D047428,"Protein Kinase Inhibitors",MESHPA +CHEMBL942,D002400,Cathartics,MESHPA +CHEMBL942,D054368,Laxatives,MESHPA +CHEMBL94394,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL94454,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL945,D004232,Diuretics,MESHPA +CHEMBL945,D062646,"Acid Sensing Ion Channel Blockers",MESHPA +CHEMBL945,D062686,"Epithelial Sodium Channel Blockers",MESHPA +CHEMBL946,D006634,"Histamine H1 Antagonists",MESHPA +CHEMBL95,D002800,"Cholinesterase Inhibitors",MESHPA +CHEMBL95,D010277,Parasympathomimetics,MESHPA +CHEMBL95,D018697,"Nootropic Agents",MESHPA +CHEMBL951,D003287,"Contrast Media",MESHPA +CHEMBL953,D000978,"Antiparkinson Agents",MESHPA +CHEMBL953,D065098,"Catechol O-Methyltransferase Inhibitors",MESHPA +CHEMBL956,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL956,D016861,"Cyclooxygenase Inhibitors",MESHPA +CHEMBL957,D000959,"Antihypertensive Agents",MESHPA +CHEMBL957,D065128,"Endothelin Receptor Antagonists",MESHPA +CHEMBL959,D000998,"Antiviral Agents",MESHPA +CHEMBL959,D019384,"Nucleic Acid Synthesis Inhibitors",MESHPA +CHEMBL960,D004791,"Enzyme Inhibitors",MESHPA +CHEMBL960,D007166,"Immunosuppressive Agents",MESHPA +CHEMBL963,D000701,"Analgesics, Opioid",MESHPA +CHEMBL963,D000759,"Adjuvants, Anesthesia",MESHPA +CHEMBL963,D009294,Narcotics,MESHPA +CHEMBL964,D000427,"Alcohol Deterrents",MESHPA +CHEMBL964,D065086,"Acetaldehyde Dehydrogenase Inhibitors",MESHPA +CHEMBL965,D002316,"Cardiotonic Agents",MESHPA +CHEMBL965,D008916,Miotics,MESHPA +CHEMBL965,D018679,"Cholinergic Agonists",MESHPA +CHEMBL965,D018712,"Analgesics, Non-Narcotic",MESHPA +CHEMBL967,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL967,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL967,D018757,"GABA Modulators",MESHPA +CHEMBL968,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL968,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL968,D018757,"GABA Modulators",MESHPA +CHEMBL969,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL969,D018757,"GABA Modulators",MESHPA +CHEMBL970,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL972,D000928,"Antidepressive Agents",MESHPA +CHEMBL972,D000978,"Antiparkinson Agents",MESHPA +CHEMBL972,D008996,"Monoamine Oxidase Inhibitors",MESHPA +CHEMBL972,D018696,"Neuroprotective Agents",MESHPA +CHEMBL976,D000871,Anthelmintics,MESHPA +CHEMBL977,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL978,D008916,Miotics,MESHPA +CHEMBL978,D010277,Parasympathomimetics,MESHPA +CHEMBL978,D016085,"Bronchoconstrictor Agents",MESHPA +CHEMBL978,D018721,"Muscarinic Agonists",MESHPA +CHEMBL979,D000894,"Anti-Inflammatory Agents, Non-Steroidal",MESHPA +CHEMBL979,D000927,Anticonvulsants,MESHPA +CHEMBL979,D006993,"Hypnotics and Sedatives",MESHPA +CHEMBL979,D009125,"Muscle Relaxants, Central",MESHPA +CHEMBL979,D014151,"Anti-Anxiety Agents",MESHPA +CHEMBL98,D000970,"Antineoplastic Agents",MESHPA +CHEMBL98,D056572,"Histone Deacetylase Inhibitors",MESHPA +CHEMBL980,D005100,Expectorants,MESHPA +CHEMBL981,D000924,"Anticholesteremic Agents",MESHPA +CHEMBL981,D000960,"Hypolipidemic Agents",MESHPA +CHEMBL982,D009292,"Narcotic Antagonists",MESHPA +CHEMBL986,D014815,Vitamins,MESHPA +CHEMBL989,D000893,"Anti-Inflammatory Agents",MESHPA +CHEMBL989,D005938,Glucocorticoids,MESHPA +CHEMBL990,D000935,"Antifungal Agents",MESHPA +CHEMBL991,D000963,Antimetabolites,MESHPA +CHEMBL991,D018894,"Reverse Transcriptase Inhibitors",MESHPA +CHEMBL991,D019380,"Anti-HIV Agents",MESHPA +CHEMBL996,D000900,"Anti-Bacterial Agents",MESHPA +CHEMBL9967,D000897,"Anti-Ulcer Agents",MESHPA +CHEMBL9967,D018727,"Muscarinic Antagonists",MESHPA +CHEMBL997,D050071,"Bone Density Conservation Agents",MESHPA +CHEMBL998,D000982,Antipruritics,MESHPA +CHEMBL998,D018926,"Anti-Allergic Agents",MESHPA +CHEMBL998,D039563,"Histamine H1 Antagonists, Non-Sedating",MESHPA +CHEMBL99946,D000068760,"Serotonin and Noradrenaline Reuptake Inhibitors",MESHPA +CHEMBL99946,D000928,"Antidepressive Agents",MESHPA +CHEMBL1000,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL100116,N0000000154,"Opioid Antagonists",MOA +CHEMBL100116,N0000175685,"Partial Opioid Agonists",MOA +CHEMBL100116,N0000175686,"Competitive Opioid Antagonists",MOA +CHEMBL1002,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1004,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1004,N0000000207,"Histamine Receptor Antagonists",MOA +CHEMBL1005,N0000175684,"Full Opioid Agonists",MOA +CHEMBL1006,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL1007,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1008,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1008,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1009,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1009,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL101,N0000000163,"Enzyme Interactions",MOA +CHEMBL1013,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1014,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL1017,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL1018,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1020,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1021,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1023,N0000000085,"Receptor Interactions",MOA +CHEMBL1023,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1024,N0000000236,"Alkylating Activity",MOA +CHEMBL1025,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1027,N0000000116,"GABA B Agonists",MOA +CHEMBL1027,N0000000196,"GABA A Agonists",MOA +CHEMBL1029,N0000020019,"Glucosylceramide Synthase Inhibitors",MOA +CHEMBL103,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1037,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL104,N0000010265,"Squalene Monooxygenase Inhibitors",MOA +CHEMBL1040,N0000000163,"Enzyme Interactions",MOA +CHEMBL1040,N0000000228,"Structural Macromolecules",MOA +CHEMBL1042,N0000000163,"Enzyme Interactions",MOA +CHEMBL1043,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL1046,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL105,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL105,N0000000236,"Alkylating Activity",MOA +CHEMBL1051,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1054,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL1054,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1055,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1059,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL106,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL106,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL106,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL106,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL1060,N0000000220,"Electrolyte Activity",MOA +CHEMBL1060,N0000010288,"Osmotic Activity",MOA +CHEMBL1064,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1064,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1064,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1068,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1069,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL107,N0000000239,"P-Glycoprotein Interactions",MOA +CHEMBL107,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL107,N0000010256,"Tubulin Interactions",MOA +CHEMBL107,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL107,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1070,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1071,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1072,N0000181006,"Sodium Potassium Chloride Symporter Inhibitors",MOA +CHEMBL1073,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1075,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1077,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1077896,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1079,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL1079,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL1079604,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL108,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL108,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL108,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL108,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL108,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL108,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL108,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL108,N0000191266,"Cytochrome P450 1A2 Inducers",MOA +CHEMBL1082,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1082407,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL1082407,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL1082407,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL1082407,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL1083659,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1083659,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1083659,N0000190998,"Orexin Receptor Antagonists",MOA +CHEMBL1085,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL1085,N0000000230,"Dopamine Antagonists",MOA +CHEMBL108545,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL108545,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1086,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL1086,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1086440,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1086440,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL1086440,N0000182139,"Cytochrome P450 2B6 Inhibitors",MOA +CHEMBL1086440,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL1086440,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1086440,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL1087,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1088,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1089,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1089318,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1089318,N0000175756,"Catechol O-Methyltransferase Inhibitors",MOA +CHEMBL1089641,N0000175533,Dyes,MOA +CHEMBL109,N0000000138,"GABA A Receptor Interactions",MOA +CHEMBL109,N0000000204,"GABA B Receptor Interactions",MOA +CHEMBL1090,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1090,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL1091,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1091,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1091,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1093,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1094,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1094636,N0000191622,"Poly(ADP-Ribose) Polymerase Inhibitors",MOA +CHEMBL1094966,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1095,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1095097,N0000011310,"Aldosterone Antagonists",MOA +CHEMBL1095097,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1095777,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1096,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1096562,N0000000163,"Enzyme Interactions",MOA +CHEMBL1096882,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1096885,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL1098,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL1098,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL11,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL11,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL11,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL110,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1101,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1102,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL1104,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL110458,N0000000163,"Enzyme Interactions",MOA +CHEMBL1106,N0000000122,"Adrenergic Agonists",MOA +CHEMBL1106,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1106,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1107,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1108,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1108,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL1110,N0000175817,"Serotonin 3 Receptor Antagonists",MOA +CHEMBL1110,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL1111,N0000175364,"Endothelin Receptor Antagonists",MOA +CHEMBL1112,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL1112,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL1113,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1113,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1113,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1113,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1115,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1117,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL1117,N0000020088,"Topoisomerase 2 Inhibitors",MOA +CHEMBL1118,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1118,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1118,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1118,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL112,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL1120,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1120,N0000000226,"Acid-Base Activity",MOA +CHEMBL1121,N0000000254,"Immunologic and Biological Factor Interactions",MOA +CHEMBL1123,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1123,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL112570,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL1129,N0000000098,"Thymidylate Synthetase Inhibitors",MOA +CHEMBL1129,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1129,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL113,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1131,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1131,N0000190478,"Interleukin 6 Receptor Antagonists",MOA +CHEMBL1136,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1139,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL114,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL114,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1140,N0000000163,"Enzyme Interactions",MOA +CHEMBL1140,N0000000231,"Enzyme Activators",MOA +CHEMBL1141,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1144,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1146,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1148,N0000181006,"Sodium Potassium Chloride Symporter Inhibitors",MOA +CHEMBL1149,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL115,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL115,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1152,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1152,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1152,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1159,N0000182728,"Potassium Channel Openers",MOA +CHEMBL1159650,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1159650,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1159650,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL116,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL116,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL116,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL116,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL116,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL116,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL116,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL116,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL116,N0000191264,"P-Glycoprotein Inducers",MOA +CHEMBL1160819,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1161,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1161,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1161,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1162,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1163,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1163,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1163,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL1163,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1163,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL1163,N0000191269,"UDP Glucuronosyltransferases Inhibitors",MOA +CHEMBL1163,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL1164729,N0000000206,"Xanthine Oxidase Inhibitors",MOA +CHEMBL1165,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1165268,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1165268,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1166,N0000000107,Antithrombins,MOA +CHEMBL1166,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL1167,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1168,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1169,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1169,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL1170,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1171837,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL1171837,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1172,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL117287,N0000175816,"Serotonin 4 Receptor Antagonists",MOA +CHEMBL1173055,N0000191622,"Poly(ADP-Ribose) Polymerase Inhibitors",MOA +CHEMBL1173655,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL1173655,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1174,N0000009962,"Platelet Glycoprotein IIb/IIIA Inhibitors",MOA +CHEMBL1175,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1175,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1175,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1177,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL117785,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL117785,N0000190855,"Vesicular Monoamine Transporter 2 Inhibitors",MOA +CHEMBL1179047,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL118,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL118,N0000008288,"Cyclooxygenase 2 Inhibitors",MOA +CHEMBL1180725,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1180725,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1182833,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1182833,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1184,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL1184,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL1185,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1185,N0000000256,"Serotonin Agonists",MOA +CHEMBL1185,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL1185,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL1186579,N0000000154,"Opioid Antagonists",MOA +CHEMBL1187833,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1187833,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1189432,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1189679,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL1189679,N0000175817,"Serotonin 3 Receptor Antagonists",MOA +CHEMBL119,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL1191,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL1193,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1194,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1194325,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1194325,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL119443,N0000000130,"Serotonin Antagonists",MOA +CHEMBL119443,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1194666,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1194666,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1194666,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1196,N0000000193,"Ion Channel Interactions",MOA +CHEMBL1197051,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL1198,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1198857,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1199080,N0000000092,"Adrenergic Antagonists",MOA +CHEMBL1199080,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL1199324,N0000010262,"Neurokinin 1 Antagonists",MOA +CHEMBL1199324,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL12,N0000000118,"GABA A Modulators",MOA +CHEMBL1200,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1200,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200335,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1200346,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1200354,N0000020024,"Sclerosing Activity",MOA +CHEMBL1200356,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1200368,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200370,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL1200374,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1200374,N0000175080,"Aromatase Inhibitors",MOA +CHEMBL1200375,N0000000087,"Chelating Activity",MOA +CHEMBL1200386,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200386,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200386,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200391,N0000009986,"Alkalinizing Activity",MOA +CHEMBL1200399,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200406,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1200412,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1200430,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1200431,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1200434,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1200436,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1200438,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1200452,N0000000087,"Chelating Activity",MOA +CHEMBL1200455,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1200455,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1200457,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1200458,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200458,N0000009986,"Alkalinizing Activity",MOA +CHEMBL1200459,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200460,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200468,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1200472,N0000000118,"GABA A Modulators",MOA +CHEMBL1200490,N0000000141,"Pituitary Hormones Receptor Interactions",MOA +CHEMBL1200490,N0000000255,"Hormone Receptor Modulators",MOA +CHEMBL1200490,N0000175084,"Gonadotropin Releasing Hormone Receptor Antagonists",MOA +CHEMBL1200500,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200500,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200507,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1200507,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1200515,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1200522,N0000000065,"Physiochemical Activity",MOA +CHEMBL1200527,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1200527,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1200535,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200539,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200539,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200542,N0000000094,"Mineralocorticoid Receptor Agonists",MOA +CHEMBL1200545,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200545,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200553,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200558,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200558,N0000009954,"Cell Membrane Fusion Complex Interactions",MOA +CHEMBL1200559,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200562,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200562,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200562,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200571,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1200572,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200572,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200572,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200572,N0000010288,"Osmotic Activity",MOA +CHEMBL1200574,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200574,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200585,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1200588,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1200593,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1200596,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200600,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200600,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200600,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200604,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1200604,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1200607,N0000010259,"Ultrasound Contrast Activity",MOA +CHEMBL1200614,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1200614,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1200617,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200617,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200622,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200624,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1200625,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200633,N0000000156,"Chloride Channel Interactions",MOA +CHEMBL1200640,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200649,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1200656,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL1200660,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL1200660,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL1200660,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL1200661,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1200666,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200668,N0000020074,"Phosphate Chelating Activity",MOA +CHEMBL1200679,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200679,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200679,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200680,N0000000065,"Physiochemical Activity",MOA +CHEMBL1200680,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200682,N0000000116,"GABA B Agonists",MOA +CHEMBL1200682,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200685,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200686,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1200686,N0000175458,"Calcineurin Inhibitors",MOA +CHEMBL1200689,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL1200689,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL1200691,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200691,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200691,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200692,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL1200694,N0000000073,"Glycine Agonists",MOA +CHEMBL1200694,N0000000118,"GABA A Modulators",MOA +CHEMBL1200695,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1200695,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1200706,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200706,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200709,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200714,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200718,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200718,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200718,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200718,N0000010288,"Osmotic Activity",MOA +CHEMBL1200721,N0000000236,"Alkylating Activity",MOA +CHEMBL1200727,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200727,N0000175869,"Positron Emitting Activity",MOA +CHEMBL1200731,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200731,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200732,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200732,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200732,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200733,N0000000073,"Glycine Agonists",MOA +CHEMBL1200733,N0000000118,"GABA A Modulators",MOA +CHEMBL1200736,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200736,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200736,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200737,N0000000079,"Surfactant Activity",MOA +CHEMBL1200747,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200761,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1200763,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200770,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1200790,N0000000118,"GABA A Modulators",MOA +CHEMBL1200799,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1200807,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1200810,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200823,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200823,N0000020074,"Phosphate Chelating Activity",MOA +CHEMBL1200826,N0000000167,"Serotonin Transporter Interactions",MOA +CHEMBL1200826,N0000000234,"Norepinephrine Transporter Interactions",MOA +CHEMBL1200826,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200829,N0000175534,Irrigation,MOA +CHEMBL1200830,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200845,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200845,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200845,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200848,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1200851,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL1200851,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1200859,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1200862,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1200862,N0000175361,"Catecholamine Synthesis Inhibitors",MOA +CHEMBL1200865,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200865,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200865,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200877,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200909,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200909,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200909,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200910,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL1200925,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200925,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200927,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1200927,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1200928,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200928,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200928,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200929,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200929,N0000000220,"Electrolyte Activity",MOA +CHEMBL1200929,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200932,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1200932,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1200934,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1200937,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1200939,N0000000226,"Acid-Base Activity",MOA +CHEMBL1200946,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1200953,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200953,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200953,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200959,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1200963,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1200969,N0000000126,"5-alpha Reductase Inhibitors",MOA +CHEMBL1200973,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1200975,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200975,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200975,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200979,N0000000163,"Enzyme Interactions",MOA +CHEMBL1200983,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1200989,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1200989,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1200989,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1200993,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1200993,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1200994,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL1201,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1201010,N0000000094,"Mineralocorticoid Receptor Agonists",MOA +CHEMBL1201012,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1201012,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1201012,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1201016,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201016,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1201039,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL1201039,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1201046,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201054,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201056,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL1201058,N0000000220,"Electrolyte Activity",MOA +CHEMBL1201058,N0000000226,"Acid-Base Activity",MOA +CHEMBL1201073,N0000175962,"Lead Chelating Activity",MOA +CHEMBL1201075,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1201084,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201087,N0000000117,"Dopamine Agonists",MOA +CHEMBL1201101,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1201109,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1201109,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1201109,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1201112,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1201112,N0000175074,"Nucleoside Synthesis Inhibitors",MOA +CHEMBL1201116,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1201117,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201129,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1201129,N0000019995,"DNA Methyltransferase Inhibitors",MOA +CHEMBL1201131,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201134,N0000175456,"Chloride Channel Activators",MOA +CHEMBL1201139,N0000000145,"Estrogen Receptor Antagonists",MOA +CHEMBL1201139,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1201151,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1201154,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1201165,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1201168,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1201168,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201170,N0000000167,"Serotonin Transporter Interactions",MOA +CHEMBL1201170,N0000000234,"Norepinephrine Transporter Interactions",MOA +CHEMBL1201173,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1201173,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1201173,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1201182,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1201182,N0000175624,"mTOR Inhibitors",MOA +CHEMBL1201185,N0000000194,"Somatostatin Receptor Agonists",MOA +CHEMBL1201186,N0000000226,"Acid-Base Activity",MOA +CHEMBL1201187,N0000175445,"Chemokine Co-receptor 5 Antagonists",MOA +CHEMBL1201187,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1201187,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL1201189,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201191,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201192,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1201192,N0000000117,"Dopamine Agonists",MOA +CHEMBL1201193,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL1201193,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1201195,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201196,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL1201196,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1201197,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL1201198,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1201199,N0000000255,"Hormone Receptor Modulators",MOA +CHEMBL1201199,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1201201,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1201201,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1201201,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201202,N0000000107,Antithrombins,MOA +CHEMBL1201202,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL1201203,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201203,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL1201203,N0000000207,"Histamine Receptor Antagonists",MOA +CHEMBL1201203,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1201206,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201206,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1201208,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1201208,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1201208,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201210,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201210,N0000000130,"Serotonin Antagonists",MOA +CHEMBL1201210,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201210,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1201210,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL1201212,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1201212,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL1201213,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1201216,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL1201217,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1201218,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1201219,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201219,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1201220,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1201220,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1201222,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201225,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201229,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1201231,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1201231,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1201231,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1201232,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201234,N0000000122,"Adrenergic Agonists",MOA +CHEMBL1201234,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201236,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201236,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201236,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL1201236,N0000175755,"DOPA Decarboxylase Inhibitors",MOA +CHEMBL1201237,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL1201244,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201244,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1201245,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201247,N0000000255,"Hormone Receptor Modulators",MOA +CHEMBL1201247,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1201248,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201248,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1201250,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201255,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1201256,N0000000065,"Physiochemical Activity",MOA +CHEMBL1201262,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1201262,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL1201262,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1201264,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201264,N0000000151,"Histamine H2 Receptor Antagonists",MOA +CHEMBL1201266,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201271,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201271,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201274,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL1201274,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL1201281,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1201284,N0000020081,"Increased Calcium-sensing Receptor Sensitivity",MOA +CHEMBL1201287,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201287,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201288,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1201291,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1201293,N0000000118,"GABA A Modulators",MOA +CHEMBL1201293,N0000020015,"NMDA Receptor Antagonists",MOA +CHEMBL1201295,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1201300,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1201300,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1201301,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1201309,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201309,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1201314,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1201314,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL1201319,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201319,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1201319,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL1201320,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL1201320,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL1201321,N0000000085,"Receptor Interactions",MOA +CHEMBL1201329,N0000175704,"Noncompetitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201334,N0000019993,"Hypothalamic Hormone Receptor Agonists",MOA +CHEMBL1201334,N0000175654,"Gonadotropin Releasing Hormone Receptor Agonists",MOA +CHEMBL1201335,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201335,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1201336,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1201338,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201341,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1201346,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1201346,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1201348,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201352,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1201352,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1201353,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201353,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201356,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1201356,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1201414,N0000000076,"Protease Inhibitors",MOA +CHEMBL1201414,N0000000107,Antithrombins,MOA +CHEMBL1201419,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201420,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL1201431,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201438,N0000000157,"Interferon Inducers",MOA +CHEMBL1201438,N0000010280,"Interleukin 2 Receptor Agonists",MOA +CHEMBL1201439,N0000010279,"Interleukin 2 Receptor Antagonists",MOA +CHEMBL1201439,N0000175621,"Interleukin 2 Receptor-directed Antibody Interactions",MOA +CHEMBL1201441,N0000000226,"Acid-Base Activity",MOA +CHEMBL1201446,N0000175355,"Binding Activity",MOA +CHEMBL1201447,N0000000079,"Surfactant Activity",MOA +CHEMBL1201448,N0000000107,Antithrombins,MOA +CHEMBL1201448,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL1201451,N0000000228,"Structural Macromolecules",MOA +CHEMBL1201451,N0000010288,"Osmotic Activity",MOA +CHEMBL1201457,N0000175089,"Calcium Chelating Activity",MOA +CHEMBL1201458,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1201458,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1201460,N0000000107,Antithrombins,MOA +CHEMBL1201460,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL1201460,N0000000231,"Enzyme Activators",MOA +CHEMBL1201460,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL1201464,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201465,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201467,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1201471,N0000175532,"Demulcent Activity",MOA +CHEMBL1201472,N0000010288,"Osmotic Activity",MOA +CHEMBL1201473,N0000175365,"Bile-acid Binding Activity",MOA +CHEMBL1201474,N0000175355,"Binding Activity",MOA +CHEMBL1201474,N0000175365,"Bile-acid Binding Activity",MOA +CHEMBL1201476,N0000000107,Antithrombins,MOA +CHEMBL1201476,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL1201476,N0000000231,"Enzyme Activators",MOA +CHEMBL1201476,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL1201477,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1201479,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201479,N0000010288,"Osmotic Activity",MOA +CHEMBL1201481,N0000010217,Photoabsorption,MOA +CHEMBL1201485,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL1201485,N0000175374,"Peroxisome Proliferator-activated Receptor Activity",MOA +CHEMBL1201487,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201490,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201493,N0000000079,"Surfactant Activity",MOA +CHEMBL1201494,N0000000220,"Electrolyte Activity",MOA +CHEMBL1201496,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201496,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1201497,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1201502,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1201506,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1201506,N0000175077,"CD33-directed Antibody Interactions",MOA +CHEMBL1201507,N0000000135,"Immunologic Adjuvants",MOA +CHEMBL1201509,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201513,N0000009960,"Antithrombin Activators",MOA +CHEMBL1201513,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL1201514,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201515,N0000000137,"IGF Type 1 Receptor Interactions",MOA +CHEMBL1201515,N0000010267,"Growth Hormone Receptor Antagonists",MOA +CHEMBL1201516,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201522,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201522,N0000000228,"Structural Macromolecules",MOA +CHEMBL1201529,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201533,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201534,N0000000107,Antithrombins,MOA +CHEMBL1201534,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL1201534,N0000000231,"Enzyme Activators",MOA +CHEMBL1201534,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL1201538,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1201539,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1201544,N0000000220,"Electrolyte Activity",MOA +CHEMBL1201544,N0000000228,"Structural Macromolecules",MOA +CHEMBL1201554,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201554,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL1201554,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL1201557,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201558,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201560,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201560,N0000191258,"RNA Replicase Inhibitors",MOA +CHEMBL1201561,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201562,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201562,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201563,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201563,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201564,N0000000242,"Transcription Factor Activity",MOA +CHEMBL1201564,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201567,N0000000213,"Receptor Protein Kinase Interactions",MOA +CHEMBL1201567,N0000020062,"Receptor Activity Modifying Protein Agonists",MOA +CHEMBL1201568,N0000020062,"Receptor Activity Modifying Protein Agonists",MOA +CHEMBL1201569,N0000009955,"Acetylcholine Transporter Interactions",MOA +CHEMBL1201569,N0000175770,"Acetylcholine Release Inhibitors",MOA +CHEMBL1201570,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1201570,N0000175709,"Interleukin 1 Receptor Antagonists",MOA +CHEMBL1201571,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201572,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201572,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL1201572,N0000175447,"Tumor Necrosis Factor beta Receptor Blocking Activity",MOA +CHEMBL1201572,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL1201573,N0000175968,"Thrombopoietin Receptor Agonists",MOA +CHEMBL1201575,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201576,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201576,N0000175078,"CD20-directed Antibody Interactions",MOA +CHEMBL1201577,N0000020010,"HER1 Antagonists",MOA +CHEMBL1201580,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201580,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL1201580,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL1201581,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201581,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL1201581,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL1201582,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201582,N0000184008,"Antigen Neutralization",MOA +CHEMBL1201583,N0000020007,"Vascular Endothelial Growth Factor Receptor Inhibitors",MOA +CHEMBL1201583,N0000178291,"Vascular Endothelial Growth Factor-directed Antibody Interactions",MOA +CHEMBL1201583,N0000193542,"Vascular Endothelial Growth Factor Inhibitors",MOA +CHEMBL1201584,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1201585,N0000020008,"HER2/Neu/cerbB2 Antagonists",MOA +CHEMBL1201586,N0000175615,"Fusion Protein Inhibitors",MOA +CHEMBL1201587,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201587,N0000175079,"CD52-directed Antibody Interactions",MOA +CHEMBL1201589,N0000175792,"IgE-directed Antibody Interactions",MOA +CHEMBL1201591,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL1201593,N0000000089,"Plasminogen Activators",MOA +CHEMBL1201593,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL1201594,N0000000231,"Enzyme Activators",MOA +CHEMBL1201604,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201606,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1201606,N0000175078,"CD20-directed Antibody Interactions",MOA +CHEMBL1201607,N0000175774,"Integrin Receptor Antagonists",MOA +CHEMBL1201608,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201610,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL1201613,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1201619,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL1201620,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL1201620,N0000010266,"Growth Hormone Receptor Agonists",MOA +CHEMBL1201621,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL1201621,N0000010266,"Growth Hormone Receptor Agonists",MOA +CHEMBL1201622,N0000000079,"Surfactant Activity",MOA +CHEMBL1201624,N0000000079,"Surfactant Activity",MOA +CHEMBL1201625,N0000175365,"Bile-acid Binding Activity",MOA +CHEMBL1201632,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201633,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201636,N0000000163,"Enzyme Interactions",MOA +CHEMBL1201649,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1201650,N0000000237,"Thyroid Hormone Receptor Agonists",MOA +CHEMBL1201651,N0000000226,"Acid-Base Activity",MOA +CHEMBL1201651,N0000175981,"Heparin Binding Activity",MOA +CHEMBL1201662,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL1201666,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL1201668,N0000000085,"Receptor Interactions",MOA +CHEMBL1201670,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201688,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1201692,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1201692,N0000000255,"Hormone Receptor Modulators",MOA +CHEMBL1201724,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1201746,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1201746,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL1201747,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201748,N0000010256,"Tubulin Interactions",MOA +CHEMBL1201752,N0000010256,"Tubulin Interactions",MOA +CHEMBL1201753,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1201754,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1201758,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1201760,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL1201760,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL1201764,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1201772,N0000182143,"P2Y12 Receptor Antagonists",MOA +CHEMBL1201774,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1201774,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL1201774,N0000190482,"Phenylalanine Hydroxylase Activators",MOA +CHEMBL1201776,N0000000174,"Opioid Agonists",MOA +CHEMBL1201776,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1201779,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1201780,N0000184143,"Carbamoyl Phosphate Synthetase 1 Activators",MOA +CHEMBL1201794,N0000000163,"Enzyme Interactions",MOA +CHEMBL1201798,N0000020074,"Phosphate Chelating Activity",MOA +CHEMBL1201821,N0000020071,"Keratinocyte Growth Factor Receptor Agonists",MOA +CHEMBL1201823,N0000182150,"CD80-directed Antibody Interactions",MOA +CHEMBL1201823,N0000182151,"CD86-directed Antibody Interactions",MOA +CHEMBL1201825,N0000020007,"Vascular Endothelial Growth Factor Receptor Inhibitors",MOA +CHEMBL1201825,N0000178291,"Vascular Endothelial Growth Factor-directed Antibody Interactions",MOA +CHEMBL1201825,N0000193542,"Vascular Endothelial Growth Factor Inhibitors",MOA +CHEMBL1201827,N0000020010,"HER1 Antagonists",MOA +CHEMBL1201828,N0000175974,"Complement Inhibitors",MOA +CHEMBL1201830,N0000175709,"Interleukin 1 Receptor Antagonists",MOA +CHEMBL1201831,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201831,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL1201831,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL1201832,N0000175968,"Thrombopoietin Receptor Agonists",MOA +CHEMBL1201833,N0000000247,"Biological Response Modifiers",MOA +CHEMBL1201833,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL1201833,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL1201834,N0000175709,"Interleukin 1 Receptor Antagonists",MOA +CHEMBL1201835,N0000192796,"Interleukin-12 Antagonists",MOA +CHEMBL1201835,N0000192798,"Interleukin-23 Antagonists",MOA +CHEMBL1201836,N0000175078,"CD20-directed Antibody Interactions",MOA +CHEMBL1201837,N0000184151,"Kallikrein Inhibitors",MOA +CHEMBL1201863,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL1201864,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1201864,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL1201865,N0000000178,"Enzymatic Activity",MOA +CHEMBL1201866,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL1201867,N0000000220,"Electrolyte Activity",MOA +CHEMBL1201891,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1201891,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1206,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1208,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL1208155,N0000175084,"Gonadotropin Releasing Hormone Receptor Antagonists",MOA +CHEMBL1208155,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL1208422,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1208422,N0000175533,Dyes,MOA +CHEMBL121,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL121,N0000175374,"Peroxisome Proliferator-activated Receptor Activity",MOA +CHEMBL121,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL1213252,N0000000118,"GABA A Modulators",MOA +CHEMBL1213351,N0000175684,"Full Opioid Agonists",MOA +CHEMBL1213351,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL1214,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1214124,N0000020016,"AMPA Receptor Antagonists",MOA +CHEMBL1214185,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1215,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1215,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL1218,N0000000250,"Melatonin Receptor Agonists",MOA +CHEMBL1219,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL122,N0000008288,"Cyclooxygenase 2 Inhibitors",MOA +CHEMBL1220,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1221,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1224,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1224,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1229,N0000175436,"Neuraminidase Inhibitors",MOA +CHEMBL1229211,N0000000127,"HIV Integrase Inhibitors",MOA +CHEMBL1229211,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL1229211,N0000191423,"Multidrug and Toxin Extrusion Transporter 1 Inhibitors",MOA +CHEMBL1229517,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1229517,N0000175411,"BRAF Serine/Threonine Kinase Inhibitors",MOA +CHEMBL1229517,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL1229517,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1231,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1231574,N0000000163,"Enzyme Interactions",MOA +CHEMBL1231723,N0000020024,"Sclerosing Activity",MOA +CHEMBL1233,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1234579,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL1234886,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL1237,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1237021,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1237021,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1237021,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL1237022,N0000190478,"Interleukin 6 Receptor Antagonists",MOA +CHEMBL1237023,N0000187054,"RANK Ligand Blocking Activity",MOA +CHEMBL1237025,N0000000231,"Enzyme Activators",MOA +CHEMBL1237026,N0000000137,"IGF Type 1 Receptor Interactions",MOA +CHEMBL1237044,N0000175684,"Full Opioid Agonists",MOA +CHEMBL1237054,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1237054,N0000009958,"Bone Surface Interactions",MOA +CHEMBL1237066,N0000000220,"Electrolyte Activity",MOA +CHEMBL1237066,N0000000226,"Acid-Base Activity",MOA +CHEMBL1237080,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL1237080,N0000175817,"Serotonin 3 Receptor Antagonists",MOA +CHEMBL1237105,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1237119,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1237123,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL1237123,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL1237132,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1237132,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1238,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1241,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1241,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1241951,N0000000215,"ATP-Binding Cassette (ABC) Transporter Interactions",MOA +CHEMBL1241951,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1241951,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL1241951,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL1241951,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL1241951,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL1241951,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL1241951,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL1241951,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1241951,N0000190115,"Cytochrome P450 3A5 Inhibitors",MOA +CHEMBL1241951,N0000193801,"DNA Terminase Complex Inhibitors",MOA +CHEMBL1242,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1243,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL125,N0000181812,"Lysophospholipid Receptor Interactions",MOA +CHEMBL1251,N0000000255,"Hormone Receptor Modulators",MOA +CHEMBL1251,N0000175084,"Gonadotropin Releasing Hormone Receptor Antagonists",MOA +CHEMBL1252,N0000019994,"Hypothalamic Hormone Receptor Antagonists",MOA +CHEMBL1252,N0000175084,"Gonadotropin Releasing Hormone Receptor Antagonists",MOA +CHEMBL1255,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL1255,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1255800,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1255943,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL1256,N0000000073,"Glycine Agonists",MOA +CHEMBL1256,N0000000118,"GABA A Modulators",MOA +CHEMBL1256391,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1256786,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1256786,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1257,N0000000073,"Glycine Agonists",MOA +CHEMBL1257,N0000000118,"GABA A Modulators",MOA +CHEMBL1257051,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1257051,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL1257073,N0000193860,"Viral Envelope Wrapping Protein Inhibitors",MOA +CHEMBL1259,N0000000143,"Cholinergic Nicotinic Agonists",MOA +CHEMBL1259059,N0000191258,"RNA Replicase Inhibitors",MOA +CHEMBL126,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL126,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1261,N0000000220,"Electrolyte Activity",MOA +CHEMBL1261,N0000000226,"Acid-Base Activity",MOA +CHEMBL1261,N0000000236,"Alkylating Activity",MOA +CHEMBL1261,N0000175089,"Calcium Chelating Activity",MOA +CHEMBL1261,N0000175833,"Acidifying Activity",MOA +CHEMBL1262,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL1262,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1263,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1263,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1265,N0000000242,"Transcription Factor Activity",MOA +CHEMBL1266,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1269025,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL127,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL12713,N0000000256,"Serotonin Agonists",MOA +CHEMBL12713,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL1272,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1272,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL1274,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL1276308,N0000000110,"Glucocorticoid Receptor Antagonists",MOA +CHEMBL1276308,N0000000115,"Progestational Hormone Receptor Antagonists",MOA +CHEMBL1276308,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1278,N0000000256,"Serotonin Agonists",MOA +CHEMBL1278,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL1278,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL1279,N0000000256,"Serotonin Agonists",MOA +CHEMBL1279,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL1279,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL128,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL128,N0000000256,"Serotonin Agonists",MOA +CHEMBL128,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL128,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL1282,N0000000157,"Interferon Inducers",MOA +CHEMBL12856,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1286,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1289601,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL1289926,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL129,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL1290,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL1290,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL1291,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL1292,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1294,N0000000140,"Calcium Channel Interactions",MOA +CHEMBL1294,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1294,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL1294,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1295,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL1295,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1296,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1297,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL13,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL13,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL130,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1303,N0000000117,"Dopamine Agonists",MOA +CHEMBL1305,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1306,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1308,N0000000179,"Alcohol Dehydrogenase Inhibitors",MOA +CHEMBL131,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL131,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL131,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1311,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL1311,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL1311,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL1314,N0000175549,"Cystine Disulfide Reduction",MOA +CHEMBL1316,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL13209,N0000000118,"GABA A Modulators",MOA +CHEMBL13209,N0000000196,"GABA A Agonists",MOA +CHEMBL1321,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1321,N0000000236,"Alkylating Activity",MOA +CHEMBL1323,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1323,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1323,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1323699,N0000000065,"Physiochemical Activity",MOA +CHEMBL1324,N0000175756,"Catechol O-Methyltransferase Inhibitors",MOA +CHEMBL1328,N0000000085,"Receptor Interactions",MOA +CHEMBL13280,N0000000118,"GABA A Modulators",MOA +CHEMBL13280,N0000000196,"GABA A Agonists",MOA +CHEMBL1331216,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1331216,N0000000130,"Serotonin Antagonists",MOA +CHEMBL1331216,N0000000207,"Histamine Receptor Antagonists",MOA +CHEMBL1334078,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1336,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1336,N0000175082,"Kinase Inhibitors",MOA +CHEMBL1337,N0000175808,"Hydroxyphenylpyruvate Dioxygenase Inhibitors",MOA +CHEMBL1337,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL134,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL1341,N0000000118,"GABA A Modulators",MOA +CHEMBL1341,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1342,N0000000116,"GABA B Agonists",MOA +CHEMBL1342,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1346,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1349,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL135,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1350,N0000009958,"Bone Surface Interactions",MOA +CHEMBL1351,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1353,N0000000220,"Electrolyte Activity",MOA +CHEMBL1353,N0000000226,"Acid-Base Activity",MOA +CHEMBL1354,N0000000220,"Electrolyte Activity",MOA +CHEMBL1354,N0000000226,"Acid-Base Activity",MOA +CHEMBL1354199,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1355,N0000000220,"Electrolyte Activity",MOA +CHEMBL1355,N0000000226,"Acid-Base Activity",MOA +CHEMBL1358,N0000000145,"Estrogen Receptor Antagonists",MOA +CHEMBL1358,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL1359,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1363,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1364,N0000000163,"Enzyme Interactions",MOA +CHEMBL1366,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1367605,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1368,N0000000220,"Electrolyte Activity",MOA +CHEMBL1368,N0000010288,"Osmotic Activity",MOA +CHEMBL137,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1370,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1370,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1370561,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1371,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1371770,N0000000117,"Dopamine Agonists",MOA +CHEMBL1373,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1374379,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL1377,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL1378,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1380,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL1382,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1382627,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1384,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1387,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1388,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1389,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL139,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1393,N0000011310,"Aldosterone Antagonists",MOA +CHEMBL139367,N0000175436,"Neuraminidase Inhibitors",MOA +CHEMBL1395,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1396,N0000175702,"Partial Cholinergic Nicotinic Agonists",MOA +CHEMBL1397,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1397,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL1397,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL1399,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1399,N0000175080,"Aromatase Inhibitors",MOA +CHEMBL1401,N0000000155,Uncouplers,MOA +CHEMBL1404,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1404,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1404,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL1404,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1404,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL1405,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL14060,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL141,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL1410,N0000000079,"Surfactant Activity",MOA +CHEMBL1410743,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1411979,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1412,N0000000196,"GABA A Agonists",MOA +CHEMBL1413,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1419,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1419,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1420,N0000000080,"Cholinesterase Reactivators",MOA +CHEMBL1421,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1421,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1422,N0000175912,"Dipeptidyl Peptidase 4 Inhibitors",MOA +CHEMBL1423,N0000000076,"Protease Inhibitors",MOA +CHEMBL1423,N0000000230,"Dopamine Antagonists",MOA +CHEMBL1423,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL142438,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1425,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1428,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1428,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1428,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1428,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1429,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL1430,N0000000087,"Chelating Activity",MOA +CHEMBL1431,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1433,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1434,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1435,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1436,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1436,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL1437,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1437,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL14370,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL14376,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1440,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1441,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1442422,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1442422,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1443,N0000000231,"Enzyme Activators",MOA +CHEMBL1443,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1444,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1444,N0000175080,"Aromatase Inhibitors",MOA +CHEMBL1445,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL1447,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1448,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1449,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1450,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1451,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1451,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1451,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1454,N0000000135,"Immunologic Adjuvants",MOA +CHEMBL1455,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1455,N0000000236,"Alkylating Activity",MOA +CHEMBL1456,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1456,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1457,N0000000174,"Opioid Agonists",MOA +CHEMBL1457,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL1460,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL1463,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1464,N0000000164,"Vitamin K Epoxide Reductase Inhibitors",MOA +CHEMBL1464,N0000175964,"Vitamin K Inhibitors",MOA +CHEMBL1465,N0000000164,"Vitamin K Epoxide Reductase Inhibitors",MOA +CHEMBL1466,N0000000164,"Vitamin K Epoxide Reductase Inhibitors",MOA +CHEMBL1467,N0000000206,"Xanthine Oxidase Inhibitors",MOA +CHEMBL1469,N0000175806,"Ammonium Ion Binding Activity",MOA +CHEMBL1471,N0000010262,"Neurokinin 1 Antagonists",MOA +CHEMBL1471,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1471,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL1471,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL1472,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL1473,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1473,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1475,N0000010217,Photoabsorption,MOA +CHEMBL1477,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1477036,N0000000079,"Surfactant Activity",MOA +CHEMBL1479,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL148,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1480,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1480,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1481,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL1482,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL1483,N0000010260,"beta Tubulin Interactions",MOA +CHEMBL1483,N0000191624,"Cytochrome P450 1A Inducers",MOA +CHEMBL1484,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1484,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1484,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1484,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL1484,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1484,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL1485,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL1487,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1488,N0000000236,"Alkylating Activity",MOA +CHEMBL1489,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1489,N0000019995,"DNA Methyltransferase Inhibitors",MOA +CHEMBL1490,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1491,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1491,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1492,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1492500,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1492500,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1493,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1493,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1496,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1501,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1501,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1501,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1502,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL1503,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL1503,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL1505,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1505,N0000000256,"Serotonin Agonists",MOA +CHEMBL1505,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL1505,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL1506,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1508,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1508,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1509,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1510,N0000000256,"Serotonin Agonists",MOA +CHEMBL1510,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL1510,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL1510,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1511,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL1512,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1512,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1513,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL1514,N0000000174,"Opioid Agonists",MOA +CHEMBL1514,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1515,N0000000132,"Organic Anion Transporter Interactions",MOA +CHEMBL1515,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1515,N0000000155,Uncouplers,MOA +CHEMBL1515,N0000175917,"Thyroid Hormone Synthesis Inhibitors",MOA +CHEMBL1517,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1518,N0000000132,"Organic Anion Transporter Interactions",MOA +CHEMBL1518,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1518,N0000000155,Uncouplers,MOA +CHEMBL1518,N0000175917,"Thyroid Hormone Synthesis Inhibitors",MOA +CHEMBL1519,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1519,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL152,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL1520,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL1520,N0000190484,"Guanylate Cyclase Stimulators",MOA +CHEMBL1521,N0000000138,"GABA A Receptor Interactions",MOA +CHEMBL1521,N0000000196,"GABA A Agonists",MOA +CHEMBL15245,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL1525,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1525,N0000000224,"Chloride Channel Antagonists",MOA +CHEMBL1528,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1530428,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1530428,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1530428,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1531,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1532,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1533,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL1534,N0000000163,"Enzyme Interactions",MOA +CHEMBL1535,N0000000065,"Physiochemical Activity",MOA +CHEMBL1535,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1536,N0000000163,"Enzyme Interactions",MOA +CHEMBL1536,N0000000228,"Structural Macromolecules",MOA +CHEMBL1538,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL1539,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL154,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1540,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1540,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL1541,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL154111,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1542,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1542,N0000000236,"Alkylating Activity",MOA +CHEMBL1544,N0000000237,"Thyroid Hormone Receptor Agonists",MOA +CHEMBL1546,N0000000122,"Adrenergic Agonists",MOA +CHEMBL1547,N0000000163,"Enzyme Interactions",MOA +CHEMBL1549,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1549,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1549,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1550,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1551,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1554,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1554,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1560,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1561,N0000000166,"alpha Glucosidase Inhibitors",MOA +CHEMBL1566,N0000000166,"alpha Glucosidase Inhibitors",MOA +CHEMBL1566,N0000010274,"Amylase Inhibitors",MOA +CHEMBL1571,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL157101,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL157101,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL157101,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL157101,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL157101,N0000190115,"Cytochrome P450 3A5 Inhibitors",MOA +CHEMBL1572,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1572,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1574,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1574,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1574,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1576,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1577,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL15770,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL1578,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1578,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL158,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1580,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1581,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1581,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL1583,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1583,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1585,N0000000236,"Alkylating Activity",MOA +CHEMBL1587,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1589,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL1589,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL15891,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL159,N0000010256,"Tubulin Interactions",MOA +CHEMBL1590,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1590,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1590,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL1591,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1592,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1592,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL1592101,N0000000226,"Acid-Base Activity",MOA +CHEMBL1594,N0000000163,"Enzyme Interactions",MOA +CHEMBL1594,N0000000220,"Electrolyte Activity",MOA +CHEMBL1595,N0000175684,"Full Opioid Agonists",MOA +CHEMBL1597,N0000175472,"Metal Chelating Activity",MOA +CHEMBL1599,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL16,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL16,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL16,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL16,N0000187063,"Cytochrome P450 2C8 Inducers",MOA +CHEMBL16,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL16,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL16,N0000191266,"Cytochrome P450 1A2 Inducers",MOA +CHEMBL16,N0000191267,"Cytochrome P450 2D6 Inducers",MOA +CHEMBL160,N0000000135,"Immunologic Adjuvants",MOA +CHEMBL160,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL160,N0000175458,"Calcineurin Inhibitors",MOA +CHEMBL160,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL160,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1604,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1605,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL16073,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL161,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1614,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL1614637,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1615438,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1615439,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1615439,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL1615439,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1615807,N0000175533,Dyes,MOA +CHEMBL1617,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1618018,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL1618018,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1619,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1621,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1621597,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1621597,N0000000174,"Opioid Agonists",MOA +CHEMBL1621597,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL1622,N0000000163,"Enzyme Interactions",MOA +CHEMBL1623,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1623,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1624,N0000000237,"Thyroid Hormone Receptor Agonists",MOA +CHEMBL1625,N0000000065,"Physiochemical Activity",MOA +CHEMBL1626,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1626223,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1628227,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL1628227,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL1628227,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1628233,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1628233,N0000175533,Dyes,MOA +CHEMBL1628385,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1628502,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL163,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL163,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL163,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL163,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL163,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL163,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL163,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL163,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL163,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL163,N0000190117,"UDP Glucuronosyltransferases Inducers",MOA +CHEMBL163,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL163,N0000191266,"Cytochrome P450 1A2 Inducers",MOA +CHEMBL1639,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1639,N0000175899,"Renin Inhibitors",MOA +CHEMBL1643,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1644,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1644695,N0000000065,"Physiochemical Activity",MOA +CHEMBL1644695,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1648,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1648,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1650,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1650,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1650,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1650559,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1651906,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1651906,N0000000236,"Alkylating Activity",MOA +CHEMBL1652,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL1655,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL1657,N0000000085,"Receptor Interactions",MOA +CHEMBL1657,N0000000254,"Immunologic and Biological Factor Interactions",MOA +CHEMBL1660,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1663,N0000010259,"Ultrasound Contrast Activity",MOA +CHEMBL1664,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL1668,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL1670,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1670,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL1676,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1676,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1679,N0000000163,"Enzyme Interactions",MOA +CHEMBL1680,N0000000194,"Somatostatin Receptor Agonists",MOA +CHEMBL1681,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL1682,N0000000065,"Physiochemical Activity",MOA +CHEMBL1683,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1683,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1683,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1683590,N0000010256,"Tubulin Interactions",MOA +CHEMBL1684,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1685,N0000000154,"Opioid Antagonists",MOA +CHEMBL1685,N0000000174,"Opioid Agonists",MOA +CHEMBL168815,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL1688530,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1688530,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1688530,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL1688530,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL1688530,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL1688530,N0000191267,"Cytochrome P450 2D6 Inducers",MOA +CHEMBL1689063,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL1689772,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1697733,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL1697737,N0000000116,"GABA B Agonists",MOA +CHEMBL1697737,N0000000196,"GABA A Agonists",MOA +CHEMBL1697782,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1697782,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1697782,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL1697841,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL17,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL170,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL17157,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1725,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL1725,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL1726,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL1726,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL1727,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1729,N0000000256,"Serotonin Agonists",MOA +CHEMBL1730,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1731,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1732,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL1732,N0000000130,"Serotonin Antagonists",MOA +CHEMBL1732,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1732,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL1732,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1732,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1734,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1738,N0000000087,"Chelating Activity",MOA +CHEMBL1738,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1738797,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL1738797,N0000175082,"Kinase Inhibitors",MOA +CHEMBL1739,N0000000143,"Cholinergic Nicotinic Agonists",MOA +CHEMBL174,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL1741,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL1741,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1741,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1741,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1741,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1742982,N0000193542,"Vascular Endothelial Growth Factor Inhibitors",MOA +CHEMBL1742990,N0000182150,"CD80-directed Antibody Interactions",MOA +CHEMBL1742990,N0000182151,"CD86-directed Antibody Interactions",MOA +CHEMBL1742991,N0000193802,"Interleukin 5 Receptor alpha-directed Antibody Interactions",MOA +CHEMBL1742992,N0000175617,"CD3-directed Antibody Interactions",MOA +CHEMBL1742992,N0000175618,"CD3 Receptor Agonists",MOA +CHEMBL1742992,N0000191422,"CD19-directed Antibody Interactions",MOA +CHEMBL1742994,N0000009950,"Tumor Necrosis Factor Receptor Interactions",MOA +CHEMBL1742994,N0000182966,"CD30-directed Antibody Interactions",MOA +CHEMBL1742996,N0000193278,"Interleukin 17 Receptor A Interactions",MOA +CHEMBL1742996,N0000193279,"Interleukin 17 Receptor A Antagonists",MOA +CHEMBL1743007,N0000192335,"CD38-directed Antibody Interactions",MOA +CHEMBL1743010,N0000192337,"SLAMF7-directed Antibody Interactions",MOA +CHEMBL1743029,N0000193805,"CD4-directed Antibody Interactions",MOA +CHEMBL1743029,N0000193807,"HIV 1 Post-attachment Fusion Inhibitors",MOA +CHEMBL1743034,N0000191494,"Interleukin-17A Antagonists",MOA +CHEMBL1743041,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL1743043,N0000193616,"CD22-directed Antibody Interactions",MOA +CHEMBL1743047,N0000020010,"HER1 Antagonists",MOA +CHEMBL1743048,N0000175078,"CD20-directed Antibody Interactions",MOA +CHEMBL1743049,N0000000254,"Immunologic and Biological Factor Interactions",MOA +CHEMBL1743049,N0000020028,"Platelet-derived Growth Factor alpha Receptor Inhibitors",MOA +CHEMBL1743062,N0000020032,"VEGFR2 Inhibitors",MOA +CHEMBL1743068,N0000191494,"Interleukin-17A Antagonists",MOA +CHEMBL1743070,N0000191004,"Interleukin-6 Antagonists",MOA +CHEMBL1743082,N0000020008,"HER2/Neu/cerbB2 Antagonists",MOA +CHEMBL1743087,N0000175774,"Integrin Receptor Antagonists",MOA +CHEMBL1747,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1749,N0000175089,"Calcium Chelating Activity",MOA +CHEMBL1749,N0000175962,"Lead Chelating Activity",MOA +CHEMBL1750,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL1750,N0000175082,"Kinase Inhibitors",MOA +CHEMBL1751,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1751,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL1752,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1752,N0000175789,"Adenosine Receptor Antagonists",MOA +CHEMBL175247,N0000009916,"Lipase Inhibitors",MOA +CHEMBL1754,N0000000085,"Receptor Interactions",MOA +CHEMBL1754,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1755,N0000020044,"Vasopressin Receptor Antagonists",MOA +CHEMBL1755,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1755,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1755,N0000193178,"Vasopressin V2 Receptor Antagonists",MOA +CHEMBL1755,N0000193179,"Vasopressin V1 Receptor Antagonists",MOA +CHEMBL1756,N0000000236,"Alkylating Activity",MOA +CHEMBL175691,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL175691,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL1757,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1760,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL1762,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL1763,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL1764,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL1764,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL1764,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL1764,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1764,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL1766,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL1766,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL1766,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL177,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1770248,N0000187058,"Sodium-Glucose Transporter 2 Inhibitors",MOA +CHEMBL1771,N0000182143,"P2Y12 Receptor Antagonists",MOA +CHEMBL1771,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL1773,N0000000098,"Thymidylate Synthetase Inhibitors",MOA +CHEMBL1773,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL177367,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL1774461,N0000175869,"Positron Emitting Activity",MOA +CHEMBL178,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL178,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL178,N0000020088,"Topoisomerase 2 Inhibitors",MOA +CHEMBL17860,N0000000215,"ATP-Binding Cassette (ABC) Transporter Interactions",MOA +CHEMBL17860,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL17860,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL17860,N0000191423,"Multidrug and Toxin Extrusion Transporter 1 Inhibitors",MOA +CHEMBL1789843,N0000182636,"B Lymphocyte Stimulator-directed Antibody Interactions",MOA +CHEMBL1789844,N0000182634,"CTLA-4-directed Antibody Interactions",MOA +CHEMBL1789941,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1789941,N0000190857,"Janus Kinase Inhibitors",MOA +CHEMBL1790041,N0000000151,"Histamine H2 Receptor Antagonists",MOA +CHEMBL1796997,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL180022,N0000175082,"Kinase Inhibitors",MOA +CHEMBL180022,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL181,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL181,N0000182728,"Potassium Channel Openers",MOA +CHEMBL182,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL182,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL184,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL184412,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL184412,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL18442,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL185,N0000000098,"Thymidylate Synthetase Inhibitors",MOA +CHEMBL185,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL185073,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL185073,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL186,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL1863513,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL1863514,N0000000163,"Enzyme Interactions",MOA +CHEMBL1863515,N0000000163,"Enzyme Interactions",MOA +CHEMBL1873475,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1888176,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL189,N0000175086,"Phosphodiesterase 3 Inhibitors",MOA +CHEMBL189963,N0000175082,"Kinase Inhibitors",MOA +CHEMBL189963,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL19,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL190,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL1900528,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL1900528,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL19019,N0000000154,"Opioid Antagonists",MOA +CHEMBL190461,N0000000256,"Serotonin Agonists",MOA +CHEMBL190461,N0000181009,"Cannabinoid Receptor Antagonists",MOA +CHEMBL1908360,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1908360,N0000175624,"mTOR Inhibitors",MOA +CHEMBL1908360,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL1908360,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL1908360,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL1908362,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL1908370,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL1908370,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL1909079,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL191,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL191083,N0000000236,"Alkylating Activity",MOA +CHEMBL191083,N0000175355,"Binding Activity",MOA +CHEMBL191083,N0000175545,"Oxidation-Reduction Activity",MOA +CHEMBL192,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL19224,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL193,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL193,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL193240,N0000182960,"Phosphodiesterase 4 Inhibitors",MOA +CHEMBL1946170,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL1946170,N0000175082,"Kinase Inhibitors",MOA +CHEMBL1946170,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL1951095,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL196,N0000000163,"Enzyme Interactions",MOA +CHEMBL196,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL1963681,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL1963681,N0000190484,"Guanylate Cyclase Stimulators",MOA +CHEMBL1963683,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL1964120,N0000000178,"Enzymatic Activity",MOA +CHEMBL1983350,N0000000196,"GABA A Agonists",MOA +CHEMBL198362,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL2,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL20,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL2007641,N0000020008,"HER2/Neu/cerbB2 Antagonists",MOA +CHEMBL2009089,N0000000065,"Physiochemical Activity",MOA +CHEMBL2010601,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL2010601,N0000184145,"Chloride Channel Activation Potentiators",MOA +CHEMBL2010601,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2010601,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL2010601,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2021423,N0000000163,"Enzyme Interactions",MOA +CHEMBL2021423,N0000000220,"Electrolyte Activity",MOA +CHEMBL2021423,N0000000226,"Acid-Base Activity",MOA +CHEMBL2023898,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2023898,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL2023898,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL2023898,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2023898,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL2028019,N0000000117,"Dopamine Agonists",MOA +CHEMBL2028019,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL2028661,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL2028661,N0000180999,"Angiotensin 2 Type 1 Receptor Antagonists",MOA +CHEMBL2028663,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL2028663,N0000175411,"BRAF Serine/Threonine Kinase Inhibitors",MOA +CHEMBL2028663,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL2028663,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL2028663,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL2028663,N0000187063,"Cytochrome P450 2C8 Inducers",MOA +CHEMBL2028663,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL2028663,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL2028663,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL2028663,N0000190110,"Organic Anion Transporter 1 Inhibitors",MOA +CHEMBL2028663,N0000190111,"Organic Anion Transporter 3 Inhibitors",MOA +CHEMBL2028663,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2028850,N0000182964,"Bradykinin B2 Receptor Antagonists",MOA +CHEMBL2040682,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL2042122,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL2043437,N0000184148,"Smoothened Receptor Antagonists",MOA +CHEMBL204656,N0000000127,"HIV Integrase Inhibitors",MOA +CHEMBL204656,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL2048028,N0000192700,"Lymphocyte Function-Associated Antigen-1 Antagonists",MOA +CHEMBL2048484,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2048484,N0000187058,"Sodium-Glucose Transporter 2 Inhibitors",MOA +CHEMBL206253,N0000010262,"Neurokinin 1 Antagonists",MOA +CHEMBL206253,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL206253,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL206253,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2063090,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL2063090,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL2063090,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL2063090,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2063090,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2063090,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL2068237,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL2070241,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL207538,N0000000118,"GABA A Modulators",MOA +CHEMBL2079587,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL2095207,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL2095208,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL2095208,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2095208,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL2095208,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL2095208,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2095208,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2095212,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL2095212,N0000185007,"Adrenergic beta3-Agonists",MOA +CHEMBL2096629,N0000000087,"Chelating Activity",MOA +CHEMBL2096629,N0000175356,"Ion Exchange Activity",MOA +CHEMBL2096633,N0000000163,"Enzyme Interactions",MOA +CHEMBL2096633,N0000000220,"Electrolyte Activity",MOA +CHEMBL2096633,N0000000226,"Acid-Base Activity",MOA +CHEMBL2096654,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL2096659,N0000175869,"Positron Emitting Activity",MOA +CHEMBL2097081,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL21,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL2103737,N0000000163,"Enzyme Interactions",MOA +CHEMBL2103742,N0000000065,"Physiochemical Activity",MOA +CHEMBL2103749,N0000000107,Antithrombins,MOA +CHEMBL2103749,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL2103752,N0000020069,"N-Calcium Channel Receptor Antagonists",MOA +CHEMBL2103758,N0000020064,"Amylin Agonists",MOA +CHEMBL2103774,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL2103784,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL2103802,N0000000079,"Surfactant Activity",MOA +CHEMBL2103822,N0000000250,"Melatonin Receptor Agonists",MOA +CHEMBL2103830,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL2103830,N0000175789,"Adenosine Receptor Antagonists",MOA +CHEMBL2103846,N0000191262,"Selective Progesterone Receptor Modulators",MOA +CHEMBL2103867,N0000175456,"Chloride Channel Activators",MOA +CHEMBL2103867,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL2103870,N0000184145,"Chloride Channel Activation Potentiators",MOA +CHEMBL2103870,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2103870,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL2103870,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL2103870,N0000185607,"Cytochrome P450 2C19 Inducers",MOA +CHEMBL2103870,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL2103870,N0000187063,"Cytochrome P450 2C8 Inducers",MOA +CHEMBL2103870,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL2103870,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL2103870,N0000191264,"P-Glycoprotein Inducers",MOA +CHEMBL2103872,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL2103873,N0000175364,"Endothelin Receptor Antagonists",MOA +CHEMBL2103875,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL2103877,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL2103877,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL2103883,N0000000215,"ATP-Binding Cassette (ABC) Transporter Interactions",MOA +CHEMBL2103883,N0000175968,"Thrombopoietin Receptor Agonists",MOA +CHEMBL2104045,N0000000065,"Physiochemical Activity",MOA +CHEMBL2104045,N0000010217,Photoabsorption,MOA +CHEMBL2104095,N0000000108,"Prostaglandin Receptor Antagonists",MOA +CHEMBL2104095,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL2104415,N0000000156,"Chloride Channel Interactions",MOA +CHEMBL2104415,N0000188367,"Membrane Transporter Interactions",MOA +CHEMBL2104987,N0000190990,"Glucagon-like Peptide-2 (GLP-2) Agonists",MOA +CHEMBL2104993,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL2104993,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL2104993,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL2105395,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL2105669,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL2105669,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL2105689,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL2105689,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL2105695,N0000193302,"Tryptophan Hydroxylase Inhibitors",MOA +CHEMBL2105717,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL2105717,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL2105720,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL2105720,N0000192340,"Urate Transporter 1 Inhibitors",MOA +CHEMBL2105737,N0000184148,"Smoothened Receptor Antagonists",MOA +CHEMBL2105755,N0000000154,"Opioid Antagonists",MOA +CHEMBL2105755,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL2105759,N0000190857,"Janus Kinase Inhibitors",MOA +CHEMBL2105760,N0000000117,"Dopamine Agonists",MOA +CHEMBL2105760,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL2105897,N0000010257,"Imaging Contrast Activity",MOA +CHEMBL2105897,N0000010258,"X-Ray Contrast Activity",MOA +CHEMBL2106111,N0000000220,"Electrolyte Activity",MOA +CHEMBL2106119,N0000020074,"Phosphate Chelating Activity",MOA +CHEMBL2106123,N0000000220,"Electrolyte Activity",MOA +CHEMBL2106123,N0000020074,"Phosphate Chelating Activity",MOA +CHEMBL2106439,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL2106439,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL2106439,N0000000230,"Dopamine Antagonists",MOA +CHEMBL2106975,N0000000220,"Electrolyte Activity",MOA +CHEMBL2106975,N0000000226,"Acid-Base Activity",MOA +CHEMBL2106978,N0000000220,"Electrolyte Activity",MOA +CHEMBL2106978,N0000000226,"Acid-Base Activity",MOA +CHEMBL2107067,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL2107525,N0000000220,"Electrolyte Activity",MOA +CHEMBL2107525,N0000010288,"Osmotic Activity",MOA +CHEMBL2107567,N0000000220,"Electrolyte Activity",MOA +CHEMBL2107797,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL2107825,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL2107830,N0000187058,"Sodium-Glucose Transporter 2 Inhibitors",MOA +CHEMBL2107831,N0000175968,"Thrombopoietin Receptor Agonists",MOA +CHEMBL2107834,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL2107834,N0000190484,"Guanylate Cyclase Stimulators",MOA +CHEMBL2107840,N0000178377,"Potassium Ion Binding Activity",MOA +CHEMBL2107841,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL2107857,N0000000175,"Cytokine Receptor Superfamily Interactions",MOA +CHEMBL2107869,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL2107874,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL2107884,N0000191871,"Interleukin-5 Antagonists",MOA +CHEMBL2107885,N0000000089,"Plasminogen Activators",MOA +CHEMBL2107885,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL2107886,N0000000107,Antithrombins,MOA +CHEMBL2107902,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL2108027,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL2108041,N0000175078,"CD20-directed Antibody Interactions",MOA +CHEMBL2108074,N0000000178,"Enzymatic Activity",MOA +CHEMBL2108078,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL2108147,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL2108184,N0000000224,"Chloride Channel Antagonists",MOA +CHEMBL2108232,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2108236,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL2108247,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL2108250,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL2108278,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL2108278,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL2108282,N0000000231,"Enzyme Activators",MOA +CHEMBL2108311,N0000000178,"Enzymatic Activity",MOA +CHEMBL2108336,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL2108396,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL2108429,N0000191871,"Interleukin-5 Antagonists",MOA +CHEMBL2108448,N0000000228,"Structural Macromolecules",MOA +CHEMBL2108448,N0000010288,"Osmotic Activity",MOA +CHEMBL2108512,N0000184009,"Virus Neutralization",MOA +CHEMBL2108546,N0000000178,"Enzymatic Activity",MOA +CHEMBL2108574,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL2108574,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL2108574,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL2108611,N0000193616,"CD22-directed Antibody Interactions",MOA +CHEMBL2108638,N0000192702,"Anthrax Protective Antigen-directed Antibody Interactions",MOA +CHEMBL2108670,N0000175355,"Binding Activity",MOA +CHEMBL2108670,N0000184011,"Bacterial Toxin Neutralization",MOA +CHEMBL2108675,N0000193341,"Interleukin 4 Receptor alpha Antagonists",MOA +CHEMBL2108677,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2108681,N0000192798,"Interleukin-23 Antagonists",MOA +CHEMBL2108709,N0000000231,"Enzyme Activators",MOA +CHEMBL2108724,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL2108727,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL2108728,N0000000163,"Enzyme Interactions",MOA +CHEMBL2108730,N0000190478,"Interleukin 6 Receptor Antagonists",MOA +CHEMBL2108738,N0000191259,"Programmed Death Receptor-1-directed Antibody Interactions",MOA +CHEMBL2108750,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL2108780,N0000175532,"Demulcent Activity",MOA +CHEMBL2108791,N0000000241,"Tissue Plasminogen Activators",MOA +CHEMBL2108806,N0000000107,Antithrombins,MOA +CHEMBL2108806,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL2108806,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL2108832,N0000175355,"Binding Activity",MOA +CHEMBL2108834,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL2108956,N0000000076,"Protease Inhibitors",MOA +CHEMBL2108956,N0000175532,"Demulcent Activity",MOA +CHEMBL2108989,N0000000163,"Enzyme Interactions",MOA +CHEMBL2109001,N0000000075,"Stool Bulking Activity",MOA +CHEMBL2109001,N0000175532,"Demulcent Activity",MOA +CHEMBL2109016,N0000000065,"Physiochemical Activity",MOA +CHEMBL2109047,N0000000247,"Biological Response Modifiers",MOA +CHEMBL2109065,N0000000231,"Enzyme Activators",MOA +CHEMBL2109152,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2109540,N0000191730,"PCSK9 Inhibitors",MOA +CHEMBL2109624,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL2110563,N0000000163,"Enzyme Interactions",MOA +CHEMBL2110576,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL2110576,N0000009958,"Bone Surface Interactions",MOA +CHEMBL2110588,N0000020019,"Glucosylceramide Synthase Inhibitors",MOA +CHEMBL2110588,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL2110588,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2110588,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2110732,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL2111018,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL2111101,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL211456,N0000000122,"Adrenergic Agonists",MOA +CHEMBL211456,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL211456,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL2141296,N0000175075,"Proteasome Inhibitors",MOA +CHEMBL2146883,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL2146883,N0000175082,"Kinase Inhibitors",MOA +CHEMBL2159122,N0000000154,"Opioid Antagonists",MOA +CHEMBL2159122,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL21731,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL21731,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL218394,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL218394,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL218394,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL218394,N0000190115,"Cytochrome P450 3A5 Inhibitors",MOA +CHEMBL218490,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL219916,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL22,N0000000111,"Folic Acid Metabolism Inhibitors",MOA +CHEMBL22,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL22,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL22,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL220491,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL220492,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL220492,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL220492,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL22097,N0000000118,"GABA A Modulators",MOA +CHEMBL22097,N0000000196,"GABA A Agonists",MOA +CHEMBL22097,N0000175456,"Chloride Channel Activators",MOA +CHEMBL2216870,N0000175082,"Kinase Inhibitors",MOA +CHEMBL2216870,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2218860,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL2218885,N0000010217,Photoabsorption,MOA +CHEMBL2218894,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL2218896,N0000181008,"Cannabinoid Receptor Agonists",MOA +CHEMBL2218908,N0000000226,"Acid-Base Activity",MOA +CHEMBL2218913,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2219418,N0000000154,"Opioid Antagonists",MOA +CHEMBL2219418,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL2219425,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL2219425,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL221959,N0000190857,"Janus Kinase Inhibitors",MOA +CHEMBL2219642,N0000000163,"Enzyme Interactions",MOA +CHEMBL2219642,N0000000220,"Electrolyte Activity",MOA +CHEMBL2219642,N0000000226,"Acid-Base Activity",MOA +CHEMBL2219740,N0000000220,"Electrolyte Activity",MOA +CHEMBL2221312,N0000175862,"Magnetic Resonance Contrast Activity",MOA +CHEMBL222559,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL222559,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL222645,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL222813,N0000175436,"Neuraminidase Inhibitors",MOA +CHEMBL223228,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL223228,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL223228,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL223228,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL223228,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL223228,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL225072,N0000000098,"Thymidylate Synthetase Inhibitors",MOA +CHEMBL225072,N0000000111,"Folic Acid Metabolism Inhibitors",MOA +CHEMBL225072,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL225072,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL23,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL23,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL231068,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL231068,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL2311030,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL2311030,N0000000130,"Serotonin Antagonists",MOA +CHEMBL2311030,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL231779,N0000000107,Antithrombins,MOA +CHEMBL231779,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL231813,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL231813,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL231813,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL231813,N0000190109,"Organic Anion Transporting Polypeptide 2B1 Inhibitors",MOA +CHEMBL231813,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL2336071,N0000181815,"Sphingosine 1-Phosphate Receptor Modulators",MOA +CHEMBL2354773,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2355051,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL2356023,N0000000085,"Receptor Interactions",MOA +CHEMBL235668,N0000191869,"Thymidine Phosphorylase Inhibitors",MOA +CHEMBL2359370,N0000000163,"Enzyme Interactions",MOA +CHEMBL2362016,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL2364608,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL2364608,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL2364632,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL2364632,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2364639,N0000190855,"Vesicular Monoamine Transporter 2 Inhibitors",MOA +CHEMBL2364648,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL2364648,N0000192798,"Interleukin-23 Antagonists",MOA +CHEMBL2364655,N0000191730,"PCSK9 Inhibitors",MOA +CHEMBL2367706,N0000175355,"Binding Activity",MOA +CHEMBL2368861,N0000000154,"Opioid Antagonists",MOA +CHEMBL2368861,N0000175685,"Partial Opioid Agonists",MOA +CHEMBL2368925,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL2368925,N0000175817,"Serotonin 3 Receptor Antagonists",MOA +CHEMBL2374220,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL2374220,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL237500,N0000175912,"Dipeptidyl Peptidase 4 Inhibitors",MOA +CHEMBL238804,N0000020068,"Prostacyclin Receptor Agonists",MOA +CHEMBL238804,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL2396661,N0000175082,"Kinase Inhibitors",MOA +CHEMBL24,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL24,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL2403108,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL2403108,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL2403108,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL24778,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL24778,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL24778,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL24828,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL24828,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL24828,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL24828,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL248702,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL248702,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL248702,N0000000256,"Serotonin Agonists",MOA +CHEMBL25,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL250270,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL251940,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL251940,N0000000230,"Dopamine Antagonists",MOA +CHEMBL254219,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL254219,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL254316,N0000000127,"HIV Integrase Inhibitors",MOA +CHEMBL254328,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL254328,N0000182632,"Cytochrome P450 17A1 Inhibitors",MOA +CHEMBL254328,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL255863,N0000020009,"Bcr-Abl Tyrosine Kinase Inhibitors",MOA +CHEMBL255863,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL259209,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL259209,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL259209,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL262777,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL264241,N0000020027,"Glucan Synthase Inhibitors",MOA +CHEMBL266481,N0000010275,"Glucagon Receptor Interactions",MOA +CHEMBL267345,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL267648,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL267648,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL267894,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL267936,N0000000227,"Cholinergic Nicotinic Antagonists",MOA +CHEMBL269732,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL269732,N0000175458,"Calcineurin Inhibitors",MOA +CHEMBL27,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL27,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL27,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL270190,N0000000154,"Opioid Antagonists",MOA +CHEMBL270190,N0000175686,"Competitive Opioid Antagonists",MOA +CHEMBL276832,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL277062,N0000000118,"GABA A Modulators",MOA +CHEMBL277100,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL277100,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL277474,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL277535,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL277535,N0000182136,"Cytochrome P450 Inhibitors",MOA +CHEMBL278020,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL27810,N0000009920,"Adrenergic alpha2-Antagonists",MOA +CHEMBL27810,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL27810,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL278172,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL278398,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL278623,N0000193786,"Growth Hormone Secretagogue Receptor Agonists",MOA +CHEMBL282052,N0000000118,"GABA A Modulators",MOA +CHEMBL282575,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL284348,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL284906,N0000000215,"ATP-Binding Cassette (ABC) Transporter Interactions",MOA +CHEMBL284906,N0000182728,"Potassium Channel Openers",MOA +CHEMBL285674,N0000000118,"GABA A Modulators",MOA +CHEMBL288441,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL288441,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL288441,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL29,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL290916,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL294199,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL296306,N0000010288,"Osmotic Activity",MOA +CHEMBL296306,N0000175833,"Acidifying Activity",MOA +CHEMBL296419,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL297302,N0000000230,"Dopamine Antagonists",MOA +CHEMBL298470,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL3,N0000000143,"Cholinergic Nicotinic Agonists",MOA +CHEMBL30,N0000000151,"Histamine H2 Receptor Antagonists",MOA +CHEMBL30008,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL30008,N0000020066,"T-Calcium Channel Receptor Antagonists",MOA +CHEMBL301265,N0000000117,"Dopamine Agonists",MOA +CHEMBL3039502,N0000175082,"Kinase Inhibitors",MOA +CHEMBL3039514,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3039514,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3039514,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3039514,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3039514,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL3039537,N0000000085,"Receptor Interactions",MOA +CHEMBL3039583,N0000000194,"Somatostatin Receptor Agonists",MOA +CHEMBL3039594,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL3039598,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL305187,N0000020014,"Ionotropic Glutamate Receptor Antagonists",MOA +CHEMBL306700,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL308954,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL31,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL31,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL3112741,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL312448,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL312448,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL312448,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL312448,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL3127326,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL3127326,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL3137301,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL3137309,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3137309,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL3137312,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL3137312,N0000187063,"Cytochrome P450 2C8 Inducers",MOA +CHEMBL3137312,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3137312,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL3137312,N0000191258,"RNA Replicase Inhibitors",MOA +CHEMBL3137312,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL3137320,N0000191622,"Poly(ADP-Ribose) Polymerase Inhibitors",MOA +CHEMBL3137321,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL3137342,N0000000082,"Immunologic Factor Interactions",MOA +CHEMBL3137342,N0000191499,"Glycolipid Disialoganglioside-directed Antibody Interactions",MOA +CHEMBL3137343,N0000191259,"Programmed Death Receptor-1-directed Antibody Interactions",MOA +CHEMBL314854,N0000181815,"Sphingosine 1-Phosphate Receptor Modulators",MOA +CHEMBL315795,N0000000118,"GABA A Modulators",MOA +CHEMBL315838,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL315985,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL315985,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL315985,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL317052,N0000175788,"Adenosine Receptor Agonists",MOA +CHEMBL317094,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL3182343,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL3183075,N0000000151,"Histamine H2 Receptor Antagonists",MOA +CHEMBL3183184,N0000000065,"Physiochemical Activity",MOA +CHEMBL3183409,N0000000074,"GABA A Antagonists",MOA +CHEMBL3183409,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL3187723,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL32,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL32,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL3218576,N0000175082,"Kinase Inhibitors",MOA +CHEMBL325041,N0000020084,"Ubiquitin Ligase Inhibitors",MOA +CHEMBL325041,N0000175075,"Proteasome Inhibitors",MOA +CHEMBL32800,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL3286830,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL3286830,N0000175082,"Kinase Inhibitors",MOA +CHEMBL3286830,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL3286830,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL33,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL33,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL3301581,N0000000158,"Parathormone Receptor Agonists",MOA +CHEMBL3301582,N0000020023,"Antibody-Surface Protein Interactions",MOA +CHEMBL3301587,N0000193336,"Programmed Death Ligand-1-directed Antibody Interactions",MOA +CHEMBL3301587,N0000193337,"Programmed Death Ligand-1 Antagonists",MOA +CHEMBL3301592,N0000000220,"Electrolyte Activity",MOA +CHEMBL3301592,N0000175833,"Acidifying Activity",MOA +CHEMBL3301597,N0000000220,"Electrolyte Activity",MOA +CHEMBL3301610,N0000175082,"Kinase Inhibitors",MOA +CHEMBL3301612,N0000175411,"BRAF Serine/Threonine Kinase Inhibitors",MOA +CHEMBL3301622,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL3301669,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL3301675,N0000175456,"Chloride Channel Activators",MOA +CHEMBL3301675,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL3301800,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL3317857,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL334966,N0000182143,"P2Y12 Receptor Antagonists",MOA +CHEMBL3353410,N0000175082,"Kinase Inhibitors",MOA +CHEMBL3353410,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL3353410,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3353410,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL3353410,N0000191266,"Cytochrome P450 1A2 Inducers",MOA +CHEMBL3391662,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL3391662,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3391662,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3391662,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3391662,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3391662,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL3391662,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL339427,N0000175703,"Competitive Cholinergic Nicotinic Antagonists",MOA +CHEMBL339427,N0000175718,"Cholinergic Neuromuscular Nicotinic Antagonists",MOA +CHEMBL33986,N0000000154,"Opioid Antagonists",MOA +CHEMBL33986,N0000000174,"Opioid Agonists",MOA +CHEMBL33986,N0000175685,"Partial Opioid Agonists",MOA +CHEMBL33986,N0000175686,"Competitive Opioid Antagonists",MOA +CHEMBL34259,N0000000098,"Thymidylate Synthetase Inhibitors",MOA +CHEMBL34259,N0000000111,"Folic Acid Metabolism Inhibitors",MOA +CHEMBL34259,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL343448,N0000175071,"Histone Deacetylase Inhibitors",MOA +CHEMBL344159,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL344159,N0000193178,"Vasopressin V2 Receptor Antagonists",MOA +CHEMBL35,N0000181006,"Sodium Potassium Chloride Symporter Inhibitors",MOA +CHEMBL354077,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL3544921,N0000000163,"Enzyme Interactions",MOA +CHEMBL3544926,N0000192702,"Anthrax Protective Antigen-directed Antibody Interactions",MOA +CHEMBL3544974,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL3544996,N0000010226,"Antibody Interactions",MOA +CHEMBL3545062,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3545062,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3545062,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3545062,N0000190109,"Organic Anion Transporting Polypeptide 2B1 Inhibitors",MOA +CHEMBL3545062,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3545110,N0000175082,"Kinase Inhibitors",MOA +CHEMBL3545110,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL3545123,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL3545123,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3545123,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3545123,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3545123,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3545123,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL3545123,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL3545126,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL3545126,N0000193789,"Rho Kinase Inhibitors",MOA +CHEMBL3545184,N0000020081,"Increased Calcium-sensing Receptor Sensitivity",MOA +CHEMBL3545185,N0000188367,"Membrane Transporter Interactions",MOA +CHEMBL3545189,N0000184151,"Kallikrein Inhibitors",MOA +CHEMBL3545306,N0000010259,"Ultrasound Contrast Activity",MOA +CHEMBL3545311,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL3545311,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL3545363,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL3545363,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL3545363,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3545363,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3545363,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3545363,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3545363,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL3545363,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL3545376,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL354541,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL354541,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL354541,N0000186778,"Microsomal Triglyceride Transfer Protein Inhibitors",MOA +CHEMBL3545985,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL3545985,N0000000153,"Adrenergic Receptor Interactions",MOA +CHEMBL3545985,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL36,N0000000111,"Folic Acid Metabolism Inhibitors",MOA +CHEMBL36,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL360328,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL360328,N0000185009,"Serotonin 2c Receptor Agonists",MOA +CHEMBL364713,N0000182148,"Sigma-1 Receptor Antagonists",MOA +CHEMBL370143,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL3707227,N0000191259,"Programmed Death Receptor-1-directed Antibody Interactions",MOA +CHEMBL3707314,N0000000085,"Receptor Interactions",MOA +CHEMBL3707328,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL3707331,N0000010262,"Neurokinin 1 Antagonists",MOA +CHEMBL3707331,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL3707331,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3707331,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3707348,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL3707372,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL3707372,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3707372,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL3707372,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL3707372,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL370805,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL370805,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL372795,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL373742,N0000000165,"Pituitary Hormone Receptor Agonists",MOA +CHEMBL374478,N0000000076,"Protease Inhibitors",MOA +CHEMBL374478,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL374731,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL376140,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL376359,N0000175912,"Dipeptidyl Peptidase 4 Inhibitors",MOA +CHEMBL376488,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL376897,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL38,N0000000085,"Receptor Interactions",MOA +CHEMBL38,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL3813873,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL3833303,N0000000220,"Electrolyte Activity",MOA +CHEMBL3833319,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL3833319,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL3833322,N0000000163,"Enzyme Interactions",MOA +CHEMBL3833322,N0000000220,"Electrolyte Activity",MOA +CHEMBL3833322,N0000000226,"Acid-Base Activity",MOA +CHEMBL3833339,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL3833350,N0000000220,"Electrolyte Activity",MOA +CHEMBL3833350,N0000000226,"Acid-Base Activity",MOA +CHEMBL3833351,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL3833369,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL3833369,N0000175546,"Oxidation Activity",MOA +CHEMBL3833373,N0000193336,"Programmed Death Ligand-1-directed Antibody Interactions",MOA +CHEMBL3833373,N0000193337,"Programmed Death Ligand-1 Antagonists",MOA +CHEMBL3833383,N0000175869,"Positron Emitting Activity",MOA +CHEMBL3833401,N0000009958,"Bone Surface Interactions",MOA +CHEMBL384467,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL384467,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL384467,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL385517,N0000175912,"Dipeptidyl Peptidase 4 Inhibitors",MOA +CHEMBL386630,N0000000146,"Androgen Receptor Agonists",MOA +CHEMBL38827,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL38827,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL38827,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL3889654,N0000193859,"Tropomyosin Receptor Kinases Inhibitors",MOA +CHEMBL389621,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL389621,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL389621,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL395091,N0000181818,"Noncompetitive NMDA Receptor Antagonists",MOA +CHEMBL395429,N0000000152,"G-Protein-linked Receptor Interactions",MOA +CHEMBL396778,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL396778,N0000000224,"Chloride Channel Antagonists",MOA +CHEMBL396778,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL396778,N0000175760,"Monoamine Oxidase-A Inhibitors",MOA +CHEMBL396778,N0000175761,"Monoamine Oxidase-B Inhibitors",MOA +CHEMBL396778,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL396778,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL396778,N0000182139,"Cytochrome P450 2B6 Inhibitors",MOA +CHEMBL396778,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL396778,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL396778,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL396778,N0000190115,"Cytochrome P450 3A5 Inhibitors",MOA +CHEMBL398435,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL398435,N0000182143,"P2Y12 Receptor Antagonists",MOA +CHEMBL398435,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL398435,N0000190115,"Cytochrome P450 3A5 Inhibitors",MOA +CHEMBL398435,N0000190482,"Phenylalanine Hydroxylase Activators",MOA +CHEMBL398440,N0000000065,"Physiochemical Activity",MOA +CHEMBL398707,N0000175684,"Full Opioid Agonists",MOA +CHEMBL398707,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL3988900,N0000000065,"Physiochemical Activity",MOA +CHEMBL3989480,N0000000075,"Stool Bulking Activity",MOA +CHEMBL3989480,N0000000163,"Enzyme Interactions",MOA +CHEMBL3989480,N0000000220,"Electrolyte Activity",MOA +CHEMBL3989480,N0000000226,"Acid-Base Activity",MOA +CHEMBL3989517,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL3989523,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL3989529,N0000020024,"Sclerosing Activity",MOA +CHEMBL3989640,N0000000163,"Enzyme Interactions",MOA +CHEMBL3989640,N0000000220,"Electrolyte Activity",MOA +CHEMBL3989640,N0000000226,"Acid-Base Activity",MOA +CHEMBL3989698,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL3989698,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL3989698,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL3989714,N0000000226,"Acid-Base Activity",MOA +CHEMBL3989714,N0000000227,"Cholinergic Nicotinic Antagonists",MOA +CHEMBL3989727,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL3989751,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL3989858,N0000000163,"Enzyme Interactions",MOA +CHEMBL3989858,N0000000220,"Electrolyte Activity",MOA +CHEMBL3989858,N0000000226,"Acid-Base Activity",MOA +CHEMBL3989866,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL3989908,N0000193614,"Isocitrate Dehydrogenase 2 Inhibitors",MOA +CHEMBL3989917,N0000010262,"Neurokinin 1 Antagonists",MOA +CHEMBL3989917,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL3989917,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL3989917,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL3989958,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL3989977,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL3989977,N0000193855,"Interferon gamma Antagonists",MOA +CHEMBL3989986,N0000175974,"Complement Inhibitors",MOA +CHEMBL3990026,N0000000178,"Enzymatic Activity",MOA +CHEMBL3990029,N0000192798,"Interleukin-23 Antagonists",MOA +CHEMBL3990047,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL3990047,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL4,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL4,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL40,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL403,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL403664,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL404,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL404422,N0000000118,"GABA A Modulators",MOA +CHEMBL404422,N0000000196,"GABA A Agonists",MOA +CHEMBL404422,N0000020014,"Ionotropic Glutamate Receptor Antagonists",MOA +CHEMBL405,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL405,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL405,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL406,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL406,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL407,N0000000074,"GABA A Antagonists",MOA +CHEMBL407,N0000000229,"GABA B Antagonists",MOA +CHEMBL408,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL408,N0000175377,"Peroxisome Proliferator-activated Receptor gamma Agonists",MOA +CHEMBL408403,N0000000152,"G-Protein-linked Receptor Interactions",MOA +CHEMBL408513,N0000175071,"Histone Deacetylase Inhibitors",MOA +CHEMBL409,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL409153,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL409153,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL409153,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL41,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL41,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL411,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL413,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL413,N0000175624,"mTOR Inhibitors",MOA +CHEMBL41355,N0000182728,"Potassium Channel Openers",MOA +CHEMBL414357,N0000020058,"Glucagon-like Peptide-1 (GLP-1) Agonists",MOA +CHEMBL414804,N0000000065,"Physiochemical Activity",MOA +CHEMBL414804,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL415,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL415,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL415,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL415606,N0000175084,"Gonadotropin Releasing Hormone Receptor Antagonists",MOA +CHEMBL416,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL416,N0000010217,Photoabsorption,MOA +CHEMBL416956,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL417,N0000000135,"Immunologic Adjuvants",MOA +CHEMBL417,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL417,N0000020088,"Topoisomerase 2 Inhibitors",MOA +CHEMBL419,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL419,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL42,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL42,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL42,N0000000130,"Serotonin Antagonists",MOA +CHEMBL42,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL42,N0000000230,"Dopamine Antagonists",MOA +CHEMBL420,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL421,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL421,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL422,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL422,N0000000230,"Dopamine Antagonists",MOA +CHEMBL423,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL423,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL424,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL42403,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL425,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL425,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL427,N0000000236,"Alkylating Activity",MOA +CHEMBL428,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL428647,N0000000135,"Immunologic Adjuvants",MOA +CHEMBL428647,N0000010260,"beta Tubulin Interactions",MOA +CHEMBL428880,N0000000247,"Biological Response Modifiers",MOA +CHEMBL428880,N0000175356,"Ion Exchange Activity",MOA +CHEMBL429,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL429,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL429,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL429,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL4297185,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL4297503,N0000193853,"Polymerase Acidic Endonuclease Inhibitors",MOA +CHEMBL4297549,N0000000169,"Serine Proteinase Inhibitors",MOA +CHEMBL4297549,N0000184151,"Kallikrein Inhibitors",MOA +CHEMBL4297573,N0000175614,"Fusion Protein Interactions",MOA +CHEMBL4297573,N0000193865,"CD123 Interactions",MOA +CHEMBL4297620,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL4297620,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL4297620,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL4297723,N0000191259,"Programmed Death Receptor-1-directed Antibody Interactions",MOA +CHEMBL4297756,N0000009949,"Antibody-Receptor Interactions",MOA +CHEMBL4297802,N0000000163,"Enzyme Interactions",MOA +CHEMBL4297862,N0000009955,"Acetylcholine Transporter Interactions",MOA +CHEMBL4297862,N0000175770,"Acetylcholine Release Inhibitors",MOA +CHEMBL429910,N0000187058,"Sodium-Glucose Transporter 2 Inhibitors",MOA +CHEMBL430,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL430,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL431,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL434,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL434,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL434,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL434394,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL43452,N0000020085,"E3 Ubiquitin Ligase Inhibitors",MOA +CHEMBL435,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL437,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL439,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL439849,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL439849,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL440,N0000000116,"GABA B Agonists",MOA +CHEMBL440,N0000000196,"GABA A Agonists",MOA +CHEMBL441,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL441738,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL442,N0000000130,"Serotonin Antagonists",MOA +CHEMBL442,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL442,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL442,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL442,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL443,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL443,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL443052,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL44354,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL444,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL444,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL444633,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL445,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL445,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL445,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL446061,N0000000079,"Surfactant Activity",MOA +CHEMBL44657,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL447,N0000000118,"GABA A Modulators",MOA +CHEMBL447,N0000000251,"GABA B Modulators",MOA +CHEMBL448,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL44884,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL449,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL45,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL450,N0000000118,"GABA A Modulators",MOA +CHEMBL45029,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL45029,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL450449,N0000000236,"Alkylating Activity",MOA +CHEMBL450895,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL451,N0000000118,"GABA A Modulators",MOA +CHEMBL451,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL451887,N0000175075,"Proteasome Inhibitors",MOA +CHEMBL452,N0000000118,"GABA A Modulators",MOA +CHEMBL452231,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL453,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL454,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL454446,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL455,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL455917,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL456,N0000181006,"Sodium Potassium Chloride Symporter Inhibitors",MOA +CHEMBL457,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL457547,N0000020027,"Glucan Synthase Inhibitors",MOA +CHEMBL45816,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL45816,N0000020066,"T-Calcium Channel Receptor Antagonists",MOA +CHEMBL459,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL459,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL459,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL459265,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL46,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL46,N0000175817,"Serotonin 3 Receptor Antagonists",MOA +CHEMBL460,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL460,N0000000230,"Dopamine Antagonists",MOA +CHEMBL460291,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL46058,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL461101,N0000175968,"Thrombopoietin Receptor Agonists",MOA +CHEMBL461101,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL461101,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL461101,N0000191272,"UGT1A1 Inhibitors",MOA +CHEMBL461101,N0000191273,"UGT2B7 Inhibitors",MOA +CHEMBL461101,N0000191274,"UGT2B15 Inhibitors",MOA +CHEMBL461101,N0000191275,"UGT1A3 Inhibitors",MOA +CHEMBL461101,N0000191276,"UGT1A4 Inhibitors",MOA +CHEMBL461101,N0000191277,"UGT1A6 Inhibitors",MOA +CHEMBL461101,N0000191278,"UGT1A9 Inhibitors",MOA +CHEMBL461332,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL462605,N0000181003,"Histamine H3 Receptor Antagonists",MOA +CHEMBL463,N0000000065,"Physiochemical Activity",MOA +CHEMBL46469,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL465,N0000181008,"Cannabinoid Receptor Agonists",MOA +CHEMBL46516,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL466659,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL467,N0000000212,"Ribonucleotide Reductase Inhibitors",MOA +CHEMBL46740,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL468,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL468,N0000175446,"Tumor Necrosis Factor alpha Receptor Blocking Activity",MOA +CHEMBL469,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL471,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL471,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL471,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL471737,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL471737,N0000191546,"Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists",MOA +CHEMBL472,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL472,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL473,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL473417,N0000184148,"Smoothened Receptor Antagonists",MOA +CHEMBL474579,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL475534,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL476,N0000000236,"Alkylating Activity",MOA +CHEMBL477,N0000000228,"Structural Macromolecules",MOA +CHEMBL477,N0000175788,"Adenosine Receptor Agonists",MOA +CHEMBL477772,N0000020007,"Vascular Endothelial Growth Factor Receptor Inhibitors",MOA +CHEMBL477772,N0000020030,"Platelet-derived Growth Factor Receptor Inhibitors",MOA +CHEMBL477772,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL477772,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL477772,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL477772,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL479,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL479,N0000000230,"Dopamine Antagonists",MOA +CHEMBL479,N0000182136,"Cytochrome P450 Inhibitors",MOA +CHEMBL480,N0000000147,"Proton Pump Inhibitors",MOA +CHEMBL481,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL483254,N0000175071,"Histone Deacetylase Inhibitors",MOA +CHEMBL483254,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL48449,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL484785,N0000182960,"Phosphodiesterase 4 Inhibitors",MOA +CHEMBL485,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL485,N0000175684,"Full Opioid Agonists",MOA +CHEMBL485253,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL485253,N0000000256,"Serotonin Agonists",MOA +CHEMBL487253,N0000000236,"Alkylating Activity",MOA +CHEMBL488,N0000000162,"Steroid Receptor Antagonists",MOA +CHEMBL488,N0000175080,"Aromatase Inhibitors",MOA +CHEMBL488,N0000175921,"Adrenal Steroid Synthesis Inhibitors",MOA +CHEMBL49,N0000000256,"Serotonin Agonists",MOA +CHEMBL49,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL490,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL490,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL491571,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL492,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL493,N0000000117,"Dopamine Agonists",MOA +CHEMBL493287,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL493982,N0000190995,"Protease-activated Receptor-1 Antagonists",MOA +CHEMBL494,N0000020068,"Prostacyclin Receptor Agonists",MOA +CHEMBL495,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL496,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL497,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL498,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL499,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL499,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL499,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL499808,N0000020027,"Glucan Synthase Inhibitors",MOA +CHEMBL5,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL500,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL500,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL500,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL501122,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL501849,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL501849,N0000182638,"HCV NS3/4A Protease Inhibitors",MOA +CHEMBL501849,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL501849,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL501849,N0000190108,"Organic Anion Transporting Polypeptide 1B3 Inhibitors",MOA +CHEMBL501867,N0000010256,"Tubulin Interactions",MOA +CHEMBL502,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL502835,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL502835,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL503,N0000000121,"Hydroxymethylglutaryl-CoA Reductase Inhibitors",MOA +CHEMBL503,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL503,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL504760,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL505,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL506,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL506110,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL506110,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL507674,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL509,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL511,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL512351,N0000175635,"Factor Xa Inhibitors",MOA +CHEMBL513,N0000000236,"Alkylating Activity",MOA +CHEMBL514,N0000000236,"Alkylating Activity",MOA +CHEMBL514800,N0000182960,"Phosphodiesterase 4 Inhibitors",MOA +CHEMBL515,N0000000236,"Alkylating Activity",MOA +CHEMBL515606,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL516,N0000000130,"Serotonin Antagonists",MOA +CHEMBL516,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL516,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL517,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL517,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL517712,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL517712,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL521,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL521686,N0000191622,"Poly(ADP-Ribose) Polymerase Inhibitors",MOA +CHEMBL524004,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL52440,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL52440,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL52440,N0000181819,"Uncompetitive NMDA Receptor Antagonists",MOA +CHEMBL52440,N0000182147,"Sigma-1 Receptor Agonists",MOA +CHEMBL525076,N0000175615,"Fusion Protein Inhibitors",MOA +CHEMBL525610,N0000000149,"Hormone Receptor Agonists",MOA +CHEMBL526,N0000000118,"GABA A Modulators",MOA +CHEMBL527,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL528,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL529,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL53,N0000000117,"Dopamine Agonists",MOA +CHEMBL531,N0000000117,"Dopamine Agonists",MOA +CHEMBL532,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL533,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL534,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL53463,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL53463,N0000020088,"Topoisomerase 2 Inhibitors",MOA +CHEMBL535,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL535,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL537,N0000020001,"Tyrosine Kinase Inhibitors",MOA +CHEMBL537,N0000175850,"Melanin Synthesis Inhibitors",MOA +CHEMBL539697,N0000009963,"Thrombin Inhibitors",MOA +CHEMBL54,N0000000230,"Dopamine Antagonists",MOA +CHEMBL541,N0000175806,"Ammonium Ion Binding Activity",MOA +CHEMBL542,N0000000065,"Physiochemical Activity",MOA +CHEMBL544,N0000175850,"Melanin Synthesis Inhibitors",MOA +CHEMBL545,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL545,N0000000196,"GABA A Agonists",MOA +CHEMBL546,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL546,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL547,N0000000085,"Receptor Interactions",MOA +CHEMBL547,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL548,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL549,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL549,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL55,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL550,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL550,N0000175369,"Cholinergic Agonists",MOA +CHEMBL550348,N0000000144,"Iron Chelating Activity",MOA +CHEMBL550348,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL550348,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL550348,N0000187062,"Cytochrome P450 2C8 Inhibitors",MOA +CHEMBL553,N0000020010,"HER1 Antagonists",MOA +CHEMBL553,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL553025,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL553025,N0000010256,"Tubulin Interactions",MOA +CHEMBL554,N0000020008,"HER2/Neu/cerbB2 Antagonists",MOA +CHEMBL554,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL556,N0000000144,"Iron Chelating Activity",MOA +CHEMBL558,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL559,N0000000237,"Thyroid Hormone Receptor Agonists",MOA +CHEMBL559,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL561,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL562,N0000010256,"Tubulin Interactions",MOA +CHEMBL563,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL564,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL564,N0000000230,"Dopamine Antagonists",MOA +CHEMBL564085,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL565,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL566315,N0000192560,"Farnesoid X Receptor Agonists",MOA +CHEMBL566534,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL566534,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL566752,N0000175869,"Positron Emitting Activity",MOA +CHEMBL567,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL567,N0000000230,"Dopamine Antagonists",MOA +CHEMBL568,N0000000118,"GABA A Modulators",MOA +CHEMBL569,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL569713,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL569713,N0000000130,"Serotonin Antagonists",MOA +CHEMBL569713,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL569713,N0000175370,"Cholinergic Antagonists",MOA +CHEMBL57,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL57,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL57,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL57,N0000187064,"Cytochrome P450 2B6 Inducers",MOA +CHEMBL57,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL570,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL570,N0000000130,"Serotonin Antagonists",MOA +CHEMBL570,N0000000230,"Dopamine Antagonists",MOA +CHEMBL571,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL572,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL572,N0000010255,"Cellular Structure Molecule Interactions",MOA +CHEMBL573,N0000000163,"Enzyme Interactions",MOA +CHEMBL575,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL577,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL578,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL578,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL579205,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL58,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL580,N0000000118,"GABA A Modulators",MOA +CHEMBL58323,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL584,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL584,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL585,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL588,N0000000117,"Dopamine Agonists",MOA +CHEMBL589,N0000000117,"Dopamine Agonists",MOA +CHEMBL59,N0000000117,"Dopamine Agonists",MOA +CHEMBL59,N0000000122,"Adrenergic Agonists",MOA +CHEMBL590,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL591,N0000000118,"GABA A Modulators",MOA +CHEMBL591665,N0000000163,"Enzyme Interactions",MOA +CHEMBL591665,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL592,N0000175684,"Full Opioid Agonists",MOA +CHEMBL592,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL593,N0000009948,"Non-Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL594,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL595,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL595,N0000175374,"Peroxisome Proliferator-activated Receptor Activity",MOA +CHEMBL595,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL596,N0000175684,"Full Opioid Agonists",MOA +CHEMBL597,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL599,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL6,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL600,N0000000170,"Free Radical Scavenging Activity",MOA +CHEMBL600,N0000175547,"Reduction Activity",MOA +CHEMBL601,N0000000163,"Enzyme Interactions",MOA +CHEMBL601719,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL601719,N0000182139,"Cytochrome P450 2B6 Inhibitors",MOA +CHEMBL601719,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL601719,N0000187061,"Organic Cation Transporter 2 Inhibitors",MOA +CHEMBL601719,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL601719,N0000191265,"Organic Cation Transporter 1 Inhibitors",MOA +CHEMBL602,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL602,N0000175549,"Cystine Disulfide Reduction",MOA +CHEMBL603,N0000000083,"Leukotriene Receptor Antagonists",MOA +CHEMBL603,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL605846,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL606,N0000000106,"Prostaglandin Receptor Agonists",MOA +CHEMBL607,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL607,N0000175684,"Full Opioid Agonists",MOA +CHEMBL607400,N0000192345,"Epoxide Hydrolase Inhibitors",MOA +CHEMBL607710,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL608,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL608533,N0000020000,"Receptor Tyrosine Kinase Inhibitors",MOA +CHEMBL609,N0000175472,"Metal Chelating Activity",MOA +CHEMBL61,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL611,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL612,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL612,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL612,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL614,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL615,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL61593,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL61593,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL617,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL621,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL621,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL621,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL621,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL621,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL622,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL623,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL623,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL623,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL623,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL625,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL626,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL628,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL629,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL629,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL629,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL631,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL631,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL632,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL632,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL632,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL633,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL633,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL633,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL633,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL633,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL633,N0000182138,"Cytochrome P450 1A2 Inhibitors",MOA +CHEMBL633,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL633,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL633,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL634,N0000175684,"Full Opioid Agonists",MOA +CHEMBL635,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL635,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL635,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL636,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL637,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL637,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL637,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL638,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL638,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL638,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL638,N0000185504,"Cytochrome P450 2C9 Inhibitors",MOA +CHEMBL639,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL64,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL640,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL641,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL641,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL642,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL642,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL643,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL643,N0000000230,"Dopamine Antagonists",MOA +CHEMBL6437,N0000000130,"Serotonin Antagonists",MOA +CHEMBL6437,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL6437,N0000009920,"Adrenergic alpha2-Antagonists",MOA +CHEMBL64391,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL64391,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL64391,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL64391,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL64391,N0000190113,"Breast Cancer Resistance Protein Inhibitors",MOA +CHEMBL644,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL644,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL644,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL645,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL645,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL646,N0000000118,"GABA A Modulators",MOA +CHEMBL647,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL647,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL647,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL648,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL648,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL649,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL649,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL649,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL650,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL650,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL650,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL651,N0000000174,"Opioid Agonists",MOA +CHEMBL651,N0000020015,"NMDA Receptor Antagonists",MOA +CHEMBL651,N0000175684,"Full Opioid Agonists",MOA +CHEMBL652,N0000000193,"Ion Channel Interactions",MOA +CHEMBL654,N0000000090,"Serotonin 5HT-3 Antagonists",MOA +CHEMBL654,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL654,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL654,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL654,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL654,N0000009920,"Adrenergic alpha2-Antagonists",MOA +CHEMBL655,N0000000118,"GABA A Modulators",MOA +CHEMBL656,N0000175684,"Full Opioid Agonists",MOA +CHEMBL657,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL65794,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL658,N0000175684,"Full Opioid Agonists",MOA +CHEMBL659,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL660,N0000000193,"Ion Channel Interactions",MOA +CHEMBL660,N0000000203,"Dopamine Receptor Interactions",MOA +CHEMBL660,N0000175542,"M2 Protein Inhibitors",MOA +CHEMBL661,N0000000118,"GABA A Modulators",MOA +CHEMBL661,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL6622,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL6622,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL6622,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL666,N0000000087,"Chelating Activity",MOA +CHEMBL666,N0000000103,"Reverse Transcriptase Inhibitors",MOA +CHEMBL666,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL667,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL667,N0000175369,"Cholinergic Agonists",MOA +CHEMBL668,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL668,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL668,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL669,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL669,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL671,N0000000236,"Alkylating Activity",MOA +CHEMBL672,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL677,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL679,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL679,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL679,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL679,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL680,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL681,N0000000118,"GABA A Modulators",MOA +CHEMBL681,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL684,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL684,N0000175955,"5-Lipoxygenase Inhibitors",MOA +CHEMBL685,N0000000085,"Receptor Interactions",MOA +CHEMBL685,N0000010256,"Tubulin Interactions",MOA +CHEMBL686,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL689,N0000010288,"Osmotic Activity",MOA +CHEMBL691,N0000000100,"Estrogen Receptor Agonists",MOA +CHEMBL692,N0000000075,"Stool Bulking Activity",MOA +CHEMBL695,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL696,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL696,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL6966,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL6966,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL6966,N0000020065,"L-Calcium Channel Receptor Antagonists",MOA +CHEMBL6966,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL6966,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL6966,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL697,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL698,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL6995,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL70,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL70,N0000175684,"Full Opioid Agonists",MOA +CHEMBL70,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL700,N0000009946,"Para-Aminobenzoic Acid Inhibitors",MOA +CHEMBL701,N0000000116,"GABA B Agonists",MOA +CHEMBL701,N0000000196,"GABA A Agonists",MOA +CHEMBL702,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL703,N0000175717,"Cholinergic Neuromuscular Nicotinic Agonists",MOA +CHEMBL704,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL704,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL70418,N0000000118,"GABA A Modulators",MOA +CHEMBL70418,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL70418,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL705,N0000000085,"Receptor Interactions",MOA +CHEMBL707,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL707,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL708,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL708,N0000000130,"Serotonin Antagonists",MOA +CHEMBL708,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL708,N0000000230,"Dopamine Antagonists",MOA +CHEMBL709,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL709,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL709,N0000182141,"Cytochrome P450 3A4 Inhibitors",MOA +CHEMBL70927,N0000000144,"Iron Chelating Activity",MOA +CHEMBL71,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL71,N0000000230,"Dopamine Antagonists",MOA +CHEMBL71,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL710,N0000000126,"5-alpha Reductase Inhibitors",MOA +CHEMBL712,N0000000164,"Vitamin K Epoxide Reductase Inhibitors",MOA +CHEMBL713,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL714,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL715,N0000000074,"GABA A Antagonists",MOA +CHEMBL715,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL715,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL715,N0000000130,"Serotonin Antagonists",MOA +CHEMBL715,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL715,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL715,N0000000230,"Dopamine Antagonists",MOA +CHEMBL71595,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL716,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL716,N0000000130,"Serotonin Antagonists",MOA +CHEMBL716,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL716,N0000000230,"Dopamine Antagonists",MOA +CHEMBL717,N0000000185,"Progestational Hormone Receptor Agonists",MOA +CHEMBL719,N0000175516,"RNA Synthetase Inhibitors",MOA +CHEMBL72,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL72,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL72,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL723,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL723,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL723,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL726,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL726,N0000000230,"Dopamine Antagonists",MOA +CHEMBL726,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL727,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL728,N0000000230,"Dopamine Antagonists",MOA +CHEMBL729,N0000000246,"HIV Protease Inhibitors",MOA +CHEMBL729,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL729,N0000190107,"Organic Anion Transporting Polypeptide 1B1 Inhibitors",MOA +CHEMBL729,N0000190114,"Cytochrome P450 3A Inhibitors",MOA +CHEMBL729,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL730,N0000000120,"Nitric Oxide Donors",MOA +CHEMBL730,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL730,N0000185499,"Guanylate Cyclase Activators",MOA +CHEMBL73234,N0000000085,"Receptor Interactions",MOA +CHEMBL734,N0000175087,"Urease Inhibitors",MOA +CHEMBL741,N0000000191,"Dihydrofolate Reductase Inhibitors",MOA +CHEMBL741,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL7413,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL742,N0000000117,"Dopamine Agonists",MOA +CHEMBL742,N0000020014,"Ionotropic Glutamate Receptor Antagonists",MOA +CHEMBL744,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL746,N0000000247,"Biological Response Modifiers",MOA +CHEMBL74632,N0000000163,"Enzyme Interactions",MOA +CHEMBL750,N0000000235,"Carbonic Anhydrase Inhibitors",MOA +CHEMBL750,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL750,N0000185503,"P-Glycoprotein Inhibitors",MOA +CHEMBL752,N0000000228,"Structural Macromolecules",MOA +CHEMBL752,N0000175788,"Adenosine Receptor Agonists",MOA +CHEMBL753,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL75435,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL76,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL760,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL760,N0000175086,"Phosphodiesterase 3 Inhibitors",MOA +CHEMBL761,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL762,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL76370,N0000000256,"Serotonin Agonists",MOA +CHEMBL76370,N0000175816,"Serotonin 4 Receptor Antagonists",MOA +CHEMBL765,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL765,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL766,N0000175513,"Dipeptidase Inhibitors",MOA +CHEMBL768,N0000000069,"Calcium Channel Antagonists",MOA +CHEMBL768,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL768,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL770,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL771,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL772,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL773,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL776,N0000009922,"Adrenergic beta2-Agonists",MOA +CHEMBL777,N0000000202,"beta Lactamase Inhibitors",MOA +CHEMBL778,N0000009917,"Adrenergic alpha1-Agonists",MOA +CHEMBL778,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL779,N0000020026,"Phosphodiesterase 5 Inhibitors",MOA +CHEMBL780,N0000000144,"Iron Chelating Activity",MOA +CHEMBL780,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL780,N0000020076,"Plutonium Chelating Activity",MOA +CHEMBL780,N0000175962,"Lead Chelating Activity",MOA +CHEMBL781,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL781,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL781,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL782,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL783,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL783,N0000175448,"Potassium Channel Antagonists",MOA +CHEMBL787,N0000000083,"Leukotriene Receptor Antagonists",MOA +CHEMBL788,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL79,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL790,N0000000065,"Physiochemical Activity",MOA +CHEMBL796,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL796,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL796,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL797,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL799,N0000175086,"Phosphodiesterase 3 Inhibitors",MOA +CHEMBL8,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL8,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL80,N0000000154,"Opioid Antagonists",MOA +CHEMBL802,N0000000211,"Potassium Channel Interactions",MOA +CHEMBL803,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL803,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL806,N0000000243,"Androgen Receptor Antagonists",MOA +CHEMBL807,N0000020015,"NMDA Receptor Antagonists",MOA +CHEMBL808,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL8085,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL809,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL809,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL81,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL810,N0000000236,"Alkylating Activity",MOA +CHEMBL811,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL811,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL813,N0000000070,"Angiotensin 2 Receptor Antagonists",MOA +CHEMBL814,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL814,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL817,N0000000225,"Insulin Receptor Agonists",MOA +CHEMBL819,N0000000231,"Enzyme Activators",MOA +CHEMBL819,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL820,N0000000236,"Alkylating Activity",MOA +CHEMBL821,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL822,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL826,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL827,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL827,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL827,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL829,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL83,N0000000168,"Selective Estrogen Receptor Modulators",MOA +CHEMBL830,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL830,N0000175844,"Decarboxylase Inhibitors",MOA +CHEMBL831,N0000000130,"Serotonin Antagonists",MOA +CHEMBL831,N0000000230,"Dopamine Antagonists",MOA +CHEMBL832,N0000000132,"Organic Anion Transporter Interactions",MOA +CHEMBL833,N0000009961,"Platelet Activating Factor Inhibitors",MOA +CHEMBL834,N0000009958,"Bone Surface Interactions",MOA +CHEMBL836,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL836,N0000009919,"Adrenergic alpha1-Antagonists",MOA +CHEMBL83668,N0000010265,"Squalene Monooxygenase Inhibitors",MOA +CHEMBL838,N0000000181,"Angiotensin-converting Enzyme Inhibitors",MOA +CHEMBL838,N0000191727,"Neprilysin Inhibitors",MOA +CHEMBL839,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL839,N0000009923,"Adrenergic beta1-Antagonists",MOA +CHEMBL839,N0000009924,"Adrenergic beta2-Antagonists",MOA +CHEMBL84,N0000000176,"Topoisomerase Inhibitors",MOA +CHEMBL841,N0000000174,"Opioid Agonists",MOA +CHEMBL842,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL844,N0000000209,"Adrenergic alpha-Agonists",MOA +CHEMBL844,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL846,N0000000163,"Enzyme Interactions",MOA +CHEMBL846,N0000000228,"Structural Macromolecules",MOA +CHEMBL847,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL848,N0000020085,"E3 Ubiquitin Ligase Inhibitors",MOA +CHEMBL849,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL85,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL85,N0000000130,"Serotonin Antagonists",MOA +CHEMBL85,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL85,N0000000230,"Dopamine Antagonists",MOA +CHEMBL850,N0000020086,"DNA Gyrase Inhibitors",MOA +CHEMBL852,N0000000236,"Alkylating Activity",MOA +CHEMBL853,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL855,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL855,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL856,N0000000105,"Neurotransmitter Transporter Interactions",MOA +CHEMBL857,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL857,N0000000163,"Enzyme Interactions",MOA +CHEMBL86,N0000000230,"Dopamine Antagonists",MOA +CHEMBL86,N0000175799,"Dopamine D2 Antagonists",MOA +CHEMBL861,N0000000180,"Sodium Channel Interactions",MOA +CHEMBL862,N0000009918,"Adrenergic alpha2-Agonists",MOA +CHEMBL864,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL864,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL865,N0000008288,"Cyclooxygenase 2 Inhibitors",MOA +CHEMBL866,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL867,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL86715,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL869,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL870,N0000009958,"Bone Surface Interactions",MOA +CHEMBL871,N0000009958,"Bone Surface Interactions",MOA +CHEMBL87493,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL87493,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL87493,N0000000198,"Serotonin Receptor Interactions",MOA +CHEMBL877,N0000010264,"Plasmin Inhibitors",MOA +CHEMBL878,N0000181005,"Sodium Chloride Symporter Inhibitors",MOA +CHEMBL87992,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL87992,N0000182140,"Cytochrome P450 2C19 Inhibitors",MOA +CHEMBL87992,N0000185506,"Cytochrome P450 3A4 Inducers",MOA +CHEMBL88,N0000000236,"Alkylating Activity",MOA +CHEMBL880,N0000020060,"DNA Polymerase Inhibitors",MOA +CHEMBL885,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL887,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL887,N0000175761,"Monoamine Oxidase-B Inhibitors",MOA +CHEMBL888,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL891,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL893,N0000010215,"Transpeptidase Inhibitors",MOA +CHEMBL894,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL894,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL894,N0000000114,"Dopamine Uptake Inhibitors",MOA +CHEMBL894,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL894,N0000182137,"Cytochrome P450 2D6 Inhibitors",MOA +CHEMBL895,N0000000174,"Opioid Agonists",MOA +CHEMBL895,N0000175685,"Partial Opioid Agonists",MOA +CHEMBL895,N0000175686,"Competitive Opioid Antagonists",MOA +CHEMBL89598,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL896,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL896,N0000000207,"Histamine Receptor Antagonists",MOA +CHEMBL897,N0000000132,"Organic Anion Transporter Interactions",MOA +CHEMBL898,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL9,N0000020087,"Topoisomerase 4 Inhibitors",MOA +CHEMBL9,N0000020088,"Topoisomerase 2 Inhibitors",MOA +CHEMBL900,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL902,N0000000151,"Histamine H2 Receptor Antagonists",MOA +CHEMBL905,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL905,N0000000256,"Serotonin Agonists",MOA +CHEMBL905,N0000175763,"Serotonin 1b Receptor Agonists",MOA +CHEMBL905,N0000175764,"Serotonin 1d Receptor Agonists",MOA +CHEMBL90593,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL908,N0000000099,"Adrenergic alpha-Antagonists",MOA +CHEMBL908,N0000000130,"Serotonin Antagonists",MOA +CHEMBL908,N0000000230,"Dopamine Antagonists",MOA +CHEMBL91,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL91,N0000020025,"14-alpha Demethylase Inhibitors",MOA +CHEMBL911,N0000000118,"GABA A Modulators",MOA +CHEMBL911,N0000000196,"GABA A Agonists",MOA +CHEMBL914,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL916,N0000009962,"Platelet Glycoprotein IIb/IIIA Inhibitors",MOA +CHEMBL917,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL918,N0000181004,"Sodium Channel Antagonists",MOA +CHEMBL92,N0000000150,"Protein Synthesis Inhibitors",MOA +CHEMBL92,N0000010256,"Tubulin Interactions",MOA +CHEMBL922,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL923,N0000009958,"Bone Surface Interactions",MOA +CHEMBL924,N0000009958,"Bone Surface Interactions",MOA +CHEMBL925,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL926,N0000000245,"Adrenergic beta-Agonists",MOA +CHEMBL926,N0000009921,"Adrenergic beta1-Agonists",MOA +CHEMBL927,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL93,N0000175955,"5-Lipoxygenase Inhibitors",MOA +CHEMBL930,N0000000142,"Biological Macromolecular Activity",MOA +CHEMBL931,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL932,N0000000128,"Phosphodiesterase Inhibitors",MOA +CHEMBL932,N0000000187,"Adenosine Deaminase Inhibitors",MOA +CHEMBL932,N0000175789,"Adenosine Receptor Antagonists",MOA +CHEMBL934,N0000175921,"Adrenal Steroid Synthesis Inhibitors",MOA +CHEMBL936,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL93645,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL93645,N0000175451,"Tumor Necrosis Factor Receptor Blocking Activity",MOA +CHEMBL939,N0000020010,"HER1 Antagonists",MOA +CHEMBL939,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL94,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL94,N0000175369,"Cholinergic Agonists",MOA +CHEMBL940,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL941,N0000020009,"Bcr-Abl Tyrosine Kinase Inhibitors",MOA +CHEMBL941,N0000175076,"Protein Kinase Inhibitors",MOA +CHEMBL942,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL945,N0000000238,"Sodium-Potassium Exchanging ATPase Interactions",MOA +CHEMBL946,N0000000140,"Calcium Channel Interactions",MOA +CHEMBL946,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL95,N0000000177,"Cholinesterase Inhibitors",MOA +CHEMBL951,N0000000205,"Radiopharmaceutical Activity",MOA +CHEMBL953,N0000175756,"Catechol O-Methyltransferase Inhibitors",MOA +CHEMBL956,N0000000160,"Cyclooxygenase Inhibitors",MOA +CHEMBL957,N0000175364,"Endothelin Receptor Antagonists",MOA +CHEMBL957,N0000185507,"Cytochrome P450 2C9 Inducers",MOA +CHEMBL957,N0000190118,"Cytochrome P450 3A Inducers",MOA +CHEMBL959,N0000000193,"Ion Channel Interactions",MOA +CHEMBL959,N0000175542,"M2 Protein Inhibitors",MOA +CHEMBL960,N0000000233,"Nucleic Acid Synthesis Inhibitors",MOA +CHEMBL963,N0000175684,"Full Opioid Agonists",MOA +CHEMBL963,N0000191866,"Opioid mu-Receptor Agonists",MOA +CHEMBL964,N0000000183,"Acetyl Aldehyde Dehydrogenase Inhibitors",MOA +CHEMBL965,N0000000104,"Cholinergic Muscarinic Agonists",MOA +CHEMBL965,N0000175369,"Cholinergic Agonists",MOA +CHEMBL967,N0000000118,"GABA A Modulators",MOA +CHEMBL968,N0000000118,"GABA A Modulators",MOA +CHEMBL969,N0000000118,"GABA A Modulators",MOA +CHEMBL970,N0000000118,"GABA A Modulators",MOA +CHEMBL972,N0000000184,"Monoamine Oxidase Inhibitors",MOA +CHEMBL972,N0000175761,"Monoamine Oxidase-B Inhibitors",MOA +CHEMBL973,N0000185501,"Dihydroorotate Dehydrogenase Inhibitors",MOA +CHEMBL976,N0000000140,"Calcium Channel Interactions",MOA +CHEMBL977,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL977,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL977,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL978,N0000000161,"Adrenergic beta-Antagonists",MOA +CHEMBL978,N0000175369,"Cholinergic Agonists",MOA +CHEMBL979,N0000009915,"Unknown Cellular or Molecular Interaction",MOA +CHEMBL98,N0000175071,"Histone Deacetylase Inhibitors",MOA +CHEMBL981,N0000175375,"Peroxisome Proliferator-activated Receptor alpha Agonists",MOA +CHEMBL982,N0000000154,"Opioid Antagonists",MOA +CHEMBL985,N0000000065,"Physiochemical Activity",MOA +CHEMBL989,N0000000134,"Lipoxygenase Inhibitors",MOA +CHEMBL989,N0000000159,"Glucocorticoid Receptor Agonists",MOA +CHEMBL989,N0000175450,"Corticosteroid Hormone Receptor Agonists",MOA +CHEMBL990,N0000009957,"Ergosterol Synthesis Inhibitors",MOA +CHEMBL991,N0000009947,"Nucleoside Reverse Transcriptase Inhibitors",MOA +CHEMBL996,N0000000133,"Enzyme Inhibitors",MOA +CHEMBL9967,N0000000125,"Cholinergic Muscarinic Antagonists",MOA +CHEMBL997,N0000009958,"Bone Surface Interactions",MOA +CHEMBL998,N0000000190,"Histamine H1 Receptor Antagonists",MOA +CHEMBL99946,N0000000102,"Norepinephrine Uptake Inhibitors",MOA +CHEMBL99946,N0000000109,"Serotonin Uptake Inhibitors",MOA +CHEMBL99946,N0000000184,"Monoamine Oxidase Inhibitors",MOA -- 2.24.1